
<html lang="en"     class="pb-page"  data-request-id="13330209-380d-4b0f-abdd-410efab179cb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2008.51.issue-18;ctype:string:Journal Content;article:article:10.1021/jm8004527;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase" /></meta><meta name="dc.Creator" content="Dirk A.  Heerding" /></meta><meta name="dc.Creator" content="Nelson  Rhodes" /></meta><meta name="dc.Creator" content="Jack D.  Leber" /></meta><meta name="dc.Creator" content="Tammy J.  Clark" /></meta><meta name="dc.Creator" content="Richard M.  Keenan" /></meta><meta name="dc.Creator" content="Louis V.  Lafrance" /></meta><meta name="dc.Creator" content="Mei  Li" /></meta><meta name="dc.Creator" content="Igor G.  Safonov" /></meta><meta name="dc.Creator" content="Dennis T.  Takata" /></meta><meta name="dc.Creator" content="Joseph W.  Venslavsky" /></meta><meta name="dc.Creator" content="Dennis S.  Yamashita" /></meta><meta name="dc.Creator" content="Anthony E.  Choudhry" /></meta><meta name="dc.Creator" content="Robert A.  Copeland" /></meta><meta name="dc.Creator" content="Zhihong  Lai" /></meta><meta name="dc.Creator" content="Michael D.  Schaber" /></meta><meta name="dc.Creator" content="Peter J.  Tummino" /></meta><meta name="dc.Creator" content="Susan L.  Strum" /></meta><meta name="dc.Creator" content="Edgar R.  Wood" /></meta><meta name="dc.Creator" content="Derek R.  Duckett" /></meta><meta name="dc.Creator" content="Derek  Eberwein" /></meta><meta name="dc.Creator" content="Victoria B.  Knick" /></meta><meta name="dc.Creator" content="Timothy J.  Lansing" /></meta><meta name="dc.Creator" content="Randy T.  McConnell" /></meta><meta name="dc.Creator" content="ShuYun  Zhang" /></meta><meta name="dc.Creator" content="Elisabeth A.  Minthorn" /></meta><meta name="dc.Creator" content="Nestor O.  Concha" /></meta><meta name="dc.Creator" content="Gregory L.  Warren" /></meta><meta name="dc.Creator" content="Rakesh  Kumar" /></meta><meta name="dc.Description" content="Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhib..." /></meta><meta name="Description" content="Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhib..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 23, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8004527" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8004527" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8004527" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8004527" /></link>
        
    
    

<title>Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8004527" /></meta><meta property="og:title" content="Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0001.jpeg" /></meta><meta property="og:description" content=" Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhibitors of AKT kinase activity might be useful as monotherapy for the treatment of tumors with activated AKT. Herein, we describe our lead optimization studies culminating in the discovery of compound 3g (GSK690693). Compound 3g is a novel ATP competitive, pan-AKT kinase inhibitor with IC50 values of 2, 13, and 9 nM against AKT1, 2, and 3, respectively. An X-ray cocrystal structure was solved with 3g and the kinase domain of AKT2, confirming that 3g bound in the ATP binding pocket. Compound 3g potently inhibits intracellular AKT activity as measured by the inhibition of the phosphorylation levels of GSK3β. Intraperitoneal administration of 3g in immunocompromised mice results in the inhibition of GSK3β phosphorylation and tumor growth in human breast carcinoma (BT474) xenografts." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8004527"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8004527">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8004527&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8004527&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8004527&amp;href=/doi/10.1021/jm8004527" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 5663-5679</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800456k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm8005838" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dirk+A.++Heerding">Dirk A. Heerding</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nelson++Rhodes">Nelson Rhodes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jack+D.++Leber">Jack D. Leber</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tammy+J.++Clark">Tammy J. Clark</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+M.++Keenan">Richard M. Keenan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis+V.++Lafrance">Louis V. Lafrance</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mei++Li">Mei Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Igor+G.++Safonov">Igor G. Safonov</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+T.++Takata">Dennis T. Takata</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+W.++Venslavsky">Joseph W. Venslavsky</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+S.++Yamashita">Dennis S. Yamashita</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+E.++Choudhry">Anthony E. Choudhry</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+A.++Copeland">Robert A. Copeland</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhihong++Lai">Zhihong Lai</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Schaber">Michael D. Schaber</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Tummino">Peter J. Tummino</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+L.++Strum">Susan L. Strum</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edgar+R.++Wood">Edgar R. Wood</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Derek+R.++Duckett">Derek R. Duckett</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Derek++Eberwein">Derek Eberwein</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Victoria+B.++Knick">Victoria B. Knick</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+J.++Lansing">Timothy J. Lansing</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Randy+T.++McConnell">Randy T. McConnell</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=ShuYun++Zhang">ShuYun Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisabeth+A.++Minthorn">Elisabeth A. Minthorn</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nestor+O.++Concha">Nestor O. Concha</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+L.++Warren">Gregory L. Warren</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rakesh++Kumar">Rakesh Kumar</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 610-917-7944. Fax: 610-917-4206. E-mail: <a href="/cdn-cgi/l/email-protection#c0a4a9b2abeea1eea8a5a5b2a4a9aea780a7b3abeea3afad"><span class="__cf_email__" data-cfemail="680c011a03460946000d0d1a0c01060f280f1b03460b0705">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Present address: Dana College, 2848 College Drive, Blair, NE 68008.</div><div class="corresp-fn" id="afn2">‡Present address: Drug Discovery, Scripps Florida, 5353 Parkside Drive, Jupiter, FL 33458.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8004527&amp;href=/doi/10.1021%2Fjm8004527" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 5663–5679</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 23, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 April 2008</li><li><span class="item_label"><b>Published</b> online</span>23 August 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 September 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8004527" title="DOI URL">https://doi.org/10.1021/jm8004527</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5663%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDirk%2BA.%2BHeerding%252C%2BNelson%2BRhodes%252C%2BJack%2BD.%2BLeber%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D18%26contentID%3Djm8004527%26title%3DIdentification%2Bof%2B4-%25282-%25284-Amino-1%252C2%252C5-oxadiazol-3-yl%2529-1-ethyl-7-%257B%255B%25283S%2529-3-piperidinylmethyl%255Doxy%257D-1H-imidazo%255B4%252C5-c%255Dpyridin-4-yl%2529-2-methyl-3-butyn-2-ol%2B%2528GSK690693%2529%252C%2Ba%2BNovel%2BInhibitor%2Bof%2BAKT%2BKinase%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5679%26publicationDate%3DSeptember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8004527"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5138</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">99</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8004527" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;A. Heerding&quot;},{&quot;first_name&quot;:&quot;Nelson&quot;,&quot;last_name&quot;:&quot;Rhodes&quot;},{&quot;first_name&quot;:&quot;Jack&quot;,&quot;last_name&quot;:&quot;D. Leber&quot;},{&quot;first_name&quot;:&quot;Tammy&quot;,&quot;last_name&quot;:&quot;J. Clark&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;M. Keenan&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;V. Lafrance&quot;},{&quot;first_name&quot;:&quot;Mei&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Igor&quot;,&quot;last_name&quot;:&quot;G. Safonov&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;T. Takata&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;W. Venslavsky&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;S. Yamashita&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;E. Choudhry&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;A. Copeland&quot;},{&quot;first_name&quot;:&quot;Zhihong&quot;,&quot;last_name&quot;:&quot;Lai&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Schaber&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Tummino&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;L. Strum&quot;},{&quot;first_name&quot;:&quot;Edgar&quot;,&quot;last_name&quot;:&quot;R. Wood&quot;},{&quot;first_name&quot;:&quot;Derek&quot;,&quot;last_name&quot;:&quot;R. Duckett&quot;},{&quot;first_name&quot;:&quot;Derek&quot;,&quot;last_name&quot;:&quot;Eberwein&quot;},{&quot;first_name&quot;:&quot;Victoria&quot;,&quot;last_name&quot;:&quot;B. Knick&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;J. Lansing&quot;},{&quot;first_name&quot;:&quot;Randy&quot;,&quot;last_name&quot;:&quot;T. McConnell&quot;},{&quot;first_name&quot;:&quot;ShuYun&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Elisabeth&quot;,&quot;last_name&quot;:&quot;A. Minthorn&quot;},{&quot;first_name&quot;:&quot;Nestor&quot;,&quot;last_name&quot;:&quot;O. Concha&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;L. Warren&quot;},{&quot;first_name&quot;:&quot;Rakesh&quot;,&quot;last_name&quot;:&quot;Kumar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;5663-5679&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8004527&quot;},&quot;abstract&quot;:&quot;Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhibitors of AKT kinase activity might be useful as monotherapy for the treatment of tumors with activated AKT. Herein, we describe our lead optimization studies culminating in the discovery of compound 3g (GSK690693). Compound 3g is a novel ATP competitive, pan-AKT kinase inhibitor with IC50 values of 2, 13, and 9 nM against AKT1, 2, and 3, respectively. An X-ray cocrystal structure was solved with 3g and the kinase domain of AKT2, confirming that 3g bound in the ATP binding pocket. Compound 3g potently inhibits intracellular AKT activity as measured by the inhibition of the phosphorylation levels of GSK3β. Intraperitoneal administration of 3g in immunocompromised mice results in the inhibition of GSK3β phosphorylation and tumor growth in human breast carcinoma (BT474) xenografts.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8004527&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8004527" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8004527&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8004527" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8004527&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8004527" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8004527&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8004527&amp;href=/doi/10.1021/jm8004527" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8004527" /></input><a href="/doi/pdf/10.1021/jm8004527" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (886 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8004527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8004527%26sid%3Dliteratum%253Aachs%26pmid%3D18800763%26genre%3Darticle%26aulast%3DHeerding%26date%3D2008%26atitle%3DIdentification%2Bof%2B4-%25282-%25284-Amino-1%252C2%252C5-oxadiazol-3-yl%2529-1-ethyl-7-%257B%255B%25283S%2529-3-piperidinylmethyl%255Doxy%257D-1H-imidazo%255B4%252C5-c%255Dpyridin-4-yl%2529-2-methyl-3-butyn-2-ol%2B%2528GSK690693%2529%252C%2Ba%2BNovel%2BInhibitor%2Bof%2BAKT%2BKinase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D18%26spage%3D5663%26epage%3D5679%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhibitors of AKT kinase activity might be useful as monotherapy for the treatment of tumors with activated AKT. Herein, we describe our lead optimization studies culminating in the discovery of compound <b>3g</b> (GSK690693). Compound <b>3g</b> is a novel ATP competitive, pan-AKT kinase inhibitor with IC<sub>50</sub> values of 2, 13, and 9 nM against AKT1, 2, and 3, respectively. An X-ray cocrystal structure was solved with <b>3g</b> and the kinase domain of AKT2, confirming that <b>3g</b> bound in the ATP binding pocket. Compound <b>3g</b> potently inhibits intracellular AKT activity as measured by the inhibition of the phosphorylation levels of GSK3β. Intraperitoneal administration of <b>3g</b> in immunocompromised mice results in the inhibition of GSK3β phosphorylation and tumor growth in human breast carcinoma (BT474) xenografts.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">AKT kinases have been implicated as key mediators of proliferation and survival pathways that are critical for cancer growth. As such, aberrant activation of AKT pathway has been observed in a variety of malignancies including breast, ovarian, prostate, pancreatic, and skin cancers. For example, increased AKT1 activity has been observed in about 40% of breast and ovarian cancers and >50% of prostate carcinomas. In addition, activation of AKT2 kinase has been observed in 30−40% of ovarian and pancreatic cancers whereas increased AKT3 enzymatic activity was found in estrogen-receptor-deficient breast cancer and androgen-insensitive prostate cancer cell lines. Furthermore, overexpression of AKT has an antiapoptotic effect in many cell types and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Perturbations in both positive and negative regulators of AKT activity commonly occur in human cancers.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> Phosphatase and tensin homologue deleted on chromosome 10 (PTEN), a critical negative regulator of AKT, is lost in many cancers, including breast and prostate carcinomas, glioblastomas, and several cancer syndromes including Bannayan−Zonana syndrome, Cowden disease, and Lhermitte−Duclos disease.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a></div><div class="NLM_p last">The importance of AKT mediated signaling in tumor proliferation and survival makes AKT kinases promising targets for therapeutic intervention.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Therefore, inhibitors of AKT kinase activity could be useful for the treatment of tumors with activated AKT. In fact, several small molecule AKT inhibitors have recently been reported.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> Herein, we describe our lead optimization studies, which starting from compounds <b>1</b> and <b>2</b>, culminated in the discovery of compound <b>3g</b> (GSK690693) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Compound <b>3g</b> is a novel ATP competitive, pan-AKT kinase inhibitor with IC<sub>50</sub> values of 2, 13, and 9 nM against AKT1, 2 and 3, respectively. Compound <b>3g</b> inhibits proliferation and induces apoptosis in a subset of tumor cells with activity that is consistent with intracellular inhibition of AKT kinase activity. Compound <b>3g</b> also demonstrated pharmacodynamic activity in vivo and has been shown to inhibit BT474 tumor xenograft growth in mice.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Compound <b>3g</b> is currently in clinical trials as an iv agent to treat patients with solid tumors or hematological malignancies.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>2</b> and <b>4</b>−<b>9</b> were prepared according to literature methods.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The remaining compounds were prepared according to Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>−<a class="ref internalNav" href="#sch6" aria-label="6">6</a>. The synthesis of compound <b>1</b> started from 3-bromo-<i>N</i>-ethyl-5-nitro-4-pyridinamine<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> (<b>15</b>) using established methods to append the 4-amino-1,2,5-oxadiazole.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a></div><div class="NLM_p">The synthesis of compound <b>10</b> and a key intermediate <b>26</b> was carried out as detailed in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Notable features include a tin(II) chloride mediated reduction of the nitro group in <b>15</b> with concomitant chlorination to give <b>22</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The 4-amino-1,2,5-oxadiazole moiety was introduced as noted above to give <b>26</b>. The phenol moiety in <b>28</b> was introduced by a selective halogen−metal exchange followed by reaction with trimethoxy borane and subsequent oxidation. Reaction with phenylboronic acids under Suzuki<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> conditions followed by a Mitsunobu reaction with 1,1-dimethylethyl (3-hydroxypropyl)carbamate gave <b>10</b> after removal of the protecting groups.</div><div class="NLM_p">The alkyne-containing analogues <b>12a</b>−<b>d</b> were synthesized in a similar manner starting from <b>26</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Subsequent to the preparation of <b>28</b>, we discovered that it was not necessary to protect the amino group in the 4-amino-1,2,5-oxadiazole moiety during the halogen−metal exchange reaction. Therefore, <b>26</b> was converted directly to the corresponding phenolic compound <b>29</b>. A Cs<sub>2</sub>CO<sub>3</sub>-mediated alkylation with the corresponding alkyl halide followed by a reaction of the product with an appropriate terminal acetylene under Sonogashira conditions<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> gave the penultimate products. Trifluoroacetic acid mediated deprotection gave the final compounds <b>12a</b>−<b>d</b>.</div><div class="NLM_p">The alkyne-containing analogues <b>3a</b>−<b>h</b> were also prepared from <b>29</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Compound <b>29</b> was alkylated with an appropriate Boc-protected alkyl chloride or bromide. A Sonogashira reaction with 2-methyl-3-butyn-2-ol followed by removal of the protecting group gave compounds <b>3a</b>−<b>h</b>.</div><div class="NLM_p">The heteroaryl containing analogues <b>11a</b>−<b>d</b> were prepared by reacting suitably protected arylboronic acids or esters with <b>30</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Removal of the protecting groups then furnished the final compounds.</div><div class="NLM_p">Compounds <b>14a</b>,<b>b</b> were prepared by first alkylating <b>29</b> with 1,3-dibromopropane to give <b>35</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Reaction with 4-methoxyphenethyl amine or (2<i>S</i>)-3-amino-1,2-propanediol followed by a Sonogashira reaction with 2-methyl-3-butyn-2-ol completed the syntheses.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0004.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compound <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Fe powder, AcOH, 75 °C, 1 h (93%); (b) ethyl cyanoacetate, 190 °C, 1 h (59%); (c) (i) NaNO<sub>2</sub>, MeOH; (ii) NH<sub>2</sub>OH/NaOH, 90 °C, 2 h (67%); (d) (Boc)<sub>2</sub>O, DMAP, pyridine, dichloroethane, 90 °C, 18 h (58%); (e) (i) <i>n</i>-BuLi, THF, −78 °C; (ii) B(OMe)<sub>3</sub>, THF, −78 °C to room temp, 1.5 h; (iii) H<sub>2</sub>O<sub>2</sub>/aq NaOH, room temp, 0.5 h (83%); (f) 1,1-dimethylethyl 4-hydroxy-1-piperidinecarboxylate, diethyl azadicarboxylate, polymer bound Ph<sub>3</sub>P, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1.5 h (43%); (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 40 min (97%).</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0005.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compound <b>10</b> and Key Intermediate <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SnCl<sub>2</sub>, HCl, room temp, 1 h (80%); (b) cyanoacetic acid, EDC, NMM, DMF, 0 °C to room temp, 3 h (quant); (c) AcOH, 90 °C, 1 h (88%); (d) NaNO<sub>2</sub>, HCl, room temp, 0.5 h (99%); (e) (i) aq NH<sub>2</sub>OH, Et<sub>3</sub>N, THF, 90 °C, 1.5 h; (ii) Et<sub>3</sub>N, dioxane, 150 °C, 1.5 h (52%); (f) (Boc)<sub>2</sub>O, pyridine, DMAP, dichloroethane, 85 °C, 1 h (78%); (g) (i) <i>n</i>-BuLi, THF, −100 °C; (ii) B(OMe)<sub>3</sub>, THF, −100 °C to room temp, 1.5 h; (iii) H<sub>2</sub>O<sub>2</sub>/NaOH, room temp, 1 h (84%); (h) PhB(OH)<sub>2</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, 18 h (75%); (i) 1,1-dimethylethyl (3-hydroxypropyl)carbamate, polymer-bound Ph<sub>3</sub>P, DEAD, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h; (j) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 2 h (27%, three steps).</p></p></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0006.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of compounds <b>12a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <i>n</i>-BuLi, THF, −100 °C; (ii) B(OMe)<sub>3</sub>, THF, −100 °C to room temp, 3 h; (iii) H<sub>2</sub>O<sub>2</sub>/NaOH, room temp, 45 min (59%); (b) 1,1-dimethylethyl (3-bromopropyl)carbamate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 35 °C, 15 h (77%); (c) H−C≡C−R, <i>i</i>-Pr<sub>2</sub>NH, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 110 °C, 2 h; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0007.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compounds <b>3a</b>−<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R-Br or R-Cl, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 35 °C, 15 h; (b) 2-methyl-3-butyn-2-ol, Pd(Ph<sub>3</sub>P)<sub>4</sub>, <i>i</i>-Pr<sub>2</sub>NH, dioxane, 110 °C, 2 h; (c) 2-methyl-3-butyn-2-ol, Pd(Ph<sub>3</sub>P)<sub>4</sub>, Zn dust, NaI, DBU, Et<sub>3</sub>N, DMSO, 80 °C, 3 h; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0008.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Compounds <b>11a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R-B(OH)<sub>2</sub> or R-(tetramethyldioxaborolane), Pd(Ph<sub>3</sub>P)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, 90 °C, 5 h; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (c) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (ii) <i>n</i>-Bu<sub>4</sub>NF, THF.</p></p></figure><figure id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0009.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Compounds <b>14a</b> and <b>14b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) 1,3-dibromopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 3.5 h, (67%); (b) R-NH<sub>2</sub>, Et<sub>3</sub>N, DMF, 60 °C, 30 min; (c) 2-methyl-3-butyn-2-ol, Pd(Ph<sub>3</sub>P)<sub>4</sub>, Zn dust, NaI, DBU, Et<sub>3</sub>N, DMSO, 80 °C, 3 h.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Lead Identification</h3><div class="NLM_p">The oxadiazole-containing compounds <b>1</b> and <b>2</b> were identified from the GSK compound collection as starting points for lead optimization, as both compounds were submicromolar inhibitors of AKT1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Furthermore, compounds structurally related to <b>1</b> and <b>2</b> have previously been described as ATP competitive inhibitors that bind in the ATP binding pocket of ROCK1 and MSK1 kinase.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> Not surprisingly, potent MSK1 and ROCK1 inhibition was also observed with <b>1</b> and <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Kinase Activity of Compounds <b>1</b> and <b>2</b> against AKT1, ROCK1, and MSK1</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">kinase</th><th align="center" valign="middle" char="."><b>1</b></th><th align="center" valign="middle" char="."><b>2</b></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">AKT1</td><td align="char" valign="top" char=".">0.120</td><td align="char" valign="top" char=".">0.355</td></tr><tr valign="top"><td align="left" valign="top">MSK1</td><td align="char" valign="top" char=".">0.021</td><td align="char" valign="top" char=".">0.015</td></tr><tr valign="top"><td align="left" valign="top">ROCK1</td><td align="char" valign="top" char=".">0.009</td><td align="char" valign="top" char=".">0.006</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Values are mean of two or more experiments.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Side Chain Modifications at Position-7 To Optimize AKT Potency</h3><div class="NLM_p">A model of <b>1</b> in the ATP binding pocket of AKT2 was generated on the basis of the published cocrystal structure of an activated form of the AKT kinase domain containing a S474D mutation with GSK3 peptide and AMP-PNP.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The amine side chain of <b>1</b> was in proximity to the side chain carboxylic acid of Glu236 and the backbone carbonyl of Glu279 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Initially, the lead optimization effort focused on increasing AKT kinase potency by varying the presentation of the amine-containing side chain to further optimize this interaction.</div><figure id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0002.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> modeled into AKT2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A spacer consisting of four or five atoms between the imidazopyridine core and the amino group gave analogues with low micromolar to submicromolar IC<sub>50</sub> values against the AKT isoforms (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). There was no obvious preference for a primary versus secondary amine. There was a trend toward poorer AKT activity in the amide series when the side chain was constrained into a ring (<b>2</b> versus <b>4</b>, <b>5</b>, <b>6</b>, and <b>8</b>). An ether link between the amine containing side chain and the imidazopyridine core consistently gave better AKT potency over the corresponding amide or alkylamine linked analogues (<b>1</b> versus <b>5</b>; <b>7</b> versus <b>8</b> or <b>9</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Position-7 Modification To Improve Potency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0010.gif" alt="" id="gr9" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0011.gif" alt="" id="_i14" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Rat ROCK1.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Back-Pocket Selectivity Element</h3><div class="NLM_p">While modifications at the 7-position of the imidazopyridine core influenced AKT activity, they had very little impact on kinase selectivity as measured by inhibition of MSK1 and ROCK1. Inspection of <b>1</b> docked into AKT2 revealed that the vector projecting from C4 of the imidazopyridine ring system was positioned to introduce a substituent into a pocket in the back cleft (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In AKT, a leucine residue lines the back of this pocket, whereas the corresponding residue in ROCK1 is a methionine. We reasoned that we could take advantage of this residue difference and improve selectivity for AKT by introducing a steric element at C4 of the imidazopyridine core.</div><div class="NLM_p">The side chain at C7 was fixed as an aminopropyl ether, while various groups were introduced at C4 of the imidazopyridine core (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In terms of AKT activity, there was a clear preference for five-membered over six-membered aryl rings in the back pocket (<b>11a</b>−<b>c</b> compared to <b>10</b>). The nature and position of heteroatoms within the five-membered ring aryl groups impacted AKT activity. For example, pyrrole-containing analogues (<b>11a</b> and <b>11c</b>) were slightly better inhibitors than the corresponding furanyl analogue <b>11b</b>. In contrast, the pyrazole substituent <b>11d</b> was not tolerated. Although AKT activity comparable to <b>1</b> and <b>7</b> could be maintained by introducing certain five-membered ring heteroaromatic groups at C4 of the imidazopyridine core, only modest improvements in kinase selectivity were achieved. We speculate that the five-membered heteroaryl rings did not penetrate deep enough into the back pocket to significantly impact the kinase selectivity with respect to ROCK1.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Back-Pocket Elements To Improve Selectivity<a class="ref internalNav" href="#tbl3-fn1" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0013.gif" alt="" id="gr10" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0012.gif" alt="" id="_i17" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn2"><div class="footnote" id="tbl3-fn2"><sup>a</sup><p class="last">Inhibition of phosphorylation of GSK3β in BT474 cells.</p></div><div class="footnote" id="tbl3-fn1"><sup>b</sup><p class="last">NT: not tested.</p></div></div></div><div class="NLM_p last">Closer inspection of the model of <b>1</b> in AKT2 revealed that the opening into the back pocket was narrow. We reasoned that an alkyne spacer would fit better through this opening and potentially allow a range of substituents to be introduced at the terminus of the triple bond to explore interactions within this pocket. Indeed, the cyclopropylalkyne <b>12a</b> retained AKT activity while significantly improving kinase selectivity against ROCK1 and RSK1. Introducing an alcohol at the terminus of the alkyne to give <b>12b</b> substantially boosted AKT activity over <b>12a</b> and further increased selectivity against ROCK and RSK1 by 83 and >200-fold, respectively. It was also clear that the geminal dimethyl groups contributed significantly to the selectivity (<b>12b</b> versus <b>12c</b>). Adding an extra methylene between the alkyne and the carbinol moiety (<b>12d</b>) was detrimental to AKT activity, as was the introduction of an amine (<b>13</b>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Side Chain Modification To Optimize Cell Potency</h3><div class="NLM_p">The compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were also evaluated for their ability to inhibit AKT-mediated phosphorylation of GSK3β in BT474 cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> By use of this assay, some of the more potent AKT analogues demonstrated low micromolar inhibition of GSK3β phosphorylation (<b>11a</b>, <b>11c</b>, and <b>12a</b>−<b>c</b>). Having identified the 2-methyl-3-butyn-2-ol group as a key kinase selectivity element, efforts were redirected to further SAR exploration around the amine-containing side chain at position-7 of the imidazopyridine core to try to increase cellular potency.</div><div class="NLM_p">In general, relatively minor changes in AKT activity and kinase selectivity were seen as a result of the structural modifications at R<sup>7</sup> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). However, these changes did impact cellular activity. For example, introducing a pendant aromatic ring (<b>3d</b> and <b>14a</b>) or including a cyclic constraint (<b>3f</b> and <b>3g</b>) led to an increase in the inhibition of GSK3β phosphorylation in BT474 cells over the simple linear side chain (<b>12b</b>). Incorporation of polar functionality into the amine-containing side chain, as exemplified by <b>14b</b>, was detrimental to cell activity overall.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Side Chain Modification To Improve Cell Potency<a class="ref internalNav" href="#tbl4-fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0014.gif" alt="" id="gr11" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0015.gif" alt="" id="_i20" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn2"><div class="footnote" id="tbl4-fn2"><sup>a</sup><p class="last">Inhibition of phosphorylation of GSK3β in BT474 cells.</p></div><div class="footnote" id="tbl4-fn3"><sup>b</sup><p class="last">Inhbition of proliferation.</p></div><div class="footnote" id="tbl4-fn1"><sup>c</sup><p class="last">NT: not tested.</p></div></div></div><div class="NLM_p last">As these compounds were shown to inhibit AKT-mediated phosphorylation of GSK3β in BT474 cells, they were also tested for their ability to inhibit cellular proliferation.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In fact, <b>3b</b>−<b>d</b>,<b>g</b>,<b>h</b> and <b>14a</b> inhibited proliferation of BT474<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and LNCaP<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> cells with submicromolar IC<sub>50</sub> values. The antiproliferative effects of these compounds against human foreskin fibroblast (HFF) cells were also measured and used as a surrogate for general cytotoxicity, as these are nontumor derived cells. Although the aminoethyl side chain analogue <b>3c</b> was potent in the BT474 and LNCaP proliferation assays, it exhibited a poorer window of selectivity against HFF cells. Therefore, compound <b>3g</b> was selected for further profiling, as it represented the best combination of cellular potency and selectivity within this set of analogues.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Biochemical Characterization of <b>3g</b></h3><div class="NLM_p">To estimate the selectivity of <b>3g</b>, we measured its ability to inhibit >250 in vitro expressed human protein kinases in either activity assays or binding assays.<a onclick="showRef(event, 'ref16 ref28'); return false;" href="javascript:void(0);" class="ref ref16 ref28">(16, 28)</a> IC<sub>50</sub> values were generated against 95 kinases. Kinases with IC<sub>50</sub> values less than 100 nM are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Compound <b>3g</b> is very selective for the AKT isoforms versus the majority of kinases in other families. It is also selective against some members of the AGC kinase family such as MSK1, ROCK1, and RSK1 but less so for other AGC kinases including PKA, PrkX, and PKC isozymes. The poorer selectivity for PKA, PrkX, and the PKC isozymes was not entirely surprising on the basis of the high degree of homology in the ATP binding pocket within these kinases. Other kinases inhibited by <b>3g</b> are AMPK and DAPK3 from the CAMK family and PAK4, 5, and 6 from the STE family.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Enzyme Activity of <b>3g</b> against Other Selected Protein Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">family</th><th align="center" valign="middle">kinase</th><th align="center" valign="middle" char="."><b>3g</b>, IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">AGC</td><td align="left" valign="top">AKT1</td><td align="char" valign="top" char=".">0.002</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">AKT2</td><td align="char" valign="top" char=".">0.013</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">AKT3</td><td align="char" valign="top" char=".">0.009</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PKA</td><td align="char" valign="top" char=".">0.024</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PKCη</td><td align="char" valign="top" char=".">0.002</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PKCθ</td><td align="char" valign="top" char=".">0.002</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PKCβ1</td><td align="char" valign="top" char=".">0.019</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PKCδ</td><td align="char" valign="top" char=".">0.014</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PKCε</td><td align="char" valign="top" char=".">0.021</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PKG1β</td><td align="char" valign="top" char=".">0.033</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PrkX</td><td align="char" valign="top" char=".">0.005</td></tr><tr valign="top"><td align="left" valign="top">CAMK</td><td align="left" valign="top">AMPK<a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a></td><td align="char" valign="top" char=".">0.050</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">DAPK3<a class="ref internalNav" href="#tbl5-fn3" aria-label="c">c</a></td><td align="char" valign="top" char=".">0.081</td></tr><tr valign="top"><td align="left" valign="top">STE</td><td align="left" valign="top">PAK4<a class="ref internalNav" href="#tbl5-fn3" aria-label="c">c</a></td><td align="char" valign="top" char=".">0.010</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PAK5<a class="ref internalNav" href="#tbl5-fn3" aria-label="c">c</a></td><td align="char" valign="top" char=".">0.052</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PAK6<a class="ref internalNav" href="#tbl5-fn3" aria-label="c">c</a></td><td align="char" valign="top" char=".">0.006</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">All IC<sub>50</sub> determinations were carried out with ATP concentration at <i>K</i><sub>m</sub>(app) ATP.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">Rat enzyme. All others are human enzymes.</p></div><div class="footnote" id="tbl5-fn3"><sup>c</sup><p class="last">Data are from binding assays. All other data are from activity assays.</p></div></div></div><div class="NLM_p">Some kinase inhibitors exhibit time-dependent or slow onset of inhibition of their target enzymes due to either slow on- or off-rate for binding.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The potency of such inhibitors can be grossly underestimated if the time-dependent inhibition is not properly accounted for.<a onclick="showRef(event, 'ref15 ref32'); return false;" href="javascript:void(0);" class="ref ref15 ref32">(15, 32)</a> To capture potential time-dependent inhibition, our normal IC<sub>50</sub> assays included a 30 min incubation of enzyme and compound prior to the initiation of the reaction with substrate addition.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> To understand whether <b>3g</b> inhibits the AKT enzymes in a time-dependent fashion, IC<sub>50</sub> values were determined with and without a 30 min preincubation step and found to decrease by 12- and 20-fold upon incubation with AKT1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) and AKT2,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> respectively. Because of the time dependence of inhibition, <b>3g</b> was tested for reversibility by rapidly diluting the E−I complex into a high concentration of ATP. Full activity was recovered with half-life values for dissociation of 38 and 30 min for AKT1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) and AKT2,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> respectively. To probe the mechanism of inhibition with respect to ATP, steady state IC<sub>50</sub> values were found to increase linearly with the ATP concentration; this pattern is consistent with an ATP competitive mechanism of inhibition for AKT1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C) and AKT2.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0016.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Kinetic characterization of <b>3g</b> against AKT1. (A) IC<sub>50</sub> of compound <b>3g</b> with (filled circles) and without (open circles) a preincubation with AKT1. (B) Recovery of enzymatic activity following rapidly diluting the preformed AKT1−<b>3g</b> complex into substrate mix. Filled circles represent the control reaction in the absence of <b>3g</b>, and open circles represent the dissociation of <b>3g</b> from AKT1. (C) IC<sub>50</sub> values of <b>3g</b> as a function of ATP concentration against AKT1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As <b>3g</b> is a potent inhibitor of AKT1 and AKT2 and since a nominal concentration of 10 nM AKT1 or AKT2 was used in the IC<sub>50</sub> assays, it was not clear whether the potency determined for <b>3g</b> reflected the fraction of the kinase that was capable of binding to the inhibitor or the true potency of the compound. By use of an assay format with lower concentration of the AKT enzymes (0.33, 1, and 0.2 nM of AKT1, 2, and 3, respectively) and a 1 h incubation, the <i>K</i><sub>i</sub>* of <b>3g</b> was determined to be 1, 4, and 13 nM toward AKT1, 2, and 3, respectively. The <i>K</i><sub>i</sub>* values determined for AKT1 and AKT2 were within 3-fold of their IC<sub>50</sub> values, indicating that the IC<sub>50</sub> values represented the true potency of this compound rather than the active fraction of enzyme.</div><div class="NLM_p last">Compound <b>3g</b> was also tested against the mouse AKT1 and 2 enzymes and was found to have very similar potency as against the human enzymes (data not shown).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Crystallography</h3><div class="NLM_p">Compound <b>3g</b> was successfully cocrystallized within the kinase domain of AKT2 (148−481).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The overall conformation of AKT2 in this structure is very similar to that of the kinase domain of activated AKT containing a S474D mutation (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1o6k">1o6k</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> As predicted from the docking studies, <b>3g</b> occupied the ATP binding pocket, making a key hydrogen bonding contact between N5 of the oxadiazole moiety and the backbone NH of Ala232 in the hinge binding region of AKT2 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Another key feature is an intramolecular hydrogen bond between N3 of the imidazopyridine ring and the exocyclic NH of the oxadiazole ring, keeping the two rings coplanar with respect to each other. The glycine rich loop (residues 158−165) is tucked down over the plane of the imidazopyridine ring, maximizing hydrophobic interactions between the kinase and the inhibitor. The piperidinyl side chain of <b>3g</b> is engaged in a hydrogen bond with the carboxylic acid side chain of Glu236 found in the substrate binding area. Another important interaction was the hydrogen bonding network between the backbone NH of Phe294 and the side chain carboxylic acid of Glu200 with the alkynol −OH. Interestingly, this hydroxyl group appears to have displaced a water molecule present in published structures of AKT2 crystallized with the nonhydrolyzable ATP mimetic AMP-PNP.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We speculate that the ability of <b>3g</b> to displace this water molecule may contribute to the observed time-dependent inhibition.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0017.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cocrystal structure of <b>3g</b> in AKT2(148−481). (A) Compound <b>3g</b> cocrystal structure in AKT2(148−481) with the glycine rich loop omitted for clarity. Hydrogen bonds are indicated as dotted lines. (B) Ribbon diagram representation of AKT2(148−481) cocrystallized with <b>3g</b>. Graphics were prepared using MOE 2006.08, Chemical Computing Group, Inc.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> In Vivo Characterization of <b>3g</b></h3><div class="NLM_p">In vivo characterization of <b>3g</b> showed that this compound effectively inhibited GSK3β phosphorylation in BT474 xenografts in a dose dependent fashion when analyzed 4 h following ip dosing in SCID mice (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). Dose dependent increases in blood glucose and insulin levels were also observed. We believe that this was due, in part, to the potent inhibition of AKT2 by <b>3g</b>, as this AKT isoform has been implicated in glucose homeostasis.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In a separate experiment, <b>3g</b> was found to significantly decrease GSK3β phosphorylation in BT474 tumor for up to 8 h after single ip dose in SCID mice at 20 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). Furthermore, daily dosing of <b>3g</b> (ip, 30 mg/kg) resulted in 64% inhibition of tumor growth compared to vehicle treated mice in BT474 xenografts. Details of the in vivo characterization of <b>3g</b> in xenograft models are described in a separate publication.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0018.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>3g</b> on GSK3β phosphorylation in BT474 xenografts. (A) Dose response effect of <b>3g</b> on GSK3β phosphorylation in BT474 tumors in female SCID mice analyzed 4 h following administration of <b>3g</b>. (B) Time course of inhibition on GSK3β phosphorylation in BT474 tumors in female SCID mice by <b>3g</b> dosed at 20 mg/kg (ip).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pharmacokinetic profiles of <b>3g</b> in rat, dog, and monkey were determined. Although <b>3g</b> had poor oral exposure in all three species, blood concentrations of approximately 3 μM could be achieved following iv administration of the compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). We have previously reported that this concentration of <b>3g</b> correlated with a sustained decrease of GSK3β phosphorylation in BT474 tumor xenografts.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Compound <b>3g</b> is also soluble in aqueous buffer (>5 mg/mL, sodium acetate buffer in 5% mannitol, pH 4). Therefore, an iv formulation of <b>3g</b> was selected for evaluation in patients with solid tumors or hematological malignancies.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Single Dose, iv, Pharmacokinetic Summary for <b>3g</b></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">species</th><th align="center" valign="middle" char=".">iv dose (mg/kg)</th><th align="center" valign="middle"><i>C</i><sub>max</sub> (μg/mL)</th><th align="center" valign="middle">AUC<sub>(0−inf)</sub>(μg·h)/mL)</th><th align="center" valign="middle">CL ((mL/min)/kg)</th><th align="center" valign="middle"><i>V</i><sub>ss</sub> (L/kg)</th><th align="center" valign="middle"><i>T</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">rat</td><td align="char" valign="top" char=".">10.6<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></td><td align="left" valign="top">2.13 ± 0.19</td><td align="left" valign="top">3.15 ± 0.32</td><td align="left" valign="top">56.7 ± 5.5</td><td align="left" valign="top">15.2 ± 1.3</td><td align="left" valign="top">8.92 ± 1.03</td></tr><tr valign="top"><td align="left" valign="top">dog</td><td align="char" valign="top" char=".">4.2<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></td><td align="left" valign="top">1.30 ± 0.11</td><td align="left" valign="top">2.01 ± 0.11</td><td align="left" valign="top">34.6 ± 2.0</td><td align="left" valign="top">5.29 ± 0.24</td><td align="left" valign="top">3.50 ± 0.33</td></tr><tr valign="top"><td align="left" valign="top">monkey</td><td align="char" valign="top" char=".">4.3<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></td><td align="left" valign="top">1.50 ± 0.10</td><td align="left" valign="top">3.25 ± 0.67</td><td align="left" valign="top">22.5 ± 4.3</td><td align="left" valign="top">6.54 ± 0.89</td><td align="left" valign="top">5.52 ± 0.43</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Vehicle: 0.9% saline.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">Vehicle: 1% DMSO and 20% Encapsin in saline.</p></div></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have described novel pyridylimidazole-oxadiazolyl amines as potent inhibitors of AKT1, 2, and 3. AKT kinase potency and selectivity were optimized guided by insights gleaned from a docking model of the lead structure <b>1</b> in AKT2. The validity of this model was subsequently verified by solving a cocrystal structure of <b>3g</b> bound within the kinase domain of AKT2 (148−481). Inhibition of AKT activity by <b>3g</b> was manifested in cells by the inhibition of phosphorylation of a downstream substrate of AKT (GSK3β) and inhibition of proliferation in cells with activated AKT. In immune compromised mice implanted with human breast carcinoma (BT474) xenografts, a single intraperitoneal administration of <b>3g</b> inhibited GSK3β phosphorylation in the tumor in a dose- and time-dependent manner. In addition, GSK3β phosphorylation in BT474 tumor xenografts showed >60% decrease for up to 8 h following a single dose of 20 mg/kg. Repeated daily ip administration of <b>3g</b> produced significant delay in tumor growth in mice bearing established human BT474 breast carcinoma xenografts.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Compound <b>3g</b> is currently in clinical development as an iv agent for use in patients with solid tumors or hematological malignancies.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All materials and reagents were used as is unless otherwise indicated. Air- or moisture-sensitive reactions were carried out under a nitrogen atmosphere. Microwave irradiation was carried out in a Personal Chemistry Emrys Optimizer microwave. Flash chromatography was performed using silica gel (EM Science, 230−400 mesh) under standard techniques or using silica gel cartridges (RediSep normal phase disposable flash columns) on an Isco CombiFlash. Preparative and analytical HPLC were carried out on Agilent 1100 series or Gilson 306 HPLC systems. Unless otherwise stated, the conditions for the preparative reverse phase HPLC purifications used YMC Combiscreen ODS-A 75 mm × 30 mm (30 mL/min; gradient, (A) acetonitrile−0.1%TFA, (B) water−0.1% TFA; 10−70% A during 10 min) with UV detection at 214. The <sup>1</sup>H NMR spectra were recorded at 400 MHz using a Bruker Avance 400 spectrometer. Chemical shifts are reported in parts per million (ppm) downfield of tetramethylsilane (δ scale). Multiplicity is indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). Coupling constants (<i>J</i>) are reported in hertz and refer to apparent multiplicities and not true coupling constants. Mass spectra were recorded on an Applied Biosystems MSD Sciex API 150EX single quadrupole mass spectrometer with an electrospray ionization (ESI) source. Elemental analyses were performed by Quantitative Technologies, Inc., Whitehouse, NJ.</div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-Bromo-<i>N</i><sup>4</sup>-ethylpyridine-3,4-diamine (<b>16</b>)</h3><div class="NLM_p last">A mixture of ethyl (3-bromo-5-nitropyridin-4-yl)amine (7.0 g, 28 mmol) and iron powder (9.51 g, 170 mmol, <50 μm mesh) in acetic acid (100 mL) was stirred at 75 °C for 1 h. The reaction mixture was allowed to cool to room temperature, then diluted with EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (1:4) and filtered through Celite. The filtrate was concentrated under reduced pressure. Flash chromatography (silica gel, 96:4 EtOAc/MeOH) afforded 5.68 g (93%) of <b>16</b>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 7.88 (s, 1 H), 7.77 (s, 1 H), 3.41 (q, <i>J</i> = 7.07 Hz, 2 H), 1.19 (t, <i>J</i> = 7.20 Hz, 3 H). MS <i>m</i>/<i>z</i> 216 [M + H]<sup>+</sup>.</div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (7-Bromo-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)acetonitrile (<b>17</b>)</h3><div class="NLM_p last">A solution of <b>16</b> (5.68 g, 26.3 mmol) in ethyl cyanoacetate (5.6 mL, 53 mmol) was stirred at 190 °C for 1 h. A precipitate was observed following cooling and the addition of EtOAc (50 mL). The solid was collected by filtration, washed with EtOAc, and then air-dried to afford 4.15 g (59%) of <b>17</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (s, 1 H), 8.48 (s, 1 H), 4.69 (s, 2 H), 4.46 (q, <i>J</i> = 7.07 Hz, 2 H), 1.39 (t, <i>J</i> = 7.20 Hz, 3 H). MS <i>m</i>/<i>z</i> 265 [M + H]<sup>+</sup>.</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-(7-Bromo-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i> ]pyridin-2-yl)[1,2,5]oxadiazolidin-3-ylamine (<b>18</b>)</h3><div class="NLM_p last">Sodium nitrite (1.67 g, 24.2 mmol) was added portionwise to a solution of <b>17</b> (3.20 g, 12.1 mmol) in methanol (40 mL). After being stirred for 2 h, the suspension was adjusted to pH 12 with 50% aqueous NaOH. Aqueous 50% NH<sub>2</sub>OH (33 mL) was added, and the mixture was stirred at 90 °C for 2 h. A precipitate was formed upon cooling to room temperature. The solid was collected by filtration to afford 2.50 g (67%) of <b>18</b>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 9.05 (s, 1 H), 8.56 (s, 1 H), 5.15 (q, <i>J</i> = 7.07 Hz, 2 H), 1.59 (t, <i>J</i> = 7.07 Hz, 3 H). MS <i>m</i>/<i>z</i> 309 [M + H]<sup>+</sup>.</div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> [4-(7-Bromo-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)furazan-3-yl]carbamic Acid <i>tert</i>-Butyl Ester (<b>19</b>)</h3><div class="NLM_p last">A solution of <b>18</b> (2.14 g, 6.95 mmol), di-<i>tert</i>-butyl dicarbonate (2.27 g, 10.4 mmol) and DMAP (0.85 g, 6.95 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and pyridine (20 mL) was stirred at 90 °C in a sealed tube for 2.5 h. More di-<i>tert</i>-butyl dicarbonate (2.27 g, 10.4 mmol) was added, and the mixture was stirred at 90 °C for an additional 18 h. The reaction was quenched by partitioning between EtOAc and water. The organic layer was washed with water, then brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the product was purified by flash chromatography (silica gel, 20% EtOAc/hexanes) to afford 1.60 g (58.4%) of <b>19</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.96 (s, 1 H), 8.47 (s, 1 H), 4.98 (q, <i>J</i> = 7.07 Hz, 2 H), 1.50 (t, <i>J</i> = 7.07 Hz, 3 H), 1.45 (s, 9 H). MS <i>m</i>/<i>z</i> 409 [M + H]<sup>+</sup>.</div></div><div id="sec2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> [4-(1-Ethyl-7- hydroxy-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)furazan-3-yl]carbamic Acid <i>tert</i>-Butyl Ester (<b>20</b>)</h3><div class="NLM_p last">To a solution of <b>19</b> (0.20 g, 0.50 mmol) in THF (4 mL) at −78 °C was added <i>n</i>-BuLi (0.5 mL, 2.5 M solution in hexane, 1.25 mmol). After 20 min at −78 °C, trimethyl borate (0.17 mL, 1.50 mmol) in THF (1 mL) was added. After the reaction was allowed to warm to room temperature over 1.5 h, a solution of 30% H<sub>2</sub>O<sub>2</sub> (1.10 mL) in 3 N NaOH (0.35 mL) was added and stirring continued at room temperature for 30 min. The reaction mixture was diluted with EtOAc and then extracted with 1 N NaOH. The combined aqueous extracts were acidified with 6 N HCl and then extracted with EtOAc. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure to afford 144 mg (83%) of <b>20</b> as an orange solid. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.62 (s, 1 H), 7.90 (s, 1 H), 5.04 (q, <i>J</i> = 7.07 Hz, 2 H), 1.59 (s, 9 H), 1.54−1.58 (m, 3 H). MS <i>m</i>/<i>z</i> 347 [M + H]<sup>+</sup>.</div></div><div id="sec2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-[2-(4-<i>tert</i>-Butoxycarbonylaminofurazan-3-yl)-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yloxy]piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>21</b>)</h3><div class="NLM_p last">To a stirred mixture of triphenylphosphine on polystyrene resin (2.40 g, 1.20 mmol/g, 2.88 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added 4-hydroxypiperidine-1-carboxylic acid <i>tert</i>-butyl ester (1.15 g, 5.76 mmol) followed by diethyl azodicarboxylate (0.45 mL, 2.88 mmol). After 10 min at room temperature, the mixture was cooled to 0 °C and a solution of <b>20</b> (0.20 g, 0.58 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was added. After 1.5 h at 0 °C the resin was removed by filtration and washed with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were washed with 1 N NaOH, then water and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the residue subjected to preparative HPLC to afford 131 mg (43%) of <b>21</b> as an off white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.84 (s, 1 H), 8.82 (s, 1 H), 8.07 (s, 1 H), 4.96 (q, <i>J</i> = 7.07 Hz, 2 H), 4.72−4.84 (m, 1 H), 3.61−3.79 (m, 2 H), 3.32−3.47 (m, 2 H), 2.02−2.16 (m, 2 H), 1.77−1.91 (m, 2 H), 1.55 (s, 9 H), 1.48 (t, <i>J</i> = 6.95 Hz, 3 H), 1.42 (s, 9 H). MS <i>m</i>/<i>z</i> 530 [M + H]<sup>+</sup>.</div></div><div id="sec2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-[1-Ethyl-7-(piperidin-4-yloxy)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl]furazan-3-ylamine, Trifluoroacetate (<b>1</b>)</h3><div class="NLM_p last">A solution of <b>21</b> (130 mg, 0.25 mmol) and TFA (0.75 mL) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) was stirred at room temperature for 40 min. The solvent was removed under reduced pressure and the residue subjected to preparative HPLC to afford 80 mg (97%) of <b>1</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O) δ 8.85 (s, 1 H), 8.30 (s, 1 H), 4.96−5.13 (m, 1 H), 4.84 (q, <i>J</i> = 6.82 Hz, 2 H), 3.22−3.35 (m, 2 H), 3.10−3.23 (m, 2 H), 2.19−2.32 (m, 2 H), 1.93−2.12 (m, 2 H), 1.47 (t, <i>J</i> = 7.07 Hz, 3 H). MS <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>. Anal. (C<sub>15</sub>H<sub>19</sub>N<sub>7</sub>O<sub>2</sub>·1.45C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>) calcd: C, 43.46; H, 4.17; N, 19.82. Found: C, 43.93; H, 4.13; N, 19.35.</div></div><div id="sec2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-Bromo-2-chloro-<i>N</i><sup>4</sup>-ethylpyridine-3,4-diamine (<b>22</b>)</h3><div class="NLM_p last">To a solution of ethyl (3-bromo-5-nitropyridin-4-yl)amine (22.0 g, 89.4 mmol) in concentrated HCl (250 mL) was added portionwise tin(II) chloride dihydrate (60.5 g, 270 mmol). The mixture was stirred at room temperature for 1 h and then poured into ice (300 g). EtOAc (500 mL) was added and the aqueous phase made basic with NaOH. The EtOAc extracts were sequentially washed with water, brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the residue was subjected to flash chromatography (silica gel, 25% EtOAc/hexanes) to afford 17.8 g (80%) of <b>22</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.64 (s, 1 H), 5.20 (s, 2 H), 4.86 (t, <i>J</i> = 6.6 Hz, 1 H), 3.23−3.40 (m, 2 H), 1.07 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 250 [M + H]<sup>+</sup>.</div></div><div id="sec2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-[5-Bromo-2-chloro-4-(ethylamino)-3-pyridinyl]-2-cyanoacetamide (<b>23</b>)</h3><div class="NLM_p last">To a solution of <b>22</b> (17.7 g, 70.9 mmol) in DMF (100 mL) at 0 °C was added cyanoacetic acid (9.06 g, 106 mmol), <i>N</i>-methylmorpholine (39 mL, 350 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (20.3 g, 106 mmol). The cooling bath was removed, and the mixture was stirred for 3 h. EtOAc (300 mL) was added, and the organic extracts were washed with water and then brine. The solvent was removed under reduced pressure to give a solid. Recrystallization from EtOAc/hexanes afforded 22.5 g (quantitative) of <b>23</b> as a white crystalline solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (s, 1 H), 8.12 (s, 1 H), 6.04 (t, <i>J</i> = 6.2 Hz, 1 H), 3.93 (s, 2 H), 3.38−3.52 (m, 2 H), 1.12 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 317 [M + H]<sup>+</sup>.</div></div><div id="sec2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (7-Bromo-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)acetonitrile (<b>24</b>)</h3><div class="NLM_p last">A solution of <b>23</b> (35.6 g, 112 mmol) in glacial acetic acid (300 mL) was heated to 90 °C. After 1 h, LC/MS analysis indicated that the reaction was complete. The solvent was removed under reduced pressure to give 29.5 g (87.8%) of <b>24</b> that was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (s, 1 H), 4.72 (s, 2 H), 4.49 (q, <i>J</i> = 7.3 Hz, 2 H), 1.40 (t, <i>J</i> = 7.2 Hz, 3 H). MS <i>m</i>/<i>z</i> 299 [M + H]<sup>+</sup>.</div></div><div id="sec2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (7-Bromo-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)hydroxyiminoacetonitrile (<b>25</b>)</h3><div class="NLM_p last">To a mixture of <b>24</b> (29.5 g, 98.0 mmol) in 2 N HCl (400 mL) at room temperature was added, portionwise over 20 min, sodium nitrite (14.0 g, 203 mmol). After the mixture was stirred for an additional 30 min, the resulting precipitate was isolated by filtration, washed with water, and dried to afford 32 g (99%) of <b>25</b> that was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 15.00 (s, 1 H), 8.41 (s, 1 H), 4.77 (q, <i>J</i> = 7.1 Hz, 2 H), 1.44 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 328 [M + H]<sup>+</sup>.</div></div><div id="sec2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-(7-Bromo-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-amine (<b>26</b>)</h3><div class="NLM_p last">A solution of the compound of <b>25</b> (32 g, 97 mmol), Et<sub>3</sub>N (40 mL), and 50% aqueous hydroxylamine (16 mL) in THF (250 mL) was heated to 90 °C in a sealed pressure vessel for 1.5 h. After cooling to room temperature, the mixture was poured into water and extracted with EtOAc. The combined organic extracts were washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure. The residue was dissolved in dioxane (200 mL) and Et<sub>3</sub>N (35 mL) and then heated to 150 °C in a sealed pressure vessel for 1.5 h. After the mixture was allowed to cool to room temperature, the solvent was removed under reduced pressure to give a solid. Recrystallization from CH<sub>2</sub>Cl<sub>2</sub> afforded 17.3 g (51.7%) of <b>26</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.45 (s, 1 H), 6.94 (s, 2 H), 4.93 (q, <i>J</i> = 7.1 Hz, 2 H), 1.51 (t, <i>J</i> = 7.1, 3 H). MS <i>m</i>/<i>z</i> 343 [M + H]<sup>+</sup>.</div></div><div id="sec2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1,1-Dimethylethyl [4-(7-Bromo-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-yl]carbamate (<b>27</b>)</h3><div class="NLM_p last">A solution of the compound of <b>26</b> (8.50 g, 24.7 mmol), pyridine (70 mL), di-<i>tert</i>-butyl dicarbonate (21.5 g, 98.8 mmol), and DMAP (3.01 g, 24.7 mmol) in 1,2-dichloroethane (140 mL) was stirred at 85 °C in a sealed flask for 1 h. The product mixture was partitioned between EtOAc and 1 N HCl. The layers were separated, and the organic extract was washed with 1 N HCl, brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure and the resulting solid triturated with EtOAc to afford <b>27</b> as a beige solid (5.06 g). The mother liquor was evaporated to dryness and treated with 2% trifluoroacetic acid in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) for 20 h. The reaction mixture was neutralized with saturated NaHCO<sub>3</sub>, washed with brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure and the residue was subjected to flash chromatagraphy (20% EtOAc/hexane, silica gel), affording an additional crop and giving a combined yield of 8.55 g (78%) of <b>27</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.46 (s, 1 H,) 8.49 (s, 1 H), 4.80 (q, <i>J</i> = 7.07 Hz, 2 H), 1.49 (t, <i>J</i> = 7.07 Hz, 3 H), 1.37 (s, 9 H). MS <i>m</i>/<i>z</i> 443 [M + H]<sup>+</sup>.</div></div><div id="sec2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1,1-Dimethylethyl [4-(4-Chloro-1-ethyl-7-hydroxy-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-yl]carbamate (<b>28</b>)</h3><div class="NLM_p last">To a solution of the compound of <b>27</b> (2.00 g, 4.51 mmol) in THF (60 mL), at −100 °C was added dropwise <i>n</i>-BuLi (4.50 mL, 2.5 M in hexane, 11.3 mmol). After 5 min, a solution of B(OMe)<sub>3</sub> (1.50 mL, 13.5 mmol) in THF (2 mL) was added. The cooling bath was removed after a further 10 min. After 1.5 h, 3 M NaOH (3 mL) and 30% w/w H<sub>2</sub>O<sub>2</sub> (9 mL) were added to the reaction. After an additioal 1 h, the reaction was quenched by adding EtOAc and washing sequentially with 1 N HCl, H<sub>2</sub>O, and brine and then drying over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the residue triturated with EtOAc to afford 1.45 g (84.5%) of <b>28</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.13 (s, 1 H,) 10.36 (s, 1 H), 7.80 (s, 1 H), 4.73 (q, <i>J</i> = 6.91 Hz, 2 H), 1.45 (t, <i>J</i> = 7.07 Hz, 3 H), 1.41 (s, 9 H). MS <i>m</i>/<i>z</i> 381 [M + H]<sup>+</sup>.</div></div><div id="sec2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-{7-[(3-Aminopropyl)oxy]-1-ethyl-4-phenyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl}-1,2,5-oxadiazol-3-amine, Bis-trifluoroacetate (<b>10</b>)</h3><div class="NLM_p">Compound <b>28</b> (1.40 g, 3.67 mmol), phenylboronic acid (0.90 g, 7.34 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.24 g) were added to 1,4-dioxane (40 mL) and 2 M Na<sub>2</sub>CO<sub>3</sub> (4.04 mL, 8.1 mmol). The reaction vessel was purged with nitrogen, sealed, and heated to 90 °C for 18 h. After the mixture was allowed to cool to room temperature, the solids were removed by filtration. The filtrate was concentrated under reduced pressure and the residue subjected to flash chromatography (75% EtOAc/hexanes, silica gel) to give 1.16 g (74.7%) of 1,1-dimethylethyl [4-(1-ethyl-7-hydroxy-4-phenyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-yl]carbamate. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.16 (d, <i>J</i> = 7.07 Hz, 2 H), 7.98 (s, 1 H), 7.54 (t, <i>J</i> = 7.58 Hz, 2 H), 7.44 (t, <i>J</i> = 7.33 Hz, 1 H), 5.05 (q, <i>J</i> = 6.91 Hz, 2 H), 1.54−1.59 (m, 12H). MS <i>m</i>/<i>z</i> 423 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a suspension of polymer-bound PPh<sub>3</sub> (0.87 g, 1.2 mmol/g loading, 1.05 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added 1,1-dimethylethyl (4-hydroxypropyl)carbamate (0.37 g, 2.10 mmol) and DEAD (0.16 mL, 1.05 mmol) dropwise. After 30 min, the suspension was cooled to 0 °C. A solution of 1,1-dimethylethyl [4-(1-ethyl-7-hydroxy-4-phenyl-1 <i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-yl]carbamate (0.09 g, 0.21 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added. After 1 h at 0 °C, solids were removed by filtration and exhaustively washed with CH<sub>2</sub>Cl<sub>2</sub>. The combined filtrates were concentrated under reduced pressure and the resulting residue was subjected to flash chromatography (35% EtOAc/hexane, silica gel) to give 1,1-dimethylethyl (4-{7-[(3-aminopropyl)oxy]-1-ethyl-4-phenyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl}-1,2,5-oxadiazol-3-yl)carbamate. This was used without further purification in the step below. MS <i>m</i>/<i>z</i> 580 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The 1,1-dimethylethyl (4-{7-[(3-aminopropyl)oxy]-1-ethyl-4-phenyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl}-1,2,5-oxadiazol-3-yl)carbamate was dissolved in TFA (1 mL) and CH<sub>2</sub>Cl<sub>2</sub> (2 mL). After 2 h, the solvent was removed under reduced pressure and the residue subjected to preparative reverse phase HPLC to give 37 mg (27%) of <b>10</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.30−8.36 (m, 1 H), 8.18−8.27 (m, 2 H), 7.67−7.79 (m, 3 H), 5.14 (q, <i>J</i> = 7.07 Hz, 2 H), 4.59 (t, <i>J</i> = 5.94 Hz, 2 H), 3.25−3.32 (m, 2 H), 2.35−2.48 (m, 2 H), 1.65 (t, <i>J</i> = 7.07 Hz, 3 H). MS <i>m</i>/<i>z</i> 380 [M + H]<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>21</sub>N<sub>7</sub>O<sub>2</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>) calcd: C, 45.48; H, 3.82; N, 16.14. Found: C, 45.77; H, 3.80; N, 16.22.</div></div><div id="sec2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-ol (<b>29</b>)</h3><div class="NLM_p last">A solution of <b>26</b> (2.00 g, 5.80 mmol) in THF (270 mL) was cooled to −100 °C under an atmosphere of nitrogen. <i>n</i>-Butyllithium (7.20 mL, 18.0 mmol, 2.5 M in hexanes) at −78 °C was added over 4 min using a syringe pump. After an additional 3 min at −100 °C, trimethyl borate (2.10 mL, 19.0 mmol) was added. The cooling bath was removed, and the mixture was allowed to warm to room temperature. After 3 h, a solution of 30% aqueous hydrogen peroxide (13 mL) in 3 M NaOH (4.3 mL) was added. After an additional 45 min, the reaction was quenched by partitioning between EtOAc and 1 N HCl. The aqueous layer was extracted with additional EtOAc, and the combined organic extracts were washed with water, brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the residue was triturated with 3% MeOH/CH<sub>2</sub>Cl<sub>2</sub> to give 0.96 g (59%) of <b>29</b> as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1 H), 7.79 (s, 1 H), 6.94 (br s, 2 H), 4.84 (q, <i>J</i> = 7.1 Hz, 2 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 281.2 [M + H]<sup>+</sup>.</div></div><div id="sec2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1,1-Dimethylethyl (3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}propyl)carbamate (<b>30</b>)</h3><div class="NLM_p last">To a stirred solution of <b>29</b> (250 mg, 0.89 mmol) in DMF (10 mL) at ambient temperature was added cesium carbonate (726 mg, 2.23 mmol) followed by 1,1-dimethylethyl (3-bromopropyl)carbamate (318 mg, 1.34 mmol). The reaction mixture was stirred under argon at 33 °C for 15 h, at which time it was diluted with ethyl acetate and washed with water. The combined aqueous washings were extracted with fresh ethyl acetate. The combined organic extracts were washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure to give a pale-yellow solid. The solid was suspended in a small volume of CH<sub>2</sub>Cl<sub>2</sub>/hexanes (2:1) and then isolated by filtration to afford 317 mg (77%) of pure <b>30</b> as an off-white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.97 (s, 1 H), 7.00 (t, <i>J</i> = 5.68 Hz, 1 H), 6.94 (s, 2 H), 4.83 (q, <i>J</i> = 6.99 Hz, 2 H), 4.28 (t, <i>J</i> = 5.81 Hz, 2 H), 3.18 (q, <i>J</i> = 6.48 Hz, 2 H), 1.90−2.00 (m, 2 H), 1.46 (t, <i>J</i> = 7.07 Hz, 3 H), 1.36 (s, 9 H).</div></div><div id="sec2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1,1-Dimethylethyl {4-[4-(Cyclopropylethynyl)-1-ethyl-7-hydroxy-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl]-1,2,5-oxadiazol-3-yl}carbamate (<b>31a</b>)</h3><div class="NLM_p last">Ethynylcyclopropane (70% in toluene) (0.55 mL, 4.07 mmol) and diisopropylamine (0.60 mL, 4.24 mmol) were added to a solution of <b>30</b> (150 mg, 0.34 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (60 mg, 0.052 mmol) in dioxane (6.0 mL). The reaction vessel was sealed and heated to 110 °C for 2 h. After the mixture was cooled to room temperature, the solvent was removed under reduced pressure and the residue was subjected to flash chromatography (silica gel, 0.5% to 10% methanol/chloroform) to afford 160 mg of <b>31a</b> (>80% pure by HPLC analysis). This material was used without further purification. MS <i>m</i>/<i>z</i> 468.4 [M + H]<sup>+</sup>.</div></div><div id="sec2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-[7-[(3-Aminopropyl)oxy]-4-(cyclopropylethynyl)-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl]-1,2,5-oxadiazol-3-amine, Bis-trifluoroacetate (<b>12a</b>)</h3><div class="NLM_p last">Trifluoracetic acid (1.6 mL) was added to a solution of <b>31a</b> (160 mg, 0.343 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.5 mL). After 1 h, the solvent was removed under reduced pressure and the residue was subjected to reverse phase HPLC to afford 60 mg of <b>12a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (s, 1 H), 7.81 (br s, 3 H), 7.01 (br s, 2 H), 4.82 (q, <i>J</i> = 6.8 Hz, 2 H), 4.40 (t, <i>J</i> = 5.8 Hz, 2 H), 3.04 (m, 2 H), 2.14 (m, 2 H), 1.70 (m, 1 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H), 1.00 (m, 2 H), 0.82 (m, 2 H). MS <i>m</i>/<i>z</i> 368.0 [M + H]<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>21</sub>N<sub>7</sub>O<sub>2</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) calcd: C, 43.72; H, 4.00; N, 16.22. Found: C, 43.69; H, 3.75; N, 16.05.</div></div><div id="sec2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-7-[(3-aminopropyl)oxy]-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl}-2-methyl-3-butyn-2-ol, Bis-trifluoroacetate (<b>12b</b>)</h3><div class="NLM_p last">Compound <b>12b</b> was prepared in a manner analogous to the preparation of <b>12a</b> by substituting 2-methyl-3-butyn-2-ol (0.35 mL, 3.60 mmol) for ethynylcyclopropane. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1 H), 7.82 (br s, 3 H), 7.06 (s, 2 H), 4.84 (q, <i>J</i> = 7.0 Hz, 2 H), 4.41 (t, <i>J</i> = 5.8 Hz, 2 H), 3.05 (m, 2 H), 2.15 (m, 2 H), 1.53 (s, 6 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 385.9 [M + H]<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>23</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>) calcd: C, 43.07; H, 4.11; N, 15.98. Found: C, 42.74; H, 4.31; N, 16.06.</div></div><div id="sec2_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-7-[(3-aminopropyl)oxy]-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl}-2-propyn-1-ol, Bis-trifluoroacetate (<b>12c</b>)</h3><div class="NLM_p last">Compound <b>12c</b> was prepared in a manner analogous to the preparation of <b>12a</b> by substituting (1,1-dimethylethyl)(dimethyl)(2-propyn-1-yloxy)silane (1.90 mL, 9.00 mmol) for ethynylcyclopropane and using dimethylformamide (30%v/v) as a cosolvent. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.19 (s, 1 H), 7.83 (br s, 3 H), 6.98 (br s, 2 H), 4.83 (q, <i>J</i> = 7.0 Hz, 2 H), 4.42 (m, 4 H), 3.05 (m, 2 H), 2.15 (m, 2 H), 1.46 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 357.8 [M + H]<sup>+</sup>. Anal. (C<sub>16</sub>H<sub>19</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>) calcd: C, 41.03; H, 3.62; N, 16.75. Found: C, 41.10; H, 3.59; N, 16.97.</div></div><div id="sec2_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-7-[(3-aminopropyl)oxy]-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl}-3-butyn-1-ol, Bis-trifluoroacetate (<b>12d</b>)</h3><div class="NLM_p last">Compound <b>12d</b> was prepared in a manner analogous to the preparation of <b>12a</b> by substituting 3-butyn-1-ol (0.35 mL, 4.60 mmol) for ethynylcyclopropane. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.15 (s, 1 H), 7.83 (br s, 3 H), 6.98 (br s, 2 H), 4.83 (q, <i>J</i> = 7.1 Hz, 2 H), 4.40 (t, <i>J</i> = 5.9 Hz, 2 H), 3.66 (t, <i>J</i> = 6.8 Hz, 2 H), 3.05 (m, 2 H), 2.69 (t, <i>J</i> = 6.8 Hz, 2 H), 2.15 (m, 2 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 371.7 [M + H]<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>21</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) calcd: C, 41.45; H, 3.98; N, 16.11. Found: C, 41.56; H, 3.72; N, 15.86.</div></div><div id="sec2_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-[7-[(3-Aminopropyl)oxy]-4-(3-amino-1-propyn-1-yl)-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl]-1,2,5-oxadiazol-3-amine, Tris-trifluoroacetate (<b>13</b>)</h3><div class="NLM_p">A reaction vessel was charged with <b>30</b> (0.22 g, 0.50 mmol), 1,1-dimethylethyl 2-propyn-1-ylcarbamate (0.39 g, 2.51 mmol), zinc powder (9.9 mg, 0.15 mmol), NaI (23.0 mg, 0.15 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (58.0 mg, 0.05 mmol), Et<sub>3</sub>N (0.21 mL, 1.51 mmol), DBU (0.23 mL, 1.51 mmol), and DMSO (5 mL). The reaction vessel was purged with nitrogen, sealed, and heated in an oil bath at 85 °C for 2 h. The reaction was quenched by pouring into saturated NH<sub>4</sub>Cl, and the aqueous layer was extracted with ethyl acetate. The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give a dark oil. This was subjected to flash chromatography (1% NH<sub>4</sub>OH/9% MeOH/90% CHCl<sub>3</sub> to 100% CHCl<sub>3</sub>, silica gel) to give 0.24 g of 1,1-dimethylethyl [3-(2-(4-amino-1,2,5-oxadiazol-3-yl)-7-{[3-({[(1,1-dimethylethyl)oxy]carbonyl}amino)propyl]oxy}-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-propyn-1-yl]carbamate that was used without further purification. MS <i>m</i>/<i>z</i> 556.9 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To the (1,1-dimethylethyl [3-(2-(4-amino-1,2,5-oxadiazol-3-yl)-7-{[3-({[(1,1-dimethylethyl)oxy]carbonyl}amino)propyl]oxy}-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-propyn-1-yl]carbamate) obtained above were added dichloromethane (4 mL) and trifluoroacetic acid (1.60 mL). After the mixture was stirred at room temperature for 3 h, the solvent was removed under reduced pressure. The residue was subjected to reverse phase HPLC purification to give 0.12 g of <b>13</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (br s, 3 H), 8.22 (s, 1 H), 7.91 (br s, 3 H), 6.96 (br s, 2 H), 4.84 (q, <i>J</i> = 6.8 Hz, 2 H), 4.43 (t, <i>J</i> = 5.8 Hz, 2 H), 4.18 (d, <i>J</i> = 5.3 Hz, 2 H), 3.05 (m, 2 H), 2.15 (m, 2 H), 1.46 (t, <i>J</i> = 6.9 Hz, 3 H). MS <i>m</i>/<i>z</i> 357.1 [M + H]<sup>+</sup>. Anal. (C<sub>16</sub>H<sub>20</sub>N<sub>8</sub>O<sub>2</sub>·3C<sub>2</sub>H<sub>1</sub>F<sub>3</sub>O<sub>2</sub>·0.75H<sub>2</sub>O) calcd: C, 37.11; H, 3.47; N, 15.74. Found: C, 37.26; H, 3.19; N, 15.41.</div></div><div id="sec2_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-[7-[(4-Aminobutyl)oxy]-2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl]-2-methyl-3-butyn-2-ol, Bis-trifluoroacetate (<b>3a</b>)</h3><div class="NLM_p last">Compound <b>3a</b> was prepared in a manner analogous to the preparation of <b>12a</b> by substituting 2-methyl-3-butyn-2-ol (1.00 mL, 11.0 mmol) for ethynylcyclopropane and 1,1-dimethylethyl (4-iodobutyl)carbamate (640 mg. 2.14 mmol) for 1,1-dimethylethyl (3-bromopropyl)carbamate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.18 (s, 1 H), 7.72 (br s, 3 H), 7.05 (s, 2 H), 4.84 (q, <i>J</i> = 7.0 Hz, 2 H), 4.35 (t, <i>J</i> = 6.2 Hz, 2 H), 2.92 (m, 2 H), 1.92 (m, 2 H), 1.76 (m, 2 H), 1.54 (s, 6 H), 1.46 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 399.9 [M + H]<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>25</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·H<sub>2</sub>O) calcd: C, 42.80; H, 4.53; N, 15.19. Found: C, 42.79; H, 4.41; N, 15.10.</div></div><div id="sec2_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(4-piperidinylmethyl)oxy]-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl}-2-methyl-3-butyn-2-ol, Bis-trifluoroacetate (<b>3b</b>)</h3><div class="NLM_p last">Compound <b>3b</b> was prepared in a manner analogous to the preparation of <b>12a</b> by substituting 2-methyl-3-butyn-2-ol (211 mg, 2.51 mmol) for ethynylcyclopropane and 1,1-dimethylethyl 4-(bromomethyl)-1-piperidinecarboxylate (690 mg. 2.49 mmol) for 1,1-dimethylethyl (3-iodopropyl)carbamate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61 (br s, 1 H), 8.40 (br s, 1 H), 8.18 (s, 1 H), 7.06 (br s, 2 H), 4.85 (q, <i>J</i> = 7.0 Hz, 2 H), 4.25 (d, <i>J</i> = 5.8 Hz, 2 H), 3.37 (m, 2 H), 2.98 (m, 2 H), 2.21 (m, 1 H), 1.98 (m, 2 H), 1.59 (m, 8 H), 1.46 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 426.1 [M + H]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>27</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) calcd: C, 45.32; H, 4.56; N, 14.80. Found: C, 45.32; H, 4.47; N, 14.71.</div></div><div id="sec2_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1,1-Dimethylethyl (2-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}ethyl)carbamate (<b>32c</b>)</h3><div class="NLM_p last">A mixture of <b>29</b> (130 mg, 0.46 mmol) with Cs<sub>2</sub>CO<sub>3</sub> (377 mg, 1.16 mmol) in DMF (4 mL) was stirred at room temperature for 20 min. To this was added 1,1-dimethylethyl (2-bromoethyl)carbamate (531 mg, 2.37 mmol), and stirring continued at room temperature for 18 h. The product mixture was partitioned between water (15 mL) and EtOAc (25 mL). The organic extract was washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed. The residue was triturated in cyclohexane (15 mL) and the solid collected to afford 163 mg (83%) of <b>32c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01 (s, 1 H), 7.16 (t, <i>J</i> = 5.7 Hz, 1H), 6.94 (s, 2 H), 4.84 (q, <i>J</i> = 6.8 Hz, 2 H), 4.28 (t, <i>J</i> = 4.9 Hz, 2 H), 3.45 (q, <i>J</i> = 5.0 Hz, 2 H), 1.43 (t, <i>J</i> = 7.0 Hz, 3 H), 1.38 (s, 9 H). MS <i>m</i>/<i>z</i> 424 [M + H]<sup>+</sup>.</div></div><div id="sec2_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1,1-Dimethylethyl (2-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methyl-1-butyn-1-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}ethyl)carbamate (<b>33c</b>)</h3><div class="NLM_p last">In a thick wall pressure tube, a mixture consisting of <b>32c</b> (0.150 g, 0.35 mmol), 2-methyl-3-butyn-2-ol (0.089 g, 1.06 mmol), zinc (4.05 mg, 0.062 mmol), sodium iodide (9.28 mg, 0.062 mmol), DBU (0.080 mL, 0.53 mmol), TEA (0.074 mL, 0.53 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.016 g, 0.014 mmol) in DMSO (2 mL) was purged with AR, sealed, then heated with stirring at 80 °C for 3 h. Water (5 mL) and EtOAc (7 mL) were added, and the mixture was filtered. The residue was triturated in EtOAc, and the solid was collected to afford 92 mg (55%) of <b>33c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1 H), 7.15 (t, <i>J</i> = 5.7 Hz, 1 H), 7.05 (s, 2 H), 5.67 (s, 1 H), 4.85 (q, <i>J</i> = 7.0 Hz, 2 H), 4.31 (t, <i>J</i> = 5.2 Hz, 2 H), 3.46 (q, <i>J</i> = 5.2 Hz, 2 H), 1.54 (s, 6 H), 1.42 (t, <i>J</i> = 7.1 Hz, 3 H), 1.38 (s, 9 H). MS <i>m</i>/<i>z</i> 472 [M + H]<sup>+</sup>.</div></div><div id="sec2_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-[7-[(2-Aminoethyl)oxy]-2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl]-2-methyl-3-butyn-2-ol, Trifluoroacetate (<b>3c</b>)</h3><div class="NLM_p last">A solution of <b>33c</b> (75 mg, 0.16 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.7 mL) with TFA (0.3 mL, 3.89 mmol) was stirred at room temperature for 1 h. Toluene (2 mL) was added, and all volatiles were removed at reduced pressure. The residue was subjected to reverse phase HPLC, and the product-containing fractions were collected and evaporated to dryness. The residue was sequentially triturated in EtOAc and water to give 41 mg (53%) of <b>3c</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.22 (s, 1 H), 8.05 (s, 3 H), 7.06 (s, 2 H), 5.68 (s, 1 H), 4.90 (q, <i>J</i> = 7.1 Hz, 2 H), 4.54 (t, <i>J</i> = 4.9 Hz, 2 H), 3.35 (t, <i>J</i> = 4.8 Hz, 2 H), 1.54 (s, 6 H), 1.44 (t, <i>J</i> = 7.0 Hz, 3 H). MS <i>m</i>/<i>z</i> 372 [M + H]<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>21</sub>N<sub>7</sub>O<sub>3</sub>·C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) calcd: C, 46.16; H, 4.69; N, 19.83. Found: C, 46.49; H, 4.37; N, 19.65.</div></div><div id="sec2_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1,1-Dimethylethyl [(1<i>S</i>)-3-Hydroxy-1-(phenylmethyl)propyl]carbamate</h3><div class="NLM_p last">To a 0 °C solution of (3<i>S</i>)-3-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-4-phenylbutanoic acid (1.35 g, 4.83 mmol) in THF (27 mL) was added BH<sub>3</sub>·THF complex (1.0 M in tetrahydrofuran, 24.2 mL, 24.2 mmol) via syringe over a period of 1−2 min. The reaction mixture was stirred between 0 and 5 °C for 5 h. The reaction was quenched by careful addition of 9:1 methanol/acetic acid (25 mL) followed by stirring at ambient temperature for 15 min. Solvents were removed in vacuo, and the crude residue was redissolved in ethyl acetate (50 mL). The organic phase was washed with saturated aqueous NaHCO<sub>3</sub> and brine and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure and the residue was subjected to flash chromatography (silica gel, 30%−50% ethyl acetate/hexanes) to provide 700 mg (52%) of the desired material as a clear, viscous oil that crystallized on standing to a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.27−7.35 (m, 2 H), 7.14−7.26 (m, 3 H), 4.46 (br s, 1 H), 3.98−4.19 (m, 1 H), 3.53−3.78 (m, 2 H), 2.82 (d, <i>J</i> = 6.57 Hz, 2 H), 1.77−1.93 (m, 1 H), 1.42 (s, 9 H).</div></div><div id="sec2_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1,1-Dimethylethyl [(1<i>S</i>)-3-Bromo-1-(phenylmethyl)propyl]carbamate</h3><div class="NLM_p last">A solution of 1,1-dimethylethyl [(1<i>S</i>)-3-hydroxy-1-(phenylmethyl)propyl]carbamate (700 mg, 2.64 mmol) and carbon tetrabromide (1.14 g, 3.43 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was cooled to 0 °C and treated with triphenylphosphine (969 mg, 3.69 mmol) in one portion. After the mixture was stirred at 0 °C for 2 h, the solvent was removed under reduced pressure. Purification by flash chromatography (silica gel, 10%−30% ethyl acetate/hexanes) gave 559 mg (61%) of the desired material as a white fluffy powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28−7.43 (m, 2 H), 7.13−7.27 (m, 3 H), 3.87−4.03 (m, 1 H), 3.33−3.54 (m, 2 H), 2.82−2.96 (m, 1 H), 2.73−2.82 (m, 1 H), 2.01−2.17 (m, 1 H), 1.81−2.01 (m, 1 H), 1.41 (s, 9 H).</div></div><div id="sec2_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1,1-Dimethylethyl [(1<i>S</i>)-3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}-1-(phenylmethyl)propyl]carbamate (<b>32d</b>)</h3><div class="NLM_p last">To a stirred solution of <b>29</b> (214 mg, 0.76 mmol) in DMF (5 mL) at ambient temperature was added cesium carbonate (621 mg, 1.91 mmol) followed by 1,1-dimethylethyl [(1<i>S</i>)-3-bromo-1-(phenylmethyl)propyl]carbamate (250 mg, 0.76 mmol). The reaction mixture was stirred under argon at 33 °C for 19 h, at which time it was diluted with ethyl acetate and washed with water. The combined aqueous washings were extracted with fresh ethyl acetate. The combined organic extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resultant residue was subjected to flash chromatography (silica gel, 25%−50% ethyl acetate/hexanes) to afford 350 mg (83%) of <b>32d</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (s, 1 H), 7.28−7.35 (m, 2 H), 7.17−7.27 (m, 3 H), 5.97 (s, 2 H), 4.76−4.92 (m, 2 H), 4.67 (d, <i>J</i> = 8.34 Hz, 1 H), 4.17−4.33 (m, 2 H), 2.89−3.06 (m, 1 H), 2.80 (dd, <i>J</i> = 13.26, 7.71 Hz, 1 H), 2.10−2.23 (m, 1 H), 1.81−1.94 (m, 1 H), 1.31−1.43 (m, 12 H).</div></div><div id="sec2_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1,1-Dimethylethyl [(1<i>S</i>)-3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methyl-1-butyn-1-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}-1-(phenylmethyl)propyl]carbamate (<b>33d</b>)</h3><div class="NLM_p last">A mixture of <b>32d</b> (0.19 mL, 1.99 mmol), Et<sub>3</sub>N (0.55 mL, 3.98 mmol), DBU (0.20 mL, 1.33 mmol), zinc dust (43 mg, 0.66 mmol), sodium iodide (99 mg, 0.66 mmol), and tetrakis(triphenylphosphine)palladium(0) (77 mg, 0.066 mmol) in DMSO (7 mL) was stirred under argon in a sealed flask at 80 °C for 3.5 h. The reaction mixture was diluted with ethyl acetate, washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and the solvent was removed under reduced pressure. The resultant residue was subjected to flash chromatography (silica gel, 50%−100% ethyl acetate/hexanes) to give 271 mg (67%) of <b>33d</b> as a flaky yellow solid. <sup>1</sup>H NMR (400 MHz, CH<sub>3</sub>OH-<i>d</i><sub>4</sub>) δ 7.95 (s, 1 H), 7.23−7.34 (m, 4 H), 7.16−7.22 (m, 1 H), 4.27−4.46 (m, 2 H), 3.99−4.10 (m, 1 H), 2.84−2.94 (m, 1 H), 2.73−2.82 (m, 1 H), 2.10−2.22 (m, 1 H), 1.82−1.95 (m, 1 H), 1.64 (s, 6 H), 1.42 (t, <i>J</i> = 7.07 Hz, 3 H), 1.32 (s, 9 H).</div></div><div id="sec2_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-7-{[(3<i>S</i>)-3-amino-4-phenylbutyl]oxy}-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol, Bis-trifluoroacetate (<b>3d</b>)</h3><div class="NLM_p last">A solution of <b>33d</b> (266 mg, 0.46 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) and trifluoroacetic acid (1 mL) was stirred at 30 °C for 1 h. The solvent was removed under reduced pressure to give a yellow solid. The solid was suspended in CH<sub>2</sub>Cl<sub>2</sub> (3 mL), sonicated, and isolated by filtration. The solid was further washed with CH<sub>2</sub>Cl<sub>2</sub> and air-dried to give 255 mg (77%) of <b>3d</b> as a white powder. [α]<sub class="stack">D</sub><sup class="stack">23</sup> −13.2° (<i>c</i> 0.50, methanol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08 (s, 1 H), 8.01−8.08 (m, 3 H), 7.25−7.41 (m, 5 H), 7.04 (br s, 2 H), 4.63−4.74 (m, 2 H), 4.34−4.48 (m, 2 H), 3.55−3.68 (m, 1 H), 3.07 (dd, <i>J</i> = 13.52, 5.18 Hz, 1 H), 2.88 (dd, <i>J</i> = 13.64, 8.84 Hz, 1 H), 2.01−2.15 (m, 2 H), 1.53 (s, 6 H), 1.28 (t, <i>J</i> = 7.07 Hz, 3 H). Anal. (C<sub>25</sub>H<sub>29</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>) calcd: C, 49.51; H, 4.44; N, 13.94. Found: C, 49.58; H, 4.69; N, 14.03.</div></div><div id="sec2_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1,1-Dimethylethyl 3-(Bromomethyl)-1-pyrrolidinecarboxylate</h3><div class="NLM_p last">To a solution of 1,1-dimethylethyl 3-(hydroxymethyl)-1-pyrrolidinecarboxylate (0.56 g, 2.8 mmol) with carbon tetrabromide (1.39 g, 4.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise a solution of triphenylphosphine (0.73 g, 2.8 mmol in 5 mL of CH<sub>2</sub>Cl<sub>2</sub>). Upon completion, the mixture was stirred for 18 h at room temperature. The solvent was removed at reduced pressure and the residue stirred in 10% ethyl acetate and 90% hexane. The mixture was filtered and the resulting solution chromatographed on silica eluting with a gradient of 0−25% EtOAc in hexane to afford 0.41 g (55%) of the desired compound. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.51−3.63 (m, 2 H), 3.31−3.49 (m, 2 H), 3.13−3.28 (m, 1 H), 2.90−3.03 (m, 1 H), 2.49−2.65 (m, 1 H), 1.90−2.07 (m, 1 H), 1.54−1.72 (m, 1 H), 1.40 (s, 9 H). MS <i>m</i>/<i>z</i> 264 [M + H]<sup>+</sup>.</div></div><div id="sec2_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1,1-Dimethylethyl 3-({[2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}methyl)-1-pyrrolidinecarboxylate (<b>32e</b>)</h3><div class="NLM_p last">A mixture consisting of <b>29</b> (100 mg, 0.35mmol) in DMF (2 mL) with cesium carbonate (290 mg, 0.9 mmol) and 1,1-dimethylethyl 3-(bromomethyl)-1-pyrrolidinecarboxylate (290 mg, 1.1 mmol) was stirred at room temperature for 44 h. The mixture was poured into rapidly stirring ice−water (7 mL), and stirring continued for 10 min. To this was added cyclohexane (7 mL), and stirring continued for an additional 20 min. The solid was collected by filtration, then washed with cyclohexane and dried in vacuo to afford 111 mg (69%) of <b>32e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01 (s, 1 H), 6.94 (s, 2 H), 4.82 (q, <i>J</i> = 7.1 Hz, 2 H), 4.20−4.38 (m, 2 H), 3.51−3.61 (m, 1 H), 3.39−3.48 (m, 1 H), 3.23−3.32 (m, 1 H), 3.12−3.23 (m, 1 H), 2.71−2.88 (m, 1 H), 2.02−2.15 (m, 1 H), 1.70−1.86 (m, 1 H), 1.46 (t, <i>J</i> = 7.1 Hz, 3 H), 1.40 (s, 9 H). MS <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div></div><div id="sec2_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1,1-Dimethylethyl 3-({[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methyl-1-butyn-1-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}methyl)-1-pyrrolidinecarboxylate (<b>33e</b>)</h3><div class="NLM_p last">A thick walled pressure vessel was charged with <b>32e</b> (100 mg, 0.22 mmol), 2-methyl-3-butyn-2-ol (0.25 mL, 2.6 mmol), (Ph<sub>3</sub>P)<sub>4</sub>Pd (30 mg), diisopropylamine (0.4 mL), and dioxane (4 mL). The vessel was purged with argon, sealed, and stirred 100 °C for 6 h. The mixture was concentrated at reduced pressure and then triturated with EtOAc (4 mL) to afford 82 mg (75%) of <b>33e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (s, 1 H), 705 (s, 2 H), 5.68 (s, 1 H), 4.83 (q, <i>J</i> = 6.8 Hz, 2 H), 4.23−4.42 (m, 2 H), 3.50−3.63 (m, 1 H), 3.39−3.49 (m, 1 H), 3.23−3.33 (m, 1 H), 3.13−3.23 (m, 1 H), 2.71−2.86 (m, 1 H), 2.00−2.16 (m, 1 H), 1.72−1.88 (m, 1 H), 1.54 (s, 6 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H), 1.40 (s, 9 H). MS <i>m</i>/<i>z</i> 512 [M + H]<sup>+</sup>.</div></div><div id="sec2_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3-pyrrolidinylmethyl)oxy]-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl}-2-methyl-3-butyn-2-ol, Bis-trifluoroacetate (<b>3e</b>)</h3><div class="NLM_p last">Compound <b>33e</b> (75 mg, 0.15 mmol) was stirred in a 20% solution of TFA in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) at room temperature for 20 min. Toluene (3 mL) was added, and all volatiles were removed at reduced pressure. The residue was purified by preparative reversed phase HPLC to afford 40 mg (43%) of <b>3e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69−8.85 (m, 2 H), 8.18 (s, 1H), 7.06 (s, 2 H), 4.83 (q, <i>J</i> = 7.0 Hz, 2 H), 4.29−4.45 (m, 2 H), 3.40−3.53 (m, 1 H), 3.19−3.38 (m, 2 H), 3.02−3.16 (m, 1 H), 2.79−2.95 (m, 1 H), 2.12−2.27 (m, 1 H), 1.77−1.90 (m, 1 H), 1.54 (s, 6 H), 1.46 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 412 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>25</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·2H<sub>2</sub>O) calcd: C, 42.67; H, 4.63; N, 14.51. Found: C, 42.48; H, 4.35; N, 14.47.</div></div><div id="sec2_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1,1-Dimethylethyl 4-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}-1-piperidinecarboxylate (<b>32f</b>)</h3><div class="NLM_p last">A mixture of <b>29</b> (0.25 g, 0.89 mmol), 1,1-dimethylethyl 4-bromo-1-piperidinecarboxylate (0.71 g, 2.67 mmol), and cesium carbonate (0.87 g, 2.67 mmol) in DMF (5 mL) was heated to 60 °C for 5 h. The mixture was diluted with water and extracted with ethyl acetate. The combined organic extract was washed with water, brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the resulting residue subjected to flash chromatography (10−50% EtOAc/hexane, silica gel) to give 95 mg (23%) of <b>32f</b> as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86 (s, 1 H), 5.89 (s, 2 H), 5.01 (q, <i>J</i> = 6.99 Hz, 2 H), 4.77−4.86 (m, 1 H), 3.71−3.82 (m, 2 H), 3.42−3.51 (m, 2 H), 2.09−2.20 (m, 2 H), 1.86−1.98 (m, 2 H), 1.56 (t, <i>J</i> = 7.20 Hz, 3 H), 1.51 (s, 9 H). MS <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div></div><div id="sec2_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1,1-Dimethylethyl 4-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methyl-1-butyn-1-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}-1-piperidinecarboxylate (<b>33f</b>)</h3><div class="NLM_p last">A pressure tube was charged with <b>32f</b> (93 mg, 0.20 mmol), 2-methyl-3-buty-2-ol (0.1 mL, 1.03 mmol), (Ph<sub>3</sub>P)<sub>4</sub>Pd (10 mg, 0.009 mmol), Zn dust (10 mg, 0.15 mmol), NaI (10 mg, 0.067 mmol), DBU (0.10 mL, 0.66 mmol), Et<sub>3</sub>N (0.1 mL, 0.71 mmol), and DMSO (3 mL). The mixture was purged with argon for 10 min, and then the pressure vessel was sealed and heated at 80 °C for 4 h. The mixture was diluted with water and extracted with ethyl acetate. The combined organic extract was washed with water, brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the resulting residue subjected to preparative reverse phase HPLC to give 121 mg (89%) of <b>33f</b> as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (s, 1 H), 7.05 (s, 2 H), 4.96−5.11 (m, 1 H), 4.84 (q, <i>J</i> = 6.99 Hz, 2 H), 3.57−3.72 (m, 2 H), 3.24−3.42 (m, 2 H), 1.98−2.12 (m, 2 H), 1.66−1.81 (m, 2 H), 1.54 (s, 6 H), 1.38−1.49 (m, 12 H). MS <i>m</i>/<i>z</i> 512 [M + H]<sup>+</sup>.</div></div><div id="sec2_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(4-piperidinyloxy)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl]-2-methyl-3-butyn-2-ol, Bis-trifluoroacetate (<b>3f</b>)</h3><div class="NLM_p last">Compound <b>33f</b> (121 mg, 0.19 mmol) was dissolved in TFA (2 mL) and CH<sub>2</sub>Cl<sub>2</sub> (3 mL). After 1 h, the solvent was removed under reduced pressure and the residue subjected to preparative reverse phase HPLC to give 54 mg (44%) of <b>3f</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.23 (s, 1 H), 5.11−5.20 (m, 1 H), 5.05 (q, <i>J</i> = 7.07 Hz, 2 H), 3.43−3.54 (m, 2 H), 3.35−3.40 (m, 2 H), 2.37−2.51 (m, 2 H), 2.14−2.30 (m, 2 H), 1.68 (s, 6 H), 1.60 (t, <i>J</i> = 7.07 Hz, 3 H). MS <i>m</i>/<i>z</i> 412 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>25</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>) calcd: C, 45.08; H, 4.26; N, 15.33. Found: C, 45.03; H, 4.18; N, 15.16.</div></div><div id="sec2_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 1,1-Dimethylethyl (3<i>S</i>)-3-(Bromomethyl)-1-piperidinecarboxylate</h3><div class="NLM_p last">To a solution of 1,1-dimethylethyl (3<i>S</i>)-3-(hydroxymethyl)-1-piperidinecarboxylate (30.0 g, 139 mmol) and carbon tetrabromide (72.0 g, 217 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (150 mL) was added dropwise a solution of triphenyl phosphine (42.4 g, 162 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (150 mL). An ice bath was used to maintain an internal temperature between 20 and 25 °C during the addition. After the mixture was stirred at ambient temperature for 1 h, cyclohexane (500 mL) was added. Approximately one-half of the solvent was removed under reduced pressure. The remaining solution was cooled in an ice bath, and the resulting precipitate was removed by filtration. The filtrate was concentrated under reduced pressure and the residue subjected to flash chromatography (0−25% ethyl acetate/hexanes, silica gel) to give 35.1 g (91%) of the desired product as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.99−4.12 (m, 1 H), 3.82−3.92 (m, 1 H), 3.26−3.36 (m, 2 H), 2.81−2.92 (m, 1 H), 2.65−2.79 (m, 1 H), 1.77−1.99 (m, 2H), 1.61−1.72 (m, 2 H), 1.41−1.55 (m, 9 H), 1.25−1.39 (m, 1 H). MS <i>m</i>/<i>z</i> 278 [M + H]<sup>+</sup>.</div></div><div id="sec2_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1,1-Dimethylethyl (3<i>S</i>)-3-({[2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}methyl)-1-piperidinecarboxylate (<b>32g</b>)</h3><div class="NLM_p last">A mixture consisting of <b>29</b> (25.0 g, 89.1 mmol), cesium carbonate (41.0 g, 126 mmol), and 1,1-dimethylethyl (3 <i>S</i>)-3-(bromomethyl)-1-piperidinecarboxylate (35.0 g, 126 mmol) in DMF (200 mL) was stirred at 40 °C for 8 h and then at 35 °C for 18 h. The mixture was poured into rapidly stirring ice−water (800 mL). After 10 min, ethyl acetate (300 mL) was added and the stirring continued for an additional 20 min. The solid was collected by filtration, washed with ethyl acetate (50 mL), and dried to give 36 g (85%) of <b>32g</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.99 (s, 1 H), 6.94 (s, 2 H), 4.83 (q, <i>J</i> = 7.3 Hz, 2 H), 3.92−4.26 (m, 3 H), 3.74−3.88 (m, 1 H), 2.67−3.01 (m, 2 H), 1.95−2.11 (m, 1 H), 1.81−1.94 (m, 1 H), 1.62−1.76 (m, 1 H), 1.48 (t, <i>J</i> = 7.1 Hz, 3H), 1.29−1.43 (m, 11 H). MS <i>m</i>/<i>z</i> 478 [M + H]<sup>+</sup>.</div></div><div id="sec2_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 1,1-Dimethylethyl (3<i>S</i>)-3-({[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methyl-1-butyn-1-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}methyl)-1-piperidinecarboxylate (<b>33g</b>)</h3><div class="NLM_p last">Two thick-walled pressure vessels were each charged with <b>32g</b> (18.0 g, 37.7 mmol), 2-methyl-3-buty-2-ol (8.0 mL, 82.5 mmol), (Ph<sub>3</sub>P)<sub>4</sub>Pd (0.5 g, 0.43 mmol), Zn dust (0.5 g., 7.4 mmol), NaI (1.10 g, 7.4 mmol), DBU (8.0 mL, 53.5 mmol), triethylamine (7.5 mL, 54.5 mmol), and DMSO (150 mL). Both vessels were purged with argon for 10 min, then sealed and heated at 80 °C for 4 h. The mixture from both vessels were poured into a single vessel containing rapidly stirring ice−water (1000 mL). After 10 min, ethyl acetate (300 mL) was added and stirring continued for an additional 20 min. The solid was collected by filtration, washed with ethyl acetate (50 mL), and dried to give 35.5 g (90%) of <b>33g</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1 H), 7.05 (s, 2 H), 5.68 (s, 1 H), 4.75−4.95 (m, 2 H), 4.13−4.29 (m, 2 H), 3.91−4.12 (m, 1 H), 3.71−3.89 (m, 1 H), 2.65−3.05 (m, 2 H), 1.98−2.09 (m, 1 H), 1.81−1.94 (m, <i>J</i> = 8.8 Hz, 1 H), 1.66−1.74 (m, 1 H), 1.54 (s, 6 H), 1.48 (t, <i>J</i> = 7.0 Hz, 3 H), 1.30−1.45 (m, 11 H). MS <i>m</i>/<i>z</i> 526 [M + H]<sup>+</sup>.</div></div><div id="sec2_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (<b>3g</b>)</h3><div class="NLM_p last">Compound <b>33g</b> (35.0 g, 66.6 mmol) and TFA (350 mL of a 20% solution in CH<sub>2</sub>Cl<sub>2</sub>, 808 mmol) was stirred at ambient temperature for 2.5 h. The solution was poured slowly into a rapidly stirring mixture of water, NaOH (36 g, 900 mmol), ethyl acetate (200 mL), and THF (1000 mL). The organic layer was separated, and the aqueous layer was extracted with additional ethyl acetate/THF (1:5 v/v, 150 mL). The combined organic extract was washed with saturated NaCl and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the resulting solid was recrystallized from hot ethanol (1200 mL) to give 26.3 g (93%) of <b>3g</b> as a white crystalline solid. [α]<sub class="stack">D</sub><sup class="stack">20</sup> −21.7° (<i>c</i> 1.00, water). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (s, 1 H), 7.06 (s, 2 H), 5.71 (s, 1 H), 4.83 (q, <i>J</i> = 7.1 Hz, 2 H), 4.17 (d, <i>J</i> = 6.3 Hz, 2 H), 3.10 (dd, <i>J</i> = 11.8, 2.9 Hz, 1 H), 3.34 (s, 1H), 2.81−2.93 (m, 1 H), 2.40−2.49 (m, 2 H), 1.94−2.05 (m, 1 H), 1.87 (dd, <i>J</i> = 12.1, 3.0 Hz, 1 H), 1.59−1.67 (m, 1 H), 1.54 (s, 6 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H), 1.21−1.42 (m, 2 H). MS <i>m</i>/<i>z</i> 426 [M + H]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>27</sub>N<sub>7</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) calcd: C, 58.05; H, 6.50; N, 22.57. Found: C, 58.32; H, 6.28; N, 22.32.</div></div><div id="sec2_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1,1-Dimethylethyl (3<i>R</i>)-3-(Bromomethyl)-1-piperidinecarboxylate</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to the preparation of 1,1-dimethylethyl (3<i>S</i>)-3-(bromomethyl)-1-piperidinecarboxylate by substituting dimethylethyl (3<i>R</i>)-3-(hydroxymethyl)-1-piperidinecarboxylate (1.00 g, 4.60 mmol) for dimethylethyl (3<i>S</i>)-3-(hydroxymethyl)-1-piperidinecarboxylate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.93−4.21 (m, 1 H), 3.80−3.91 (m, 1 H), 3.24−3.36 (m, 2 H), 2.75−2.93 (m, 1 H), 2.47−2.72 (m, 1 H), 1.80−1.97 (m, 2 H), 1.62−1.74 (m, 2 H), 1.48 (s, 9 H), 1.24−1.40 (m, 1 H). MS <i>m</i>/<i>z</i> 278 [M + H]<sup>+</sup>.</div></div><div id="sec2_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1,1-Dimethylethyl (3<i>R</i>)-3-({[2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}methyl)-1-piperidinecarboxylate (<b>32h</b>)</h3><div class="NLM_p last">Compound <b>32h</b> was prepared in a manner analogous to the preparation of <b>32g</b> by substituting 1,1-dimethylethyl (3<i>R</i>)-3-(bromomethyl)-1-piperidinecarboxylate (600 mg, 2.16 mmol) for 1,1-dimethylethyl (3<i>S</i>)-3-(bromomethyl)-1-piperidinecarboxylate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.02 (s, 1 H), 6.94 (s, 2 H), 4.85 (q, <i>J</i> = 7.2 Hz, 2 H), 3.93−4.26 (m, 3 H), 3.72−3.89 (m, 1 H), 2.66−3.02 (m, 2 H), 1.95−2.13 (m, 1 H), 1.82−1.95 (m, 1 H), 1.64−1.76 (m, 1 H), 1.49 (t, <i>J</i> = 7.1 Hz, 3 H), 1.27−1.45 (m, 11 H). MS <i>m</i>/<i>z</i> 478 [M + H]<sup>+</sup>.</div></div><div id="sec2_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4-(4-Chloro-1-ethyl-7-{[(3<i>R</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-amine</h3><div class="NLM_p last">A solution of <b>32h</b> (200 mg, 0.42 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3.2 mL) with TFA (0.8 mL, 10.4 mmol) was stirred at room temperature for 45 min. The solvent was removed at reduced pressure to give 220 mg (87%) the title compound as a TFA salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.95 (s, 1 H), 6.95 (s, 2 H), 4.81 (q, <i>J</i> = 7.2 Hz, 2 H), 4.13−4.27 (m, 2 H), 3.41 (dd, <i>J</i> = 12.0, 3.4 Hz, 1 H), 3.15−3.31 (m, 2 H), 2.77−2.89 (m, 2 H), 2.27−2.39 (m, 1 H), 1.83−1.95 (m, 2 H), 1.63−1.72 (m, 1 H), 1.39−1.49 (m, 4 H). MS <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>.</div></div><div id="sec2_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>R</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol, Bis-trifluoroacetate (<b>3h</b>)</h3><div class="NLM_p last">In a thick wall pressure tube, a mixture consisting of 4-(4-chloro-1-ethyl-7-{[(3<i>R</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-amine (125 mg, 0.33 mmol), 2-methyl-3-butyn-2-ol (83 mg, 0.99 mmol), tetrakis(triphenylphosphine)palladium(0) (15.3 mg, 0.013 mmol), zinc (3.8 mg, 0.058 mmol), sodium iodide (8.7 mg, 0.058 mmol), DBU (0.075 mL, 0.495 mmol), and TEA (0.069 mL, 0.495 mmol) in DMSO (3 mL) was purged with argon, sealed, and then heated with stirring at 80 °C for 3 h. The product mixture was subjected to reverse phase HPLC to afford 79 mg (36%) of <b>3h</b>. [α]<sub class="stack">D</sub><sup class="stack">23</sup> +6.7° (<i>c</i> 0.75, methanol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O) δ 8.15 (s, 1 H), 4.83 (q, <i>J</i> = 7.2 Hz, 2 H), 4.19−4.33 (m, 2 H), 3.38−3.47 (m, 1 H), 3.29 (d, <i>J</i> = 12.9 Hz, 1 H), 2.84 (t, <i>J</i> = 12.1 Hz, 2 H), 2.27−2.40 (m, 1 H), 1.85−1.97 (m, 2 H), 1.60−1.75 (m, 1 H), 1.53 (s, 6 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H), 1.41−1.50 (m, 1 H). MS <i>m</i>/<i>z</i> 426 [M + H]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>27</sub>N<sub>7</sub>O<sub>3</sub>·2TFA·H<sub>2</sub>O) calcd: C, 44.71; H, 4.65; N, 14.60. Found: C, 44.87; H, 4.48; N, 14.23.</div></div><div id="sec2_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1,1-Dimethylethyl 2-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-7-{[3-({[(1,1-dimethylethyl)oxy]-carbonyl}amino)propyl]oxy}-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>34a</b>)</h3><div class="NLM_p last">A mixture of <b>30</b> (317 mg, 0.720 mmol), (1-{[(1,1-dimethylethyl)oxy]-carbonyl}-1<i>H</i>-pyrrol-2-yl)boronic acid (382 mg, 1.81 mmol), tetrakis(triphenylphosphine)palladium(0) (125 mg, 0.110 mmol), and 2 M aqueous potassium carbonate (1.09 mL, 2.17 mmol) in 1,2-dimethoxyethane (11 mL) was heated in a sealed tube at 90 °C for 5 h. The mixture was cooled to ambient temperature, diluted with ethyl acetate (15 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel, 50% ethyl acetate in hexanes) to furnish 334 mg (69%) of <b>34a</b> as a pale-yellow foamy solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1 H), 7.43 (dd, <i>J</i> = 3.16, 1.64 Hz, 1 H), 6.61−6.71 (m, 1 H), 6.35 (t, <i>J</i> = 3.28 Hz, 1 H), 5.74 (br s, 2 H), 5.03 (q, <i>J</i> = 6.91 Hz, 2 H), 4.64−4.77 (m, 1 H), 4.35 (t, <i>J</i> = 6.06 Hz, 2 H), 3.42 (q, <i>J</i> = 5.98 Hz, 2 H), 2.09−2.21 (m, 2 H), 1.54 (t, <i>J</i> = 6.95 Hz, 3 H), 1.46 (s, 9 H), 1.22 (s, 9 H).</div></div><div id="sec2_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 4-[7-[(3-Aminopropyl)oxy]-1-ethyl-4-(1<i>H</i>-pyrrol-2-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl]-1,2,5-oxadiazol-3-amine, Bis-trifluoroacetate (<b>11a</b>)</h3><div class="NLM_p last">A solution of <b>34a</b> (334 mg, 0.59 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was treated with trifluoroacetic acid (0.75 mL). The mixture was stirred at 30 °C for 2 h and then concentrated under reduced pressure. The crude residue was redissolved in a mixture of methanol (5 mL) and dimethyl sulfoxide (1.5 mL) and subjected to purification by reverse phase HPLC to give 209 mg (57%) of <b>11a</b> as a flaky light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (br s, 1 H), 8.09 (s, 1 H), 7.90 (br s, 3 H), 7.20−7.29 (m, 1 H), 7.07 (d, <i>J</i> = 1.01 Hz, 1 H), 6.98 (br s, 2 H), 6.26−6.34 (m, 1 H), 4.86 (q, <i>J</i> = 6.99 Hz, 2 H), 4.40 (t, <i>J</i> = 5.94 Hz, 2 H), 3.00−3.14 (m, 2 H), 2.10−2.24 (m, 2 H), 1.49 (t, <i>J</i> = 7.07 Hz, 3 H). Anal. (C<sub>17</sub>H<sub>20</sub>N<sub>8</sub>O<sub>2</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) calcd: C, 41.66; H, 3.83; N, 18.51. Found: C, 41.85; H, 3.51; N, 18.49.</div></div><div id="sec2_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1,1-Dimethylethyl (3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-furanyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}propyl)carbamate (<b>34b</b>)</h3><div class="NLM_p last">Tetrakis(triphenylphosphine)palladium(0) (20 mg, 0.017 mmol) was added to a mixture of <b>30</b> (50 mg, 0.11 mol), 2 N Na<sub>2</sub>CO<sub>3</sub> (0.16 mL, 0.32 mmol), 3-furylboronic acid (25 mg, 0.23 mmol), and 1,4-dioxane (3 mL). The flask was flushed with argon, sealed, and heated with stirring for 10 min at 160 °C in a microwave apparatus. The resulting mixture was then diluted with 1,4-dioxane, filtered, and concentrated under reduced pressure to afford <b>34b</b> as a brownish-red residue. This material was used in the next step without further purification. MS <i>m</i>/<i>z</i> 470.4 [M + H]<sup>+</sup>.</div></div><div id="sec2_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-[7-[(3-Aminopropyl)oxy]-1-ethyl-4-(3-furanyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl]-1,2,5-oxadiazol-3-amine, Bis-trifluoroacetate (<b>11b</b>)</h3><div class="NLM_p last">Trifluoroacetic acid (2 mL) was added to a solution of crude <b>34b</b> in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) at ambient temperature. After 30 min, the solvent was removed under reduced pressure and the residue was subjected to reverse phase preparative HPLC to give 35 mg (49% over two steps) of <b>11b</b>. <sup>1</sup>H NMR (400 MHz, CH<sub>3</sub>OH-<i>d</i><sub>4</sub>) δ 8.82 (s, 1 H), 8.17 (s, 1 H), 7.84 (t, <i>J</i> = 1.77 Hz, 1 H), 7.35 (dd, <i>J</i> = 1.77, 0.76 Hz, 1 H), 5.09 (q, <i>J</i> = 7.07 Hz, 2 H), 4.53 (t, <i>J</i> = 5.94 Hz, 2 H), 3.28 (t, <i>J</i> = 7.71 Hz, 2 H), 2.23−2.51 (m, 2 H), 1.62 (t, <i>J</i> = 7.07 Hz, 3 H). Anal. (C<sub>17</sub>H<sub>19</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·H<sub>2</sub>O) calcd: C, 40.98; H, 3.77; N, 15.93. Found: C, 40.89; H, 3.48; N, 15.68.</div></div><div id="sec2_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 1,1-Dimethylethyl {3-[(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-{1-[tris(1-methylethyl)silyl]-1<i>H</i>-pyrrol-3-yl}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl)oxy]propyl}carbamate (<b>34c</b>)</h3><div class="NLM_p last">A mixture of <b>30</b> (135 mg, 0.31 mmol), {1-[tris(1-methylethyl)silyl]-1<i>H</i>-pyrrol-3-yl}boronic acid (165 mg, 0.62 mmol), tetrakis(triphenylphosphine)palladium(0) (71 mg, 0.062 mmol), and 2 N Na<sub>2</sub>CO<sub>3</sub> (0.48 mL, 0.95 mmol) in 1,4-dioxane (5 mL) was heated in a sealed tube at 105 °C for 2 h. The mixture was cooled to ambient temperature, diluted with ethyl acetate, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to provide <b>34c</b>. This material was used in the next step without further purification. MS <i>m</i>/<i>z</i> 625.4 [M + H]<sup>+</sup>.</div></div><div id="sec2_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 4-[7-[(3-Aminopropyl)oxy]-1-ethyl-4-(1<i>H</i>-pyrrol-3-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl]-1,2,5-oxadiazol-3-amine, Bis-trifluoroacetate (<b>11c</b>)</h3><div class="NLM_p">A solution of crude <b>34c</b> in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was treated with trifluoroacetic acid (1 mL), and the resultant mixture was stirred at 30 °C for 1 h. The reaction mixture was diluted with methanol (5 mL) and concentrated under reduced pressure to yield 4-(7-[(3-aminopropyl)oxy]-1-ethyl-4-{1-[tris(1-methylethyl)silyl]-1<i>H</i>-pyrrol-3-yl}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-amine. This material was used in the next step without further purification. MS <i>m</i>/<i>z</i> 525.4 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of crude 4-(7-[(3-aminopropyl)oxy]-1-ethyl-4-{1-[tris(1-methylethyl)silyl]-1<i>H</i>-pyrrol-3-yl}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-amine in THF (5 mL) was treated with tetrabutylammonium fluoride (1.0 M solution in tetrahydrofuran, 1 mL, 1.0 mmol), and the resultant mixture was stirred for 15 min. Concentration under reduced pressure followed by reverse phase HPLC afforded 127 mg (61%) of <b>11c</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.83 (br s, 1 H), 8.18 (br s, 1 H), 8.07 (s, 1 H), 7.99−8.06 (m, 3 H), 7.10−7.16 (m, 1 H), 7.05−7.10 (m, 1 H), 6.87 (br s, 2 H), 4.87 (q, <i>J</i> = 6.74 Hz, 2 H), 4.41 (t, <i>J</i> = 5.56 Hz, 2 H), 3.01−3.14 (m, 2 H), 2.12−2.26 (m, 2 H), 1.50 (t, <i>J</i> = 7.07 Hz, 3 H). Anal. (C<sub>17</sub>H<sub>20</sub>N<sub>8</sub>O<sub>2</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>) calcd: C, 42.29; H, 3.72; N, 18.79. Found: C, 42.07; H, 3.55; N, 18.48.</div></div><div id="sec2_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 1,1-Dimethylethyl (3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}propyl)carbamate (<b>34d</b>)</h3><div class="NLM_p last">A mixture of <b>30</b> (163 mg, 0.37 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (145 mg, 0.74 mmol), tetrakis(triphenylphosphine)palladium(0) (79 mg, 0.074 mmol), and 2 N Na<sub>2</sub>CO<sub>3</sub> (0.58 mL, 1.16 mmol) in 1,4-dioxane (5 mL) was heated in a sealed tube at 105 °C for 3 h. The mixture was cooled to ambient temperature, diluted with ethyl acetate, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to furnish <b>34d</b> that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (br s, 2 H), 8.11 (s, 1 H), 7.01 (t, <i>J</i> = 5.56 Hz, 1 H), 6.91 (br s, 2 H), 4.85 (q, <i>J</i> = 6.82 Hz, 2 H), 4.28 (t, <i>J</i> = 5.81 Hz, 2 H), 3.19 (q, <i>J</i> = 6.57 Hz, 2 H), 1.91−2.02 (m, 2 H), 1.47 (t, <i>J</i> = 6.95 Hz, 3 H), 1.36 (s, 9 H).</div></div><div id="sec2_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 4-[7-[(3-Aminopropyl)oxy]-1-ethyl-4-(1<i>H</i>-pyrazol-3-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl]-1,2,5-oxadiazol-3-amine, Bis-trifluoroacetate (<b>11d</b>)</h3><div class="NLM_p last">A solution of crude <b>34d</b> in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was treated with trifluoroacetic acid (2 mL), and the resultant mixture was stirred at 30 °C for 16 h. The reaction mixture was diluted with methanol (5 mL) and concentrated under reduced pressure. The residue was dissolved in a mixture of methanol (2.5 mL) and dimethyl sulfoxide (1 mL) and purified by reverse phase HPLC to give 180 mg (81%) of <b>11d</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (br s, 2 H), 8.17 (s, 1 H), 7.83−7.99 (m, 3 H), 6.89 (br s, 2 H), 4.86 (q, <i>J</i> = 6.91 Hz, 2 H), 4.41 (t, <i>J</i> = 5.81 Hz, 2 H), 3.01−3.12 (m, 2 H), 2.12−2.23 (m, 2 H), 1.49 (t, <i>J</i> = 7.07 Hz, 3 H). Anal. (C<sub>16</sub>H<sub>19</sub>N<sub>9</sub>O<sub>2</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) calcd: C, 39.61; H, 3.66; N, 20.79. Found: C, 39.77; H, 3.34; N, 20.54.</div></div><div id="sec2_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 4-{7-[(3-Bromopropyl)oxy]-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl}-1,2,5-oxadiazol-3-amine (<b>35</b>)</h3><div class="NLM_p last">Anhydrous Cs<sub>2</sub>CO<sub>3</sub> (7.00 g, 21.7 mmol) was added to a solution of <b>29</b> (4.70 g, 16.7 mmol) in DMF (50 mL) at room temperature. After 5 min, 1,3-dibromopropane (16.9 g, 84.0 mmol) was added and the mixture was heated to 60 °C for 3.5 h. The mixture was cooled to room temperature and quenched by partitioning between EtOAc and saturated NH<sub>4</sub>Cl. The aqueous layer was extracted with additional EtOAc, and the combined extracts were washed with water and brine, dried over MgSO<sub>4</sub>, and filtered. The filtrate was concentrated to a residue which was triturated with 0.5% methanol in CH<sub>2</sub>Cl<sub>2</sub> to give 4.46 g (67% yield) of <b>35</b> as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.04 (s, 1 H), 6.93 (s, 2 H), 4.82 (q, <i>J</i> = 6.9 Hz, 2 H), 4.41 (t, <i>J</i> = 5.8 Hz, 2 H), 3.75 (t, <i>J</i> = 6.6 Hz, 2 H), 2.40 (m, 2 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 401.2 [M + H]<sup>+</sup>.</div></div><div id="sec2_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 4-(4-Chloro-1-ethyl-7-{[3-({2-[4-(methyloxy)phenyl]ethyl}amino)propyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-amine (<b>36a</b>)</h3><div class="NLM_p last">Compound <b>35</b> (4.30 g, 10.7 mmol) was dissolved in DMF (40 mL). To this was added Et<sub>3</sub>N (4.5 mL, 32.0 mmol) and 2-[4-(methyloxy)phenyl]ethanamine (3.10 mL, 21.0 mmol), and the resulting mixture was heated to 60 °C. After 30 min, the mixture was cooled to room temperature and quenched by partitioning between EtOAc and water. The aqueous layer was extracted with additional EtOAc, and the combined extracts were washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure to give a brown solid. Trituration with cold EtOAc/hexane (3:1) gave 4.20 g (84% yield) of <b>36a</b> as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.98 (s, 1 H), 7.10 (m, 2 H), 6.93 (s, 2 H), 6.78 (m, 2 H), 4.80 (m, 2 H), 4.32 (t, <i>J</i> = 6.1 Hz, 2 H), 3.68 (s, 3 H), 2.73 (m, 4 H), 2.64 (m, 2 H), 1.97 (m, 2 H), 1.76 (br s, 1 H), 1.43 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 472.4 [M + H]<sup>+</sup>.</div></div><div id="sec2_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[3-({2-[4-(methyloxy)phenyl]ethyl}amino)propyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol, Bis-trifluoroacetate (<b>14a</b>)</h3><div class="NLM_p last">Compound <b>14a</b> was prepared in a manner analogous to the preparation of <b>3g</b> by substituting <b>36a</b> (2.50 g, 5.30 mmol) for <b>32g</b>. The reaction was quenched by partitioning between EtOAc and water. The organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resulting residue was purified by column chromatography (silica gel, 5−100% MeOH/CHCl<sub>3</sub> + 1%NH<sub>4</sub>OH). The isolated product was washed with a small amount of CHCl<sub>3</sub> and recrystallized from CH<sub>3</sub>CN. The solid was suspended in acetonitrile/water (1:1), and trifluoracetic acid (0.44 mL, 5.76mmol) was added. After the mixture was stirred for 15 min, the solvent was removed under reduced pressure and the resulting solid was dried under vaccum at 40 °C to give 1.82 g of <b>14</b> as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (br s, 2 H), 8.17 (s, 0 H), 7.20 (d, <i>J</i> = 8.6 Hz, 2 H), 7.05 (s, 2 H), 6.91 (d, <i>J</i> = 8.8 Hz, 2 H), 4.84 (d, <i>J</i> = 7.1 Hz, 2 H), 4.42 (t, <i>J</i> = 5.8 Hz, 2 H), 3.73 (s, 3 H), 3.19 (br s, 4 H), 2.86 (m, 2 H), 2.21 (m, 2 H), 1.54 (s, 6 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 519.9 [M + H]<sup>+</sup>. Anal. (C<sub>27</sub>H<sub>33</sub>N<sub>7</sub>O<sub>4</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.5CH<sub>3</sub>CN) calcd: C, 50.03; H, 4.79; N, 13.68. Found: C, 50.31; H, 5.07; N, 13.62.</div></div><div id="sec2_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (2<i>S</i>)-3-[(3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}propyl)amino]-1,2-propanediol (<b>36b</b>)</h3><div class="NLM_p last">A solution of <b>35</b> (250 mg, 0.622 mmol) and (2<i>S</i>)-3-amino-1,2-propanediol (300 mg, 3.29 mmol) in CH<sub>3</sub>CN (15 mL) was stirred at 60 °C for 18 h. The solvent was removed under reduced pressure, and the residue was triturated with water. The solid was collected and dried to give 251 mg (98%) of <b>36b</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00 (s, 1 H), 6.94 (s, 2 H), 4.83 (q, <i>J</i> = 7.0 Hz, 2 H), 4.49−4.64 (m, 1 H), 4.35 (t, <i>J</i> = 6.1 Hz, 2 H), 3.49−3.59 (m, 1 H), 3.24−3.34 (m, 1 H), 2.75 (t, <i>J</i> = 6.8 Hz, 2 H), 2.63 (dd, <i>J</i> = 11.8, 4.4 Hz, 1 H), 2.44−2.49 (m, 1 H), 1.93−2.05 (m, 2 H), 1.45 (t, <i>J</i> = 7.1 Hz, 3 H). MS <i>m</i>/<i>z</i> 412 [M + H]<sup>+</sup>.</div></div><div id="sec2_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (2<i>S</i>)-3-[(3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methyl-1-butyn-1-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-7-yl]oxy}propyl)amino]-1,2-propanediol (<b>14b</b>)</h3><div class="NLM_p last">In a thick wall pressure flask, a mixture consisting of <b>36b</b> (250 mg, 0.61 mmol), 2-methyl-3-butyn-2-ol (153 mg, 1.82 mmol), tetrakis(triphenylphosphine)palladium(0) (28.1 mg, 0.024 mmol), zinc (7.0 mg, 0.106 mmol), sodium iodide (15.9 mg, 0.106 mmol), DBU (0.137 mL, 0.911 mmol), and TEA (0.127 mL, 0.911 mmol) in DMSO (3 mL) was purged with Ar, then heated with stirring at 80 °C for 3 h. The mixture was subjected to reverse phase HPLC, and the product-containing fractions were made slightly basic with 1 N NaOH. After concentrating to approximately <sup>1</sup>/<sub>3</sub> volume, the resulting precipitate was collected and dried to afford 164 mg (60%) of <b>14b</b> as a white solid. [α]<sub class="stack">D</sub><sup class="stack">23</sup> −3.5° (<i>c</i> 0.40, methanol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O) δ 8.12 (s, 1 H), 4.82 (q, <i>J</i> = 6.7 Hz, 2 H), 4.35 (t, <i>J</i> = 5.9 Hz, 2 H), 3.49−3.58 (m, 1 H), 3.25−3.37 (m, 2 H), 2.72 (t, <i>J</i> = 6.8 Hz, 2 H), 2.60 (dd, <i>J</i> = 11.9, 4.3 Hz, 1 H), 2.44 (dd, <i>J</i> = 11.9, 7.3 Hz, 1 H), 1.93−2.04 (m, 2 H), 1.52 (s, 6 H), 1.42 (t, <i>J</i> = 7.0 Hz, 3 H). MS <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>29</sub>N<sub>7</sub>O<sub>5</sub>·H<sub>2</sub>O) calcd: C, 52.82; H, 6.54; N, 20.53. Found: C, 53.21; H, 6.55; N, 20.64.</div></div><div id="sec2_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Biological Assays and in Vivo Studies</h3><div class="NLM_p last">Details of the in vitro kinase inhibition assays, assays to measure inhibition of phosphorylation of GSK3β in BT474 cells, and studies involving tumor xenografts are described in a separate publication.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Cell proliferation assays were performed as previously described.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec2_72a" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Biochemical Characterization of <b>3g</b></h3><div id="sec2_72b" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Determination of Time-Dependent Inhibition of <b>3g</b> against Human AKT1 and 2</h4><div class="NLM_p last">To determine whether <b>3g</b> exhibits time-dependent inhibition, a filter-binding assay was used to measure IC<sub>50</sub> values with and without a 30 min preincubation step of inhibitor with AKT1 and 2 prior to the start of the reaction (preincubation). The final reaction conditions were 15 nM AKT1 or 10 nM AKT2, 1 μM AKT-tide peptide (sequence, biotin-ARKRERAYSFGHHA-NH<sub>2</sub>), 15 μM ATP, and 0.015 mCi/mL γ-<sup>33</sup>P-ATP in buffer A (25 mM MOPS, pH 7.5, 0.5 mM CHAPS, 10 mM MgCl<sub>2</sub>, 50 mM KCl, 1 mM DTT) and various concentrations of <b>3g</b> in 5% DMSO. The reactions were allowed to proceed for 10 min for AKT1 and 5 min for AKT2 and then stopped with the addition of an equal volume of 1% H<sub>3</sub>PO<sub>4</sub>. The stopped reaction was transferred to phosphocellulose filter plates and washed 5 times with 100 μL of 0.5% H<sub>3</sub>PO<sub>4</sub>. Microscint20 cocktail was added to the dried filter plates, and the plates were read using a Perkin-Elmer Microbeta liquid scintillation counter.</div></div><div id="sec2_72c" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Determination of Off-Rates of <b>3g</b> from Human AKT1 and 2</h4><div class="NLM_p last">Compound <b>3g</b> and AKT1 were incubated at 50 and 125 nM each in buffer A for 50 min at room temperature. Formation of the AKT2−<b>3g</b> complex was similarly carried out. This amount of <b>3g</b> was found to be sufficient to achieve complete inhibition. The reaction was initiated by adding the complex of <b>3g</b> and AKT1 or AKT2 to the substrate solution containing 10 μM Sox-AKT-tide peptide substrate and 1 mM ATP in buffer A. The recovery of enzymatic activity was measured in a continuous fluorescence detection assay.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The phosphorylation of Sox-labeled AKT-tide peptide was quantified in an Envision 2102 instrument (PerkinElmer) using an excitation wavelength of 380 nm and an emission wavelength of 486 nm. The time course of the recovery of enzymatic activity following rapid dilution of a preformed enzyme and inhibitor complex was fitted to the following equation:<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/jm-2008-004527_m001.gif" alt="" /></img></span> where <i>v</i><sub>i</sub> and <i>v</i><sub>s</sub> are the initial and steady state velocities of the reaction in the presence of the inhibitor, <i>k</i><sub>obs</sub> is the apparent first-order rate constant for the conversion from <i>v</i><sub>i</sub> to <i>v</i><sub>s</sub>, and <i>t</i> is time. Under the experimental conditions, <i>k</i><sub>obs</sub> represents the dissociation rate constant (<i>k</i><sub>off</sub>) of the EI complex. The dissociation half-life (<i>t</i><sub>1/2</sub>) is related to <i>k</i><sub>obs</sub> by <i>t</i><sub>1/2</sub> = 0.693/<i>k</i><sub>off</sub>.</div></div><div id="sec2_72d" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Mode of Inhibition of <b>3g</b> toward ATP</h4><div class="NLM_p last">The IC<sub>50</sub> values for <b>3g</b> were determined against AKT1 and AKT2 in a continuous fluorescence detection assay. Various concentration of ATP were tested with 2.5 nM AKT1 or 2 nM AKT2 in buffer A containing 10 μM Sox-AKT-tide peptide. Rates of catalysis were derived from the linear portion of the progress curves.</div></div><div id="sec2_72e" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Potency of Compound <b>3g</b> (<i>K</i><sub>i</sub>*) Determined against the Human and Mouse Enzymes</h4><div class="NLM_p last">Either AKT1 (final concentration 0.33 nM) or AKT2 (final concentration 1 nM) in buffer A was incubated with <b>3g</b> at various concentrations for 60 min at room temperature. The reaction was initiated by adding substrate mix in buffer A containing GSK3α peptide (Ac-KKGGRARTSSFAEPG-NH<sub>2</sub>, final concentration 10 μM), ATP (final concentration 50 μM), and γ-<sup>33</sup>P-ATP (final concentration 0.03 mCi/mL). After 120 min, the reaction was stopped with an equal volume of 1% H<sub>3</sub>PO<sub>4</sub> and detected in the filter binding format as described above. <i>K</i><sub>i</sub>* values were calculated using the following equation: <span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/jm-2008-004527_m002.gif" alt="" /></img></span></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95"><a href="/doi/suppl/10.1021/jm8004527">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Results from the combustion analysis of test compounds and from the kinetic characterization of <b>3g</b> against AKT2 kinase. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8004527/suppl_file/jm8004527_si_001.pdf">jm8004527_si_001.pdf (100.99 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm8004527" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk A. Heerding</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d5b1bca7befbb4fbbdb0b0a7b1bcbbb295b2a6befbb6bab8"><span class="__cf_email__" data-cfemail="35515c475e1b541b5d505047515c5b527552465e1b565a58">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nelson Rhodes</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jack D. Leber</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tammy J. Clark</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard M. Keenan</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis V. Lafrance</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei Li</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Igor G. Safonov</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis T. Takata</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph W. Venslavsky</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis S. Yamashita</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony E. Choudhry</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert A. Copeland</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihong Lai</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Schaber</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Tummino</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan L. Strum</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edgar R. Wood</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Derek R. Duckett</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Derek Eberwein</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victoria B. Knick</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Randy T. McConnell</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">ShuYun Zhang</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabeth A. Minthorn</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nestor O. Concha</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory L. Warren</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rakesh Kumar</span> - <span class="hlFld-Affiliation affiliation">Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jetzt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span> </span><span class="NLM_article-title">Adenoviral-Mediated Expression of a Kinase-Dead Mutant of Akt Induces Apoptosis Selectively in Tumor Cells and Suppresses Tumor Growth in Mice</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6697</span><span class="NLM_x">–</span> <span class="NLM_lpage">6706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=6697-6706&author=A.+Jetztauthor=J.+A.+Howeauthor=M.+T.+Hornauthor=E.+Maxwellauthor=Z.+Yinauthor=D.+Johnsonauthor=C.+C.+Kumar&title=Adenoviral-Mediated+Expression+of+a+Kinase-Dead+Mutant+of+Akt+Induces+Apoptosis+Selectively+in+Tumor+Cells+and+Suppresses+Tumor+Growth+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJetzt%26aufirst%3DA.%26aulast%3DHowe%26aufirst%3DJ.%2BA.%26aulast%3DHorn%26aufirst%3DM.%2BT.%26aulast%3DMaxwell%26aufirst%3DE.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DC.%2BC.%26atitle%3DAdenoviral-Mediated%2520Expression%2520of%2520a%2520Kinase-Dead%2520Mutant%2520of%2520Akt%2520Induces%2520Apoptosis%2520Selectively%2520in%2520Tumor%2520Cells%2520and%2520Suppresses%2520Tumor%2520Growth%2520in%2520Mice%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D6697%26epage%3D6706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bellacosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1016%2FS0065-230X%2805%2994002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=16095999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=29-86&author=A.+Bellacosaauthor=C.+C.+Kumarauthor=A.+Di+Cristofanoauthor=J.+R.+Testa&title=Activation+of+AKT+Kinases+in+Cancer%3A+Implications+for+Therapeutic+Targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of AKT kinases in cancer: implications for therapeutic targeting</span></div><div class="casAuthors">Bellacosa, Alfonso; Kumar, C. Chandra; Di Cristofano, Antonio; Testa, Joseph Robert</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-86</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The AKT1, AKT2, and AKT3 kinases have emerged as crit. mediators of signal transduction pathways downstream of activated tyrosine kinases and phosphatidylinositol 3-kinase.  An ever-increasing list of AKT substrates has precisely defined the multiple functions of this kinase family in normal physiol. and disease states.  Cellular processes regulated by AKT include cell proliferation and survival, cell size and response to nutrient availability, intermediary metab., angiogenesis, and tissue invasion.  All these processes represent hallmarks of cancer, and a burgeoning literature has defined the importance of AKT alterations in human cancer and exptl. models of tumorigenesis, continuing the legacy represented by the original identification of v-Akt as the transforming oncogene of a murine retrovirus.  Many oncoproteins and tumor suppressors intersect in the AKT pathway, finely regulating cellular functions at the interface of signal transduction and classical metabolic regulation.  This careful balance is altered in human cancer by a variety of activating and inactivating mechanisms that target both AKT and interrelated proteins.  Reprogramming of this altered circuitry by pharmacol. modulation of the AKT pathway represents a powerful strategy for rational cancer therapy.  In this review, we summarize a large body of data, from many types of cancer, indicating that AKT activation is one of the most common mol. alterations in human malignancy.  We also review mechanisms of activation of AKT kinases, examples of therapeutic modulation of the AKT pathway in animal models, and the current status of efforts to target mol. components of the AKT pathway for cancer therapy and, possibly, cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtUdzglK927Vg90H21EOLACvtfcHk0lg-x5Sg7oYx2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D&md5=556e3c5787e0179786db3cb2e2f1dcf6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2805%2994002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252805%252994002-5%26sid%3Dliteratum%253Aachs%26aulast%3DBellacosa%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DC.%2BC.%26aulast%3DDi%2BCristofano%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DActivation%2520of%2520AKT%2520Kinases%2520in%2520Cancer%253A%2520Implications%2520for%2520Therapeutic%2520Targeting%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2005%26volume%3D94%26spage%3D29%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">The Akt/PKB Family of Protein Kinases: A Review of Small Molecule Inhibitors and Progress towards Target Validation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.2174%2F1568026053507714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15853641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=109-125&author=S.+F.+Barnettauthor=M.+T.+Bilodeauauthor=C.+W.+Lindsley&title=The+Akt%2FPKB+Family+of+Protein+Kinases%3A+A+Review+of+Small+Molecule+Inhibitors+and+Progress+towards+Target+Validation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation</span></div><div class="casAuthors">Barnett, Stanley F.; Bilodeau, Mark T.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-125</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent advances in the development and biol. evaluation of small mol. inhibitors for the serine/threonine kinase Akt (PKB).  Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors.  Recent studies indicate that unregulated activation of the PI3K/Akt pathway is a prominent feature of many human cancers and Akt is over-expressed or activated in all major cancers.  Akt is considered an attractive target for chemotherapy and it was postulated that inhibition of Akt alone or in combination with std. cancer chemotherapeutics will reduce the apoptotic threshold and preferentially kill cancer cells.  The development of specific and potent inhibitors will allow this hypothesis to be tested in animals.  The majority of small mol. inhibitors in this nascent field are classic ATP-competitive inhibitors which provide little specificity.  Phosphatidylinositol (PI) analogs were reported to inhibit Akt, but these inhibitors may also have specificity problems with respect to other PH domain contg. proteins and may have poor bioavailability.  None of the inhibitors in these classes were reported to have Akt isoenzyme specificity.  Recently, novel allosteric inhibitors were reported which are pleckstrin homol. domain dependent and exhibit Akt isoenzyme selectivity.  Inhibitors in this class may have sufficient potency and specificity to test for tumor efficacy in animal models and recently reported preliminary expts. are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLzMZqnXaA5bVg90H21EOLACvtfcHk0ljWVzY75T2LoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLY%253D&md5=44734cf0124197d3c4d5d9be5f7499ca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026053507714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507714%26sid%3Dliteratum%253Aachs%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Akt%252FPKB%2520Family%2520of%2520Protein%2520Kinases%253A%2520A%2520Review%2520of%2520Small%2520Molecule%2520Inhibitors%2520and%2520Progress%2520towards%2520Target%2520Validation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D109%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Altomare, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Perturbations of the AKT Signaling Pathway in Human Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">7455</span><span class="NLM_x">–</span> <span class="NLM_lpage">7464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=7455-7464&author=D.+A.+Altomareauthor=J.+R.+Testa&title=Perturbations+of+the+AKT+Signaling+Pathway+in+Human+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAltomare%26aufirst%3DD.%2BA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DPerturbations%2520of%2520the%2520AKT%2520Signaling%2520Pathway%2520in%2520Human%2520Cancer%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D7455%26epage%3D7464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Dillon, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W. J.</span><span> </span><span class="NLM_article-title">The Phosphatidyl Inositol 3-Kinase Signaling Network: Implications for Human Breast Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1338</span><span class="NLM_x">–</span> <span class="NLM_lpage">1345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1338-1345&author=R.+L.+Dillonauthor=D.+E.+Whiteauthor=W.+J.+Muller&title=The+Phosphatidyl+Inositol+3-Kinase+Signaling+Network%3A+Implications+for+Human+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDillon%26aufirst%3DR.%2BL.%26aulast%3DWhite%26aufirst%3DD.%2BE.%26aulast%3DMuller%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520Phosphatidyl%2520Inositol%25203-Kinase%2520Signaling%2520Network%253A%2520Implications%2520for%2520Human%2520Breast%2520Cancer%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D1338%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chow, L. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span> </span><span class="NLM_article-title">PTEN Function in Normal and Neoplastic Growth</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1016%2Fj.canlet.2005.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=16412571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2msL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2006&pages=184-196&author=L.+M.+L.+Chowauthor=S.+J.+Baker&title=PTEN+Function+in+Normal+and+Neoplastic+Growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN function in normal and neoplastic growth</span></div><div class="casAuthors">Chow, Lionel M. L.; Baker, Suzanne J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-196</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The PTEN tumor suppressor is a central neg. regulator of the PI3K/AKT signaling cascade that influences multiple cellular functions including cell growth, survival, proliferation and migration in a context-dependent manner.  Dysregulation of this signaling pathway contributes to many cancers in man.  PTEN is the most commonly altered component of the PI3K pathway in human malignancies.  Mutations occur in both heritable and sporadic settings, with high frequency in sporadic glioblastoma, prostate and endometrial cancer.  Data from human tumors and animal models support the concept that the effects of PTEN inactivation are tissue-specific.  Elucidation of the mechanisms regulating activation of unique downstream effectors that mediate distinct outcomes of PTEN loss will augment our understanding of tumorigenesis and ultimately lead to novel therapeutic options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB0oHj4Xz-Y7Vg90H21EOLACvtfcHk0ljWVzY75T2LoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2msL4%253D&md5=5f88f68544cb93f45f0990d9b0abd668</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DL.%2BM.%2BL.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26atitle%3DPTEN%2520Function%2520in%2520Normal%2520and%2520Neoplastic%2520Growth%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D241%26spage%3D184%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaroschak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M. E.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.2174%2F156802607781696864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=17692025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1SmtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1349-1363&author=C.+W.+Lindsleyauthor=S.+F.+Barnettauthor=M.+Yaroschakauthor=M.+T.+Bilodeauauthor=M.+E.+Layton&title=Recent+Progress+in+the+Development+of+ATP-Competitive+and+Allosteric+Akt+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors</span></div><div class="casAuthors">Lindsley, Craig W.; Barnett, Stanley F.; Yaroschak, Melissa; Bilodeau, Mark T.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1349-1363</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent advances in the development and biol. evaluation of small mol. inhibitors for the serine/threonine kinase Akt (PKB).  Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors.  Recent studies indicate that unregulated activation of the PI3K/Akt pathway is a prominent feature of many human cancers and Akt is over-expressed or activated in all major cancers.  Akt is considered an attractive target for cancer therapy and inhibition of Akt alone or in combination with std. cancer chemotherapeutics has been postulated to reduce the apoptotic threshold and preferentially kill cancer cells.  The development of specific and potent inhibitors will allow this hypothesis to be tested in animals.  Recently, several series of small mol., ATP-competitive inhibitors have been reported with a range of Akt potencies and selectivities.  Phosphatidylinositol (PI) analogs have been reported to inhibit Akt, but these inhibitors may also have specificity problems with respect to other pleckstrin homol. (PH) domain contg. proteins and may have poor bioavailability.  In addn., novel allosteric inhibitors have been reported which are PH domain dependent, exhibit selectivity for the individual Akt isoenzymes and inhibit the activity and the activation of Akt.  Compds. within these classes Akt inhibitors have sufficient potency and specificity to test for tumor efficacy in animal models and recently reported preliminary expts. are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnh2ym_1aqP7Vg90H21EOLACvtfcHk0ljWVzY75T2LoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1SmtbrK&md5=e717b21ffac302e074bf80a7897e2591</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F156802607781696864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781696864%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DYaroschak%26aufirst%3DM.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520ATP-Competitive%2520and%2520Allosteric%2520Akt%2520Kinase%2520Inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1349%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Li, Q.</span><span> </span><span class="NLM_article-title">Recent Progress in the Discovery of Akt Inhibitors as Anticancer Agents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">–</span> <span class="NLM_lpage">1130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1517%2F13543776.17.9.1077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1077-1130&author=Q.+Li&title=Recent+Progress+in+the+Discovery+of+Akt+Inhibitors+as+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of Akt inhibitors as anticancer agents</span></div><div class="casAuthors">Li, Qun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1077-1130</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Akt, also referred to as protein kinase B (PKB) or Related to A and C (RAC), is one of the major direct downstream targets of phosphoinositide 3-kinase (PI3K).  As it plays a central role in promoting cancer cell proliferation and survival through a growing list of key substrates, intense efforts are underway to find inhibitors of Akt for the treatment of cancer.  Discovery of potent and novel inhibitors of Akt has been facilitated greatly by the availability of the x-ray structure of the active form of Akt and by its structural similarity with other serine/threonine kinases.  In this review, new Akt inhibitors for the treatment of cancer are comprehensively reviewed, with emphasis on small mol. inhibitors that bind to the ATP-binding site, allosteric sites and the PH domains.  Inhibitors of pseudosubstrates and antisense oligonucleotides, as well as Akt inhibitors with unknown mechanism of actions, are also reviewed.  Results of clin. trials of several Akt drug candidates are briefly discussed.  A brief summary of Akt structure and regulation and the evidences supporting Akt as a cancer target is provided as well.  The patent literature is surveyed through July 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOO0MMNIO1cbVg90H21EOLACvtfcHk0lihmEQAcUAHlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7K&md5=1dab6d144639d87043ce13f16eec6073</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.9.1077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.9.1077%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Discovery%2520of%2520Akt%2520Inhibitors%2520as%2520Anticancer%2520Agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D1077%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safonov, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, S. K.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of AKT/PKB Kinase as a Strategy for Treating Cancer</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=365-376&author=D.+A.+Heerdingauthor=I.+G.+Safonovauthor=S.+K.+Verma&title=Small+Molecule+Inhibitors+of+AKT%2FPKB+Kinase+as+a+Strategy+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DSafonov%26aufirst%3DI.%2BG.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520AKT%252FPKB%2520Kinase%2520as%2520a%2520Strategy%2520for%2520Treating%2520Cancer%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D365%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jefferson, A. B.</span><span> </span><span class="NLM_article-title">Discovery Oof 2-Pyrimidyl-5-Amidothiophenes as Potent Inhibitors for AKT: Synthesis and SAR Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4163</span><span class="NLM_x">–</span> <span class="NLM_lpage">4168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4163-4168&author=X.+Linauthor=J.+M.+Murrayauthor=A.+C.+Ricoauthor=M.+X.+Wangauthor=D.+T.+Chuauthor=Y.+Zhouauthor=M.+Del+Rosarioauthor=S.+Kaufmanauthor=S.+Maauthor=E.+Fangauthor=K.+Crawfordauthor=A.+B.+Jefferson&title=Discovery+Oof+2-Pyrimidyl-5-Amidothiophenes+as+Potent+Inhibitors+for+AKT%3A+Synthesis+and+SAR+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DRico%26aufirst%3DA.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BX.%26aulast%3DChu%26aufirst%3DD.%2BT.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDel%2BRosario%26aufirst%3DM.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DE.%26aulast%3DCrawford%26aufirst%3DK.%26aulast%3DJefferson%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520Oof%25202-Pyrimidyl-5-Amidothiophenes%2520as%2520Potent%2520Inhibitors%2520for%2520AKT%253A%2520Synthesis%2520and%2520SAR%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4163%26epage%3D4168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavetsias, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L.-J.K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Isoquinoline-5-Sulfonamide Inhibitors of Protein Kinase B</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1255-1273&author=I.+Collinsauthor=J.+Caldwellauthor=T.+Fonsecaauthor=A.+Donaldauthor=V.+Bavetsiasauthor=L.-J.K.+Hunterauthor=M.+D.+Garrettauthor=M.+G.+Rowlandsauthor=G.+W.+Aherneauthor=T.+G.+Daviesauthor=V.+Berdiniauthor=S.+J.+Woodheadauthor=D.+Daviesauthor=L.+C.+A.+Seaversauthor=P.+G.+Wyattauthor=P.+Workmanauthor=E.+McDonald&title=Structure-Based+Design+of+Isoquinoline-5-Sulfonamide+Inhibitors+of+Protein+Kinase+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DFonseca%26aufirst%3DT.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DHunter%26aufirst%3DL.-J.K.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DWoodhead%26aufirst%3DS.%2BJ.%26aulast%3DDavies%26aufirst%3DD.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%2BA.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DMcDonald%26aufirst%3DE.%26atitle%3DStructure-Based%2520Design%2520of%2520Isoquinoline-5-Sulfonamide%2520Inhibitors%2520of%2520Protein%2520Kinase%2520B%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1255%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powlas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonigal, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinghofer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramling-Evans, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mika, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span> </span><span class="NLM_article-title">Potent and Selective Inhibitors of Akt Kinases Slow the Progress of Tumors in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1158%2F1535-7163.MCT-05-0005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15956255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFWrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=977-986&author=Y.+Luoauthor=A.+R.+Shoemakerauthor=X.+Liuauthor=K.+W.+Woodsauthor=S.+A.+Thomasauthor=R.+de+Jongauthor=E.+K.+Hanauthor=T.+Liauthor=V.+S.+Stollauthor=J.+A.+Powlasauthor=A.+Oleksijewauthor=M.+J.+Mittenauthor=Y.+Shiauthor=R.+Guanauthor=T.+P.+McGonigalauthor=V.+Klinghoferauthor=E.+F.+Johnsonauthor=J.+D.+Leversonauthor=J.+J.+Bouskaauthor=M.+Mamoauthor=R.+A.+Smithauthor=E.+E.+Gramling-Evansauthor=B.+A.+Zinkerauthor=A.+K.+Mikaauthor=P.+T.+Nguyenauthor=T.+Oltersdorfauthor=S.+H.+Rosenbergauthor=Q.+Liauthor=V.+L.+Giranda&title=Potent+and+Selective+Inhibitors+of+Akt+Kinases+Slow+the+Progress+of+Tumors+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo</span></div><div class="casAuthors">Luo, Yan; Shoemaker, Alexander R.; Liu, Xuesong; Woods, Keith W.; Thomas, Sheela A.; de Jong, Ron; Han, Edward K.; Li, Tongmei; Stoll, Vincent S.; Powlas, Jessica A.; Oleksijew, Anatol; Mitten, Michael J.; Shi, Yan; Guan, Ran; McGonigal, Thomas P.; Klinghofer, Vered; Johnson, Eric F.; Leverson, Joel D.; Bouska, Jennifer J.; Mamo, Mulugeta; Smith, Richard A.; Gramling-Evans, Emily E.; Zinker, Bradley A.; Mika, Amanda K.; Nguyen, Phong T.; Oltersdorf, Tilman; Rosenberg, Saul H.; Li, Qun; Giranda, Vincent L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">977-986</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Akt kinases are central nodes in signal transduction pathways that are important for cellular transformation and tumor progression.  We report the development of a series of potent and selective indazole-pyridine based Akt inhibitors.  These compds., exemplified by A-443654 (Ki = 160 pmol/L vs. Akt1), inhibit Akt-dependent signal transduction in cells and in vivo in a dose-responsive manner.  In vivo, the Akt inhibitors slow the progression of tumors when used as monotherapy or in combination with paclitaxel or rapamycin.  Tumor growth inhibition was obsd. during the dosing interval, and the tumors regrew when compd. administration was ceased.  The therapeutic window for these compds. is narrow.  Efficacy is achieved at doses ∼2-fold lower than the maximally tolerated doses.  Consistent with data from knockout animals, the Akt inhibitors induce an increase in insulin secretion.  They also induce a reactive increase in Akt phosphorylation.  Other toxicities obsd., including malaise and wt. loss, are consistent with abnormalities in glucose metab.  These data show that direct Akt inhibition may be useful in cancer therapy, but significant metabolic toxicities are likely dose limiting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKR0NQe3pou7Vg90H21EOLACvtfcHk0lihmEQAcUAHlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFWrtr4%253D&md5=c83ac9ab9b7a880ae34bc8c7792ced31</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0005%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DThomas%26aufirst%3DS.%2BA.%26aulast%3Dde%2BJong%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DPowlas%26aufirst%3DJ.%2BA.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DMcGonigal%26aufirst%3DT.%2BP.%26aulast%3DKlinghofer%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DMamo%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DGramling-Evans%26aufirst%3DE.%2BE.%26aulast%3DZinker%26aufirst%3DB.%2BA.%26aulast%3DMika%26aufirst%3DA.%2BK.%26aulast%3DNguyen%26aufirst%3DP.%2BT.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26atitle%3DPotent%2520and%2520Selective%2520Inhibitors%2520of%2520Akt%2520Kinases%2520Slow%2520the%2520Progress%2520of%2520Tumors%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D977%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of 2,3,5-Trisubstituted Pyridine Derivatives as Potent Akt1 and Akt2 Dual Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1016%2Fj.bmcl.2004.12.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15686884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1elug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=905-909&author=Z.+Zhaoauthor=W.+H.+Leisterauthor=R.+G.+Robinsonauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=H.+E.+Huberauthor=M.+E.+Dugganauthor=C.+W.+Lindsley&title=Discovery+of+2%2C3%2C5-Trisubstituted+Pyridine+Derivatives+as+Potent+Akt1+and+Akt2+Dual+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors</span></div><div class="casAuthors">Zhao, Zhijian; Leister, William H.; Robinson, Ronald G.; Barnett, Stanley F.; Defeo-Jones, Deborah; Jones, Raymond E.; Hartman, George D.; Huff, Joel R.; Huber, Hans E.; Duggan, Mark E.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">905-909</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This letter describes the discovery of a novel series of dual Akt1/Akt2 kinase inhibitors, based on a 2,3,5-trisubstituted pyridine scaffold.  Compds. from this series, which contain a 5-tetrazolyl moiety, exhibit more potent inhibition of Akt2 than Akt1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJOzjnuD-86LVg90H21EOLACvtfcHk0lgB8GmgnQqgOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1elug%253D%253D&md5=a61e2d83a2d7ffdb660255e341deaa9c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.062%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%25202%252C3%252C5-Trisubstituted%2520Pyridine%2520Derivatives%2520as%2520Potent%2520Akt1%2520and%2520Akt2%2520Dual%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D905%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span> </span><span class="NLM_article-title">A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6652</span><span class="NLM_x">–</span> <span class="NLM_lpage">6659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1158%2F0008-5472.CAN-04-1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15374980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6652-6659&author=E.+R.+Woodauthor=A.+T.+Truesdaleauthor=O.+B.+McDonaldauthor=D.+Yuanauthor=A.+Hassellauthor=A.+H.+Dickersonauthor=B.+Ellisauthor=C.+Pennisiauthor=E.+Horneauthor=K.+Lackeyauthor=K.+J.+Alligoodauthor=D.+W.+Rusnakauthor=T.+M.+Gilmerauthor=L.+Shewchuk&title=A+Unique+Structure+for+Epidermal+Growth+Factor+Receptor+Bound+to+GW572016+%28Lapatinib%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells</span></div><div class="casAuthors">Wood, Edgar R.; Truesdale, Anne T.; McDonald, Octerloney B.; Yuan, Derek; Hassell, Anne; Dickerson, Scott H.; Ellis, Byron; Pennisi, Christopher; Horne, Earnest; Lackey, Karen; Alligood, Krystal J.; Rusnak, David W.; Gilmer, Tona M.; Shewchuk, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6652-6659</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GW572016 (Lapatinib) is a tyrosine kinase inhibitor in clin. development for cancer that is a potent dual inhibitor of epidermal growth factor receptor (EGFR, ErbB-1) and ErbB-2.  The authors detd. the crystal structure of EGFR bound to GW572016.  The compd. is bound to an inactive-like conformation of EGFR that is very different from the active-like structure bound by the selective EGFR inhibitor OSI-774 (Tarceva) described previously.  Surprisingly, the authors found that GW572016 has a very slow off-rate from the purified intracellular domains of EGFR and ErbB-2 compared with OSI-774 and another EGFR selective inhibitor, ZD-1839 (Iressa).  Treatment of tumor cells with these inhibitors results in down-regulation of receptor tyrosine phosphorylation.  The authors evaluated the duration of the drug effect after washing away free compd. and found that the rate of recovery of receptor phosphorylation in the tumor cells reflected the inhibitor off-rate from the purified intracellular domain.  The slow off-rate of GW572016 correlates with a prolonged down-regulation of receptor tyrosine phosphorylation in tumor cells.  The differences in the off-rates of these drugs and the ability of GW572016 to inhibit ErbB-2 can be explained by the enzyme-inhibitor structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXjJPy6XYk4rVg90H21EOLACvtfcHk0lgB8GmgnQqgOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D&md5=788d92fc5db9f1ecf9d3fbf3142e5c9f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1168%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DYuan%26aufirst%3DD.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DDickerson%26aufirst%3DA.%2BH.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DPennisi%26aufirst%3DC.%26aulast%3DHorne%26aufirst%3DE.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DA%2520Unique%2520Structure%2520for%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Bound%2520to%2520GW572016%2520%2528Lapatinib%2529%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6652%26epage%3D6659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug−Target Residence Time and Its Implications for Lead Optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug%E2%88%92Target+Residence+Time+and+Its+Implications+for+Lead+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug%25E2%2588%2592Target%2520Residence%2520Time%2520and%2520Its%2520Implications%2520for%2520Lead%2520Optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Rhodes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberwein, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knick, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansing, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geske, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleymenova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhry, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strum, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Characterization of an AKT Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2366</span><span class="NLM_x">–</span> <span class="NLM_lpage">2374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2366-2374&author=N.+Rhodesauthor=D.+A.+Heerdingauthor=D.+R.+Duckettauthor=D.+J.+Eberweinauthor=V.+B.+Knickauthor=T.+J.+Lansingauthor=R.+T.+McConnellauthor=T.+M.+Gilmerauthor=S.+Y.+Zhangauthor=K.+Robellauthor=J.+A.+Kahanaauthor=R.+S.+Geskeauthor=E.+V.+Kleymenovaauthor=A.+E.+Choudhryauthor=Z.+V.+Laiauthor=J.+D.+Leberauthor=E.+A.+Minthornauthor=S.+L.+Strumauthor=E.+R.+Woodauthor=P.+S.+Huangauthor=R.+Kumar&title=Characterization+of+an+AKT+Kinase+Inhibitor+with+Potent+Pharmacodynamic+and+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRhodes%26aufirst%3DN.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DDuckett%26aufirst%3DD.%2BR.%26aulast%3DEberwein%26aufirst%3DD.%2BJ.%26aulast%3DKnick%26aufirst%3DV.%2BB.%26aulast%3DLansing%26aufirst%3DT.%2BJ.%26aulast%3DMcConnell%26aufirst%3DR.%2BT.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DZhang%26aufirst%3DS.%2BY.%26aulast%3DRobell%26aufirst%3DK.%26aulast%3DKahana%26aufirst%3DJ.%2BA.%26aulast%3DGeske%26aufirst%3DR.%2BS.%26aulast%3DKleymenova%26aufirst%3DE.%2BV.%26aulast%3DChoudhry%26aufirst%3DA.%2BE.%26aulast%3DLai%26aufirst%3DZ.%2BV.%26aulast%3DLeber%26aufirst%3DJ.%2BD.%26aulast%3DMinthorn%26aufirst%3DE.%2BA.%26aulast%3DStrum%26aufirst%3DS.%2BL.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520an%2520AKT%2520Kinase%2520Inhibitor%2520with%2520Potent%2520Pharmacodynamic%2520and%2520Antitumor%2520Activity%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2366%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bailey, N.; Bamford, M. J.; Garland, S.; Goodman, K. B.; Cui, H; Hilfiker, M. A.; Lee, D.; Panchal, T. A.; Stavenger, R. A.; Wilson, D. M.; Witherington, J.</span> WO2003080610 A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bailey%2C+N.%3B+Bamford%2C+M.+J.%3B+Garland%2C+S.%3B+Goodman%2C+K.+B.%3B+Cui%2C+H%3B+Hilfiker%2C+M.+A.%3B+Lee%2C+D.%3B+Panchal%2C+T.+A.%3B+Stavenger%2C+R.+A.%3B+Wilson%2C+D.+M.%3B+Witherington%2C+J.+WO2003080610+A1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DN.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bamford, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steadman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span> </span><span class="NLM_article-title">(1<i>H</i>-Imidazo[4,5-<i>C</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine Derivatives: Further Optimisation as Highly Potent and Selective MSK-1-Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3407</span><span class="NLM_x">–</span> <span class="NLM_lpage">3411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3407-3411&author=M.+A.+Bamfordauthor=N.+Baileyauthor=S.+Daviesauthor=D.+K.+Deanauthor=L.+Francisauthor=T.+A.+Panchalauthor=C.+A.+Parrauthor=S.+Sehmiauthor=J.+G.+Steadmanauthor=A.+K.+Takleauthor=J.+T.+Townsendauthor=D.+M.+Wilson&title=%281H-Imidazo%5B4%2C5-C%5Dpyridin-2-yl%29-1%2C2%2C5-oxadiazol-3-ylamine+Derivatives%3A+Further+Optimisation+as+Highly+Potent+and+Selective+MSK-1-Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBamford%26aufirst%3DM.%2BA.%26aulast%3DBailey%26aufirst%3DN.%26aulast%3DDavies%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DFrancis%26aufirst%3DL.%26aulast%3DPanchal%26aufirst%3DT.%2BA.%26aulast%3DParr%26aufirst%3DC.%2BA.%26aulast%3DSehmi%26aufirst%3DS.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DTownsend%26aufirst%3DJ.%2BT.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26atitle%3D%25281H-Imidazo%255B4%252C5-C%255Dpyridin-2-yl%2529-1%252C2%252C5-oxadiazol-3-ylamine%2520Derivatives%253A%2520Further%2520Optimisation%2520as%2520Highly%2520Potent%2520and%2520Selective%2520MSK-1-Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3407%26epage%3D3411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bamford, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberti, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steadman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">(1<i>H</i>-Imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine Derivatives: A Novel Class of Potent MSK-1-Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3402</span><span class="NLM_x">–</span> <span class="NLM_lpage">3406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3402-3406&author=M.+J.+Bamfordauthor=M.+J.+Albertiauthor=N.+Baileyauthor=S.+Daviesauthor=D.+K.+Deanauthor=A.+Gaibaauthor=S.+Garlandauthor=J.+D.+Harlingauthor=D.+K.+Jungauthor=T.+A.+Panchalauthor=C.+A.+Parrauthor=J.+G.+Steadmanauthor=A.+K.+Takleauthor=T.+Townsendauthor=D.+M.+Wilsonauthor=J.+Witherington&title=%281H-Imidazo%5B4%2C5-c%5Dpyridin-2-yl%29-1%2C2%2C5-oxadiazol-3-ylamine+Derivatives%3A+A+Novel+Class+of+Potent+MSK-1-Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DAlberti%26aufirst%3DM.%2BJ.%26aulast%3DBailey%26aufirst%3DN.%26aulast%3DDavies%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DGarland%26aufirst%3DS.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DPanchal%26aufirst%3DT.%2BA.%26aulast%3DParr%26aufirst%3DC.%2BA.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DTownsend%26aufirst%3DT.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3D%25281H-Imidazo%255B4%252C5-c%255Dpyridin-2-yl%2529-1%252C2%252C5-oxadiazol-3-ylamine%2520Derivatives%253A%2520A%2520Novel%2520Class%2520of%2520Potent%2520MSK-1-Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3402%26epage%3D3406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Stavenger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaitanopoulos, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfiker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viet, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060873p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2-5&author=R.+A.+Stavengerauthor=H.+Cuiauthor=S.+E.+Dowdellauthor=R.+G.+Franzauthor=D.+E.+Gaitanopoulosauthor=K.+B.+Goodmanauthor=M.+A.+Hilfikerauthor=R.+L.+Ivyauthor=J.+D.+Leberauthor=J.+P.+Marinoauthor=H.-J.+Ohauthor=A.+Q.+Vietauthor=W.+Xuauthor=G.+Yeauthor=D.+Zhangauthor=Y.+Zhaoauthor=L.+J.+Jolivetteauthor=M.+S.+Headauthor=S.+F.+Semusauthor=P.+E.+Elkinsauthor=R.+B.+Kirkpatrickauthor=E.+Dulauthor=S.+S.+Khandekarauthor=T.+Yiauthor=D.+K.+Jungauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=D.+J.+Behmauthor=C.+P.+Doeauthor=R.+Bentleyauthor=Z.+X.+Chenauthor=E.+Huauthor=D.+Lee&title=Discovery+of+Aminofurazan-azabenzimidazoles+as+Inhibitors+of+Rho-Kinase+with+High+Kinase+Selectivity+and+Antihypertensive+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm060873p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060873p%26sid%3Dliteratum%253Aachs%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DDowdell%26aufirst%3DS.%2BE.%26aulast%3DFranz%26aufirst%3DR.%2BG.%26aulast%3DGaitanopoulos%26aufirst%3DD.%2BE.%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DHilfiker%26aufirst%3DM.%2BA.%26aulast%3DIvy%26aufirst%3DR.%2BL.%26aulast%3DLeber%26aufirst%3DJ.%2BD.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DViet%26aufirst%3DA.%2BQ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DHead%26aufirst%3DM.%2BS.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DElkins%26aufirst%3DP.%2BE.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DZ.%2BX.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520Aminofurazan-azabenzimidazoles%2520as%2520Inhibitors%2520of%2520Rho-Kinase%2520with%2520High%2520Kinase%2520Selectivity%2520and%2520Antihypertensive%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Irani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SantaLucia, J.,  Jr.</span><span> </span><span class="NLM_article-title">The Synthesis of Anti-Fixed 3-Methyl-3-deaza-2′-deoxyadenosine and Other 3<i>H</i>-Imidazo[4,5-<i>C</i>]pyridine Analogs</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1081%2FNCN-120016477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=12537017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslSq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=737-751&author=R.+J.+Iraniauthor=J.+SantaLucia&title=The+Synthesis+of+Anti-Fixed+3-Methyl-3-deaza-2%E2%80%B2-deoxyadenosine+and+Other+3H-Imidazo%5B4%2C5-C%5Dpyridine+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of anti-fixed 3-methyl-3-deaza-2'-deoxyadenosine and other 3H-imidazo[4,5-c]pyridine analogs</span></div><div class="casAuthors">Irani, Rostem J.; SantaLucia, John, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11 & 12</span>),
    <span class="NLM_cas:pages">737-751</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Rotation of a heterocyclic base around a glycosidic bond allows the formation of syn and anti conformations in nucleosides.  The syn conformation has been obsd. primarily in purine-purine mismatches in DNA duplexes.  Such mismatches give rise to false pos. oligonucleotide hybridization in DNA-based diagnostics.  Here the authors describe the synthesis of an analog of 2'-deoxyadenosine that retains its Watson-Crick functional groups, but cannot form the syn conformation.  In this analog, the N3 atom of 2'-deoxyadenosine is replaced by a C-CH3 group to give 7-methyl-1-β-D-deoxyribofuranosyl-1H-imidazo[4,5-c]pyridin-4-ylamine or 3-methyl-3-deaza-2'-deoxyadenosine (3mddA).  This modification sterically prevents the syn conformation and 3mddA becomes an anti-fixed nucleoside analog of 2'-deoxyadenosine.  The synthesis and conformational anal. of 3mddA and several analogs with an 3H-imidazo[4,5-c]pyridine skeleton are described, as well as their potential applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ0s7FQtdxurVg90H21EOLACvtfcHk0lgHSmV6B9viJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslSq&md5=f42a7a0aa035b6cb82098e710129a7ea</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1081%2FNCN-120016477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-120016477%26sid%3Dliteratum%253Aachs%26aulast%3DIrani%26aufirst%3DR.%2BJ.%26aulast%3DSantaLucia%26aufirst%3DJ.%26atitle%3DThe%2520Synthesis%2520of%2520Anti-Fixed%25203-Methyl-3-deaza-2%25E2%2580%25B2-deoxyadenosine%2520and%2520Other%25203H-Imidazo%255B4%252C5-C%255Dpyridine%2520Analogs%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2002%26volume%3D21%26spage%3D737%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Corbet, J. -P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignani, G.</span><span> </span><span class="NLM_article-title">Selected Patented Cross-Coupling Reaction Technologies</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">2651</span><span class="NLM_x">–</span> <span class="NLM_lpage">2710</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0505268" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVeltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=2651-2710&author=J.+-P.+Corbetauthor=G.+Mignani&title=Selected+Patented+Cross-Coupling+Reaction+Technologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Selected patented cross-coupling reaction technologies</span></div><div class="casAuthors">Corbet, Jean-Pierre; Mignani, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2651-2710</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review dealing with cross-coupling reactions : carbon-carbon coupling reactions (Miyaura-Suzuki reaction, Corriu-Kumada-Tamao reaction, Negishi reaction, etc.) and carbon-nitrogen coupling reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIXYOdKmkYGbVg90H21EOLACvtfcHk0lgHSmV6B9viJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVeltLk%253D&md5=b10d7f1479363f644363f7434e172ee1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr0505268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0505268%26sid%3Dliteratum%253Aachs%26aulast%3DCorbet%26aufirst%3DJ.%2B-P.%26aulast%3DMignani%26aufirst%3DG.%26atitle%3DSelected%2520Patented%2520Cross-Coupling%2520Reaction%2520Technologies%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26spage%3D2651%26epage%3D2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Chinchilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, C.</span><span> </span><span class="NLM_article-title">The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">874</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr050992x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2007&pages=874-922&author=R.+Chinchillaauthor=C.+Najera&title=The+Sonogashira+Reaction%3A+A+Booming+Methodology+in+Synthetic+Organic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Sonogashira reaction: a booming methodology in synthetic organic chemistry</span></div><div class="casAuthors">Chinchilla, Rafael; Najera, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-922</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The palladium-catalyzed sp2-sp coupling reaction between aryl or alkenyl halides or triflates and terminal alkynes, with or without the presence of copper(I) cocatalyst, was reviewed.  The mechanism of Sonogashira reaction was discussed, and the catalysts and reaction conditions were explored as well.  In addn., the application of Sonogashira cross-coupling reaction was also introduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ8ePd8RdbSrVg90H21EOLACvtfcHk0ljOCeOn1lhfHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbc%253D&md5=91f627efbf940c60809c2acfe597d3b7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcr050992x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr050992x%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DR.%26aulast%3DNajera%26aufirst%3DC.%26atitle%3DThe%2520Sonogashira%2520Reaction%253A%2520A%2520Booming%2520Methodology%2520in%2520Synthetic%2520Organic%2520Chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2007%26volume%3D107%26spage%3D874%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barford, D.</span><span> </span><span class="NLM_article-title">Crystal Structure of an Activated Akt/Protein Kinase B Ternary Complex with GSK3-Peptide and AMP-PNP</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">940</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=940-944&author=J.+Yangauthor=P.+Cronauthor=V.+M.+Goodauthor=V.+Thompsonauthor=B.+A.+Hemmingsauthor=D.+Barford&title=Crystal+Structure+of+an+Activated+Akt%2FProtein+Kinase+B+Ternary+Complex+with+GSK3-Peptide+and+AMP-PNP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DCron%26aufirst%3DP.%26aulast%3DGood%26aufirst%3DV.%2BM.%26aulast%3DThompson%26aufirst%3DV.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26aulast%3DBarford%26aufirst%3DD.%26atitle%3DCrystal%2520Structure%2520of%2520an%2520Activated%2520Akt%252FProtein%2520Kinase%2520B%2520Ternary%2520Complex%2520with%2520GSK3-Peptide%2520and%2520AMP-PNP%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D940%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><div class="note"><p class="first last">For a excellent description of the various binding pockets available to protein kinase inhibitors, see the following:</p></div><span class="NLM_contrib-group">Liao, J.J.-L.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.J.-L.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0ljOCeOn1lhfHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.J.-L.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><div class="note"><p class="first last">BT474 is a breast tumor line chosen because it has activated AKT1 and AKT2 by virtue of ErbB2 overexpression. See the following:</p></div><span class="NLM_contrib-group">Nicholson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streuli, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, N. G.</span><span> </span><span class="NLM_article-title">Autocrine Signalling through Erbb Receptors Promotes Constitutive Activation of Protein Kinase B/Akt in Breast Cancer Cell Lines</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1023%2FA%3A1025765215765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=14572154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlGqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2003&pages=117-128&author=K.+M.+Nicholsonauthor=C.+H.+Streuliauthor=N.+G.+Anderson&title=Autocrine+Signalling+through+Erbb+Receptors+Promotes+Constitutive+Activation+of+Protein+Kinase+B%2FAkt+in+Breast+Cancer+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Autocrine Signalling Through erbB Receptors Promotes Constitutive Activation of Protein Kinase B/Akt in Breast Cancer Cell Lines</span></div><div class="casAuthors">Nicholson, K. M.; Streuli, C. H.; Anderson, N. G.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-128</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">The protein kinase PKB/Akt plays a pivotal role in promoting cell survival and proliferation.  This study investigated the regulation of PKB/Akt activity in breast cancer cells.  In primary invasive breast cancers PKB/Akt exhibited elevated phosphorylation at regulatory site Ser473 in 80% of cases, using immunohistochem.  The degree of phospho-PKB/Akt immunoreactivity was pos. correlated with the extent of its nuclear accumulation.  Moderate/strong staining was seen in 31% of the samples but was absent in tumor-assocd. normal breast epithelia.  To examine the mechanisms of PKB/Akt activation, the authors studied its phosphorylation in a panel of breast cancer cell lines.  PKB/Akt was constitutively phosphorylated on both regulatory sites (Thr308 and Ser473) in the absence of serum growth factors in 7 of 8 lines but not in 2 cell lines derived from normal breast epithelia.  Further anal. revealed that constitutive PKB/Akt phosphorylation was assocd. with loss of PTEN phosphatase expression (CAL51, MDA-MB-468, BT549 cells) and constitutive activation of erbB2 (SKBR3, BT474 cells).  In 2 further breast cancer lines (T47D and HS578T) PKB/Akt phosphorylation was dependent upon autocrine factors acting primary through the epidermal growth factor receptor (EGFR) and erbB2.  Conditioned medium from HS578T cells stimulated EGFR-dependent PKB/Akt phosphorylation in normal breast cells.  These results demonstrate that PKB/Akt is frequently activated in breast cancer through diverse mechanisms, including autocrine signaling via erbB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2xFosv5sCrVg90H21EOLACvtfcHk0lg_KOheyWoSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlGqtrk%253D&md5=6efd41e8e1918beb3c7b75ab581a31fe</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1023%2FA%3A1025765215765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1025765215765%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DK.%2BM.%26aulast%3DStreuli%26aufirst%3DC.%2BH.%26aulast%3DAnderson%26aufirst%3DN.%2BG.%26atitle%3DAutocrine%2520Signalling%2520through%2520Erbb%2520Receptors%2520Promotes%2520Constitutive%2520Activation%2520of%2520Protein%2520Kinase%2520B%252FAkt%2520in%2520Breast%2520Cancer%2520Cell%2520Lines%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2003%26volume%3D81%26spage%3D117%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">LNCaP is a prostate line chosen because it has consitutively activated AKT1. See the following:</p></div><span class="NLM_contrib-group">Nakatani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaue, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigel, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, R. A.</span><span> </span><span class="NLM_article-title">Up-Regulation of Akt3 on Estrogen Receptor-Deficient Breast Cancers and Androgen-Independent Prostate Cancer Lines</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">21528</span><span class="NLM_x">–</span> <span class="NLM_lpage">21532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=21528-21532&author=K.+Nakataniauthor=D.+A.+Thompsonauthor=A.+Barthelauthor=H.+Sakaueauthor=W.+Liuauthor=R.+J.+Weigelauthor=R.+A.+Roth&title=Up-Regulation+of+Akt3+on+Estrogen+Receptor-Deficient+Breast+Cancers+and+Androgen-Independent+Prostate+Cancer+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakatani%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DBarthel%26aufirst%3DA.%26aulast%3DSakaue%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWeigel%26aufirst%3DR.%2BJ.%26aulast%3DRoth%26aufirst%3DR.%2BA.%26atitle%3DUp-Regulation%2520of%2520Akt3%2520on%2520Estrogen%2520Receptor-Deficient%2520Breast%2520Cancers%2520and%2520Androgen-Independent%2520Prostate%2520Cancer%2520Lines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D21528%26epage%3D21532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><div class="note"><p class="first last">The inhibition of 89 protein kinases by <b>3g</b> was characterized at GlaxoSmithKline. In addition, <b>3g</b> was also tested in the IC<sub>50</sub> Profiler Express panel (Upstate, Charlottesville, VA) against 209 protein kinases using filter binding activity assays and in the Ambit Biosciences (San Diego, CA) panel against 180 protein kinases measuring binding with phage display technology. As much as possible, the assays were configured so that the IC<sub>50</sub> values approximate the intrinsic binding constant (<i>K</i><sub>i</sub> or <i>K</i><sub>d</sub>) of <b>3g</b> to each enzyme and can therefore be compared for selectivity against these kinases.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+inhibition+of+89+protein+kinases+by+3g+was+characterized+at+GlaxoSmithKline.+In+addition%2C+3g+was+also+tested+in+the+IC50+Profiler+Express+panel+%28Upstate%2C+Charlottesville%2C+VA%29+against+209+protein+kinases+using+filter+binding+activity+assays+and+in+the+Ambit+Biosciences+%28San+Diego%2C+CA%29+panel+against+180+protein+kinases+measuring+binding+with+phage+display+technology.+As+much+as+possible%2C+the+assays+were+configured+so+that+the+IC50+values+approximate+the+intrinsic+binding+constant+%28Ki+or+Kd%29+of+3g+to+each+enzyme+and+can+therefore+be+compared+for+selectivity+against+these+kinases."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Dummler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">Physiological Roles of PKB/Akt Isoforms in Development and Disease</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1042%2FBST0350231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=17371246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1WrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=231-235&author=B.+Dummlerauthor=B.+A.+Hemmings&title=Physiological+Roles+of+PKB%2FAkt+Isoforms+in+Development+and+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological roles of PKB/Akt isoforms in development and disease</span></div><div class="casAuthors">Dummler, B.; Hemmings, B. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-235</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  PKB (protein kinase B, also known as Akt) is a serine/threonine protein kinase that is important in various signaling cascades and acts as a major signal transducer downstream of activated phosphoinositide 3-kinase.  There are three closely related isoforms of PKB in mammalian cells, PKBα (Akt1), PKBβ (Akt2) and PKBγ (Akt3), and this review discusses recent advances in our understanding of the functions of these isoforms in the regulation of adipocyte differentiation, glucose homeostasis and tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo2CyTsdm-MrVg90H21EOLACvtfcHk0lg_KOheyWoSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1WrsLg%253D&md5=bd50e4a8a2424c2f65f79e4967d9a0d8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1042%2FBST0350231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0350231%26sid%3Dliteratum%253Aachs%26aulast%3DDummler%26aufirst%3DB.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DPhysiological%2520Roles%2520of%2520PKB%252FAkt%2520Isoforms%2520in%2520Development%2520and%2520Disease%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26spage%3D231%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketih, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">The Effects of the Novel, Reversible Epidermal Growth Factor Receptor/Erbb-2 Tyrosine Kinase Inhibitor, GW2016, on the Growth of Human Normal and Tumor-Derived Cell Lines in Vitro and in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=12467226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=85-94&author=D.+W.+Rusnakauthor=K.+Lackeyauthor=K.+Affleckauthor=E.+R.+Woodauthor=K.+J.+Alligoodauthor=N.+Rhodesauthor=B.+R.+Ketihauthor=D.+M.+Murrayauthor=W.+B.+Knightauthor=R.+J.+Mullinauthor=T.+M.+Gilmer&title=The+Effects+of+the+Novel%2C+Reversible+Epidermal+Growth+Factor+Receptor%2FErbb-2+Tyrosine+Kinase+Inhibitor%2C+GW2016%2C+on+the+Growth+of+Human+Normal+and+Tumor-Derived+Cell+Lines+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo</span></div><div class="casAuthors">Rusnak, David W.; Lackey, Karen; Affleck, Karen; Wood, Edgar R.; Alligood, Krystal J.; Rhodes, Nelson; Keith, Barry R.; Murray, Doris M.; Knight, W. Blaine; Mullin, Robert J.; Gilmer, Tona M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-94</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) and ErbB-2 transmembrane tyrosine kinases are currently being targeted by various mechanisms in the treatment of cancer.  GW2016 is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, resp.  This report describes the efficacy in cell growth assays of GW2016 on human tumor cell lines overexpressing either EGFR or ErbB-2: HN5 (head and neck), A-431 (vulva), BT474 (breast), CaLu-3 (lung), and N87 (gastric).  Normal human foreskin fibroblasts, nontumorigenic epithelial cells (HB4a), and nonoverexpressing tumor cells (MCF-7 and T47D) were tested as neg. controls.  After 3 days of compd. exposure, av. IC50 values for growth inhibition in the EGFR- and ErbB-2-overexpressing tumor cell lines were <0.16 μM.  The av. selectivity for the tumor cells vs. the human foreskin fibroblast cell line was 100-fold.  Inhibition of EGFR and ErbB-2 receptor autophosphorylation and phosphorylation of the downstream modulator, AKT, was verified by Western blot anal. in the BT474 and HN5 cell lines.  As a measure of cytotoxicity vs. growth arrest, the HN5 and BT474 cells were assessed in an outgrowth assay after a transient exposure to GW2016.  The cells were treated for 3 days in five concns. of GW2016, and cell growth was monitored for an addnl. 12 days after removal of the compd.  In each of these tumor cell lines, concns. of GW2016 were reached where outgrowth did not occur.  Furthermore, growth arrest and cell death were obsd. in parallel expts., as detd. by bromodeoxyuridine incorporation and propidium iodide staining.  GW2016 treatment inhibited tumor xenograft growth of the HN5 and BT474 cells in a dose-responsive manner at 30 and 100 mg/kg orally, twice daily, with complete inhibition of tumor growth at the higher dose.  Together, these results indicate that GW2016 achieves excellent potency on tumor cells with selectivity for tumor vs. normal cells and suggest that GW2016 has value as a therapy for patients with tumors overexpressing either EGFR or ErbB-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5OJ41zsWu6rVg90H21EOLACvtfcHk0ljDJXY2Q6QvrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtbs%253D&md5=64fd8cadce83eda3b9b82ab50f1e57b0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRhodes%26aufirst%3DN.%26aulast%3DKetih%26aufirst%3DB.%2BR.%26aulast%3DMurray%26aufirst%3DD.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DThe%2520Effects%2520of%2520the%2520Novel%252C%2520Reversible%2520Epidermal%2520Growth%2520Factor%2520Receptor%252FErbb-2%2520Tyrosine%2520Kinase%2520Inhibitor%252C%2520GW2016%252C%2520on%2520the%2520Growth%2520of%2520Human%2520Normal%2520and%2520Tumor-Derived%2520Cell%2520Lines%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2001%26volume%3D1%26spage%3D85%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Shults, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauffenburger, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imperiali, B.</span><span> </span><span class="NLM_article-title">A Multiplexed Homogeneous Fluorescence-Based Assay for Protein Kinase Activity in Cell Lysates</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1038%2Fnmeth747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15782220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=277-284&author=M.+D.+Shultsauthor=K.+A.+Janesauthor=D.+A.+Lauffenburgerauthor=B.+Imperiali&title=A+Multiplexed+Homogeneous+Fluorescence-Based+Assay+for+Protein+Kinase+Activity+in+Cell+Lysates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates</span></div><div class="casAuthors">Shults, Melissa D.; Janes, Kevin A.; Lauffenburger, Douglas A.; Imperiali, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New methods to quantify protein kinase activities directly from complex cellular mixts. are crit. for understanding biol. regulatory pathways.  Herein, a fluorescence-based chemosensor strategy for the direct measurement of kinase activities in crude mammalian cell lysates is described.  We first designed a new fluorescent peptide reporter substrate for each target kinase.  These kinase chemosensors were readily phosphorylated by recombinant target enzyme and underwent a several-fold fluorescence increase upon phosphorylation.  Then, using unfractionated cell lysates, a homogeneous kinase assay was developed that was reproducible, linear and highly preferential for monitoring changes in cellular activity of the target kinase.  The general protocol was developed for the kinase Akt and then easily extended to measure protein kinase A (PKA) and mitogen-activated protein kinase-assocd. protein kinase 2 (MK2) activities.  This assay platform is immediately useful for studying protein kinase signaling in crude cellular exts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTEkshX0E50LVg90H21EOLACvtfcHk0ljDJXY2Q6QvrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFejtbs%253D&md5=428545e2f8492bc47ce340cb536a16f4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnmeth747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth747%26sid%3Dliteratum%253Aachs%26aulast%3DShults%26aufirst%3DM.%2BD.%26aulast%3DJanes%26aufirst%3DK.%2BA.%26aulast%3DLauffenburger%26aufirst%3DD.%2BA.%26aulast%3DImperiali%26aufirst%3DB.%26atitle%3DA%2520Multiplexed%2520Homogeneous%2520Fluorescence-Based%2520Assay%2520for%2520Protein%2520Kinase%2520Activity%2520in%2520Cell%2520Lysates%26jtitle%3DNat.%2520Methods%26date%3D2005%26volume%3D2%26spage%3D277%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery. A Guide for Medicinal Chemists and Pharmacologists</span>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery.+A+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery.%2520A%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><div class="note"><p class="first last">See <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><div class="note"><p class="first last">The crystallographic data described have been deposited with the RSCB Protein Data Bank (PDB code for <b>3g</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DOE">3DOE</a>).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+crystallographic+data+described+have+been+deposited+with+the+RSCB+Protein+Data+Bank+%28PDB+code+for+3g%3A+3DOE%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 99 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Svenja Wiechmann, Benjamin Ruprecht, Theresa Siekmann, Runsheng Zheng, Martin Frejno, Elena Kunold, Thomas Bajaj, Daniel P. Zolg, Stephan A. Sieber, Nils C. Gassen, <span class="NLM_string-name hlFld-ContribAuthor">Bernhard Kuster</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Phosphoproteomics Sheds New Light on the Targets and Modes of Action of AKT Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2021,</strong> <em>16 </em>
                                    (4)
                                     , 631-641. <a href="https://doi.org/10.1021/acschembio.0c00872" title="DOI URL">https://doi.org/10.1021/acschembio.0c00872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00872%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DChemical%252BPhosphoproteomics%252BSheds%252BNew%252BLight%252Bon%252Bthe%252BTargets%252Band%252BModes%252Bof%252BAction%252Bof%252BAKT%252BInhibitors%26aulast%3DWiechmann%26aufirst%3DSvenja%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09112020%26date%3D12032021%26date%3D23032021%26volume%3D16%26issue%3D4%26spage%3D631%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ross S. Mancini, Christopher J. Barden, Donald F. Weaver, <span class="NLM_string-name hlFld-ContribAuthor">Mark A. Reed</span>. </span><span class="cited-content_cbyCitation_article-title">Furazans in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1786-1815. <a href="https://doi.org/10.1021/acs.jmedchem.0c01901" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01901%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFurazans%252Bin%252BMedicinal%252BChemistry%26aulast%3DMancini%26aufirst%3DRoss%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03112020%26date%3D11022021%26volume%3D64%26issue%3D4%26spage%3D1786%26epage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaowu Dong, Wenhu Zhan, Mengting Zhao, Jinxin Che, Xiaoyang Dai, Yizhe Wu, Lei Xu, Yubo Zhou, Yanmei Zhao, Tian Tian, Gang Cheng, Zegao Jin, Jia Li, Yanfei Shao, Qiaojun He, Bo Yang, Qinjie Weng, <span class="NLM_string-name hlFld-ContribAuthor">Yongzhou Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 7264-7288. <a href="https://doi.org/10.1021/acs.jmedchem.9b00891" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00891</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00891%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3%25252C4%25252C6-Trisubstituted%252BPiperidine%252BDerivatives%252Bas%252BOrally%252BActive%25252C%252BLow%252BhERG%252BBlocking%252BAkt%252BInhibitors%252Bvia%252BConformational%252BRestriction%252Band%252BStructure-Based%252BDesign%26aulast%3DDong%26aufirst%3DXiaowu%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03062019%26date%3D24072019%26date%3D12072019%26volume%3D62%26issue%3D15%26spage%3D7264%26epage%3D7288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nathan Wlodarchak, Nathan Teachout, Jeffrey Beczkiewicz, Rebecca Procknow, Adam J. Schaenzer, Kenneth Satyshur, Martin Pavelka, William Zuercher, David Drewry, John-Demian Sauer, <span class="NLM_string-name hlFld-ContribAuthor">Rob Striker</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (11)
                                     , 5410-5426. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00905" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00905</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00905%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DIn%252BSilico%252BScreen%252Band%252BStructural%252BAnalysis%252BIdentifies%252BBacterial%252BKinase%252BInhibitors%252Bwhich%252BAct%252Bwith%252B%2525CE%2525B2-Lactams%252BTo%252BInhibit%252BMycobacterial%252BGrowth%26aulast%3DWlodarchak%26aufirst%3DNathan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28082018%26date%3D04102018%26date%3D18102018%26date%3D04102018%26volume%3D15%26issue%3D11%26spage%3D5410%26epage%3D5426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Jianwen A.  Feng</span>, <span class="hlFld-ContribAuthor ">Karen  Lyle</span>, <span class="hlFld-ContribAuthor ">Marcia  Belvin</span>, <span class="hlFld-ContribAuthor ">Jason  Boggs</span>, <span class="hlFld-ContribAuthor ">Jason D.  Burch</span>, <span class="hlFld-ContribAuthor ">Ching-ching  Chua</span>, <span class="hlFld-ContribAuthor ">Haifeng  Cui</span>, <span class="hlFld-ContribAuthor ">Antonio G.  DiPasquale</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Christopher  Heise</span>, <span class="hlFld-ContribAuthor ">Hartmut  Koeppen</span>, <span class="hlFld-ContribAuthor ">Adrian  Kotey</span>, <span class="hlFld-ContribAuthor ">Robert  Mintzer</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">David Allen  Roberts</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>, <span class="hlFld-ContribAuthor ">Christine  Tam</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Yisong  Xiao</span>, <span class="hlFld-ContribAuthor ">Amy  Young</span>, <span class="hlFld-ContribAuthor ">Yamin  Zhang</span>, and <span class="hlFld-ContribAuthor ">Klaus P.  Hoeflich</span>  . </span><span class="cited-content_cbyCitation_article-title">Back Pocket Flexibility Provides Group II p21-Activated Kinase  (PAK) Selectivity for Type I 1/2 Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 1033-1045. <a href="https://doi.org/10.1021/jm401768t" title="DOI URL">https://doi.org/10.1021/jm401768t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401768t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401768t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBack%252BPocket%252BFlexibility%252BProvides%252BGroup%252BII%252Bp21-Activated%252BKinase%252B%252528PAK%252529%252BSelectivity%252Bfor%252BType%252BI%252B1%25252F2%252BKinase%252BInhibitors%26aulast%3DStaben%26aufirst%3DSteven%2BT.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D15112013%26date%3D04022014%26date%3D13022014%26date%3D16012014%26volume%3D57%26issue%3D3%26spage%3D1033%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fiona  Pachl</span>, <span class="hlFld-ContribAuthor ">Patrik  Plattner</span>, <span class="hlFld-ContribAuthor ">Benjamin  Ruprecht</span>, <span class="hlFld-ContribAuthor ">Guillaume  Médard</span>, <span class="hlFld-ContribAuthor ">Norbert  Sewald</span>, and <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>  . </span><span class="cited-content_cbyCitation_article-title">Characterization of a Chemical Affinity Probe Targeting Akt Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteome Research</span><span> <strong>2013,</strong> <em>12 </em>
                                    (8)
                                     , 3792-3800. <a href="https://doi.org/10.1021/pr400455j" title="DOI URL">https://doi.org/10.1021/pr400455j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/pr400455j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fpr400455j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteome%2520Research%26atitle%3DCharacterization%252Bof%252Ba%252BChemical%252BAffinity%252BProbe%252BTargeting%252BAkt%252BKinases%26aulast%3DPachl%26aufirst%3DFiona%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15052013%26date%3D03072013%26date%3D02082013%26date%3D25062013%26volume%3D12%26issue%3D8%26spage%3D3792%26epage%3D3800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuuki  Hayashi</span>, <span class="hlFld-ContribAuthor ">Jumpei  Morimoto</span>, and <span class="hlFld-ContribAuthor ">Hiroaki  Suga</span>  . </span><span class="cited-content_cbyCitation_article-title">In Vitro Selection of Anti-Akt2 Thioether-Macrocyclic Peptides Leading to Isoform-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2012,</strong> <em>7 </em>
                                    (3)
                                     , 607-613. <a href="https://doi.org/10.1021/cb200388k" title="DOI URL">https://doi.org/10.1021/cb200388k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb200388k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb200388k%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DIn%252BVitro%252BSelection%252Bof%252BAnti-Akt2%252BThioether-Macrocyclic%252BPeptides%252BLeading%252Bto%252BIsoform-Selective%252BInhibitors%26aulast%3DHayashi%26aufirst%3DYuuki%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D23092011%26date%3D11012012%26date%3D24012012%26date%3D16032012%26volume%3D7%26issue%3D3%26spage%3D607%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hidehisa  Iwata</span>, <span class="hlFld-ContribAuthor ">Shinichi  Imamura</span>, <span class="hlFld-ContribAuthor ">Akira  Hori</span>, <span class="hlFld-ContribAuthor ">Mark S.  Hixon</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, and <span class="hlFld-ContribAuthor ">Hiroshi  Miki</span>  . </span><span class="cited-content_cbyCitation_article-title">Biochemical Characterization of TAK-593, a Novel VEGFR/PDGFR Inhibitor with a Two-Step Slow Binding Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2011,</strong> <em>50 </em>
                                    (5)
                                     , 738-751. <a href="https://doi.org/10.1021/bi101777f" title="DOI URL">https://doi.org/10.1021/bi101777f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi101777f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi101777f%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DBiochemical%252BCharacterization%252Bof%252BTAK-593%25252C%252Ba%252BNovel%252BVEGFR%25252FPDGFR%252BInhibitor%252Bwith%252Ba%252BTwo-Step%252BSlow%252BBinding%252BMechanism%26aulast%3DIwata%26aufirst%3DHidehisa%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D05112010%26date%3D14122010%26date%3D10012011%26date%3D08022011%26date%3D23122010%26volume%3D50%26issue%3D5%26spage%3D738%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin D.  Freeman-Cook</span>, <span class="hlFld-ContribAuthor ">Christopher  Autry</span>, <span class="hlFld-ContribAuthor ">Gary  Borzillo</span>, <span class="hlFld-ContribAuthor ">Deborah  Gordon</span>, <span class="hlFld-ContribAuthor ">Elsa  Barbacci-Tobin</span>, <span class="hlFld-ContribAuthor ">Vincent  Bernardo</span>, <span class="hlFld-ContribAuthor ">David  Briere</span>, <span class="hlFld-ContribAuthor ">Tracey  Clark</span>, <span class="hlFld-ContribAuthor ">Matthew  Corbett</span>, <span class="hlFld-ContribAuthor ">John  Jakubczak</span>, <span class="hlFld-ContribAuthor ">Shefali  Kakar</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Knauth</span>, <span class="hlFld-ContribAuthor ">Blaise  Lippa</span>, <span class="hlFld-ContribAuthor ">Michael J.  Luzzio</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Mansour</span>, <span class="hlFld-ContribAuthor ">Gary  Martinelli</span>, <span class="hlFld-ContribAuthor ">Matthew  Marx</span>, <span class="hlFld-ContribAuthor ">Kendra  Nelson</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, <span class="hlFld-ContribAuthor ">Francis  Rajamohan</span>, <span class="hlFld-ContribAuthor ">Shaughnessy  Robinson</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Subramanyam</span>, <span class="hlFld-ContribAuthor ">Liuqing  Wei</span>, <span class="hlFld-ContribAuthor ">Martin  Wythes</span> and <span class="hlFld-ContribAuthor ">Joel  Morris</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Selective, ATP-Competitive Inhibitors of Akt. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (12)
                                     , 4615-4622. <a href="https://doi.org/10.1021/jm1003842" title="DOI URL">https://doi.org/10.1021/jm1003842</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1003842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1003842%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BSelective%25252C%252BATP-Competitive%252BInhibitors%252Bof%252BAkt%26aulast%3DFreeman-Cook%26aufirst%3DKevin%2BD.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D26032010%26date%3D19052010%26date%3D24062010%26volume%3D53%26issue%3D12%26spage%3D4615%26epage%3D4622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatiana  McHardy</span>, <span class="hlFld-ContribAuthor ">John J.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Kwai-Ming  Cheung</span>, <span class="hlFld-ContribAuthor ">Lisa J.  Hunter</span>, <span class="hlFld-ContribAuthor ">Kevin  Taylor</span>, <span class="hlFld-ContribAuthor ">Martin  Rowlands</span>, <span class="hlFld-ContribAuthor ">Ruth  Ruddle</span>, <span class="hlFld-ContribAuthor ">Alan  Henley</span>, <span class="hlFld-ContribAuthor ">Alexis  de Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Melanie  Valenti</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Davies</span>, <span class="hlFld-ContribAuthor ">Lynsey  Fazal</span>, <span class="hlFld-ContribAuthor ">Lisa  Seavers</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span> and <span class="hlFld-ContribAuthor ">Ian  Collins</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides As Selective, Orally Active Inhibitors of Protein Kinase B (Akt). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2239-2249. <a href="https://doi.org/10.1021/jm901788j" title="DOI URL">https://doi.org/10.1021/jm901788j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901788j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901788j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-Amino-1-%2525287H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-4-yl%252529piperidine-4-carboxamides%252BAs%252BSelective%25252C%252BOrally%252BActive%252BInhibitors%252Bof%252BProtein%252BKinase%252BB%252B%252528Akt%252529%26aulast%3DMcHardy%26aufirst%3DTatiana%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D02122009%26date%3D12022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2239%26epage%3D2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Morphy</span>. </span><span class="cited-content_cbyCitation_article-title">Selectively Nonselective Kinase Inhibition: Striking the Right Balance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (4)
                                     , 1413-1437. <a href="https://doi.org/10.1021/jm901132v" title="DOI URL">https://doi.org/10.1021/jm901132v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901132v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelectively%252BNonselective%252BKinase%252BInhibition%25253A%252BStriking%252Bthe%252BRight%252BBalance%26aulast%3DMorphy%26aufirst%3DRichard%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D30072009%26date%3D27102009%26date%3D25022010%26volume%3D53%26issue%3D4%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mats  Ljungman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the DNA Damage Response in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2009,</strong> <em>109 </em>
                                    (7)
                                     , 2929-2950. <a href="https://doi.org/10.1021/cr900047g" title="DOI URL">https://doi.org/10.1021/cr900047g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr900047g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr900047g%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTargeting%252Bthe%252BDNA%252BDamage%252BResponse%252Bin%252BCancer%26aulast%3DLjungman%26aufirst%3DMats%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D06%252002%25202009%26date%3D22062009%26date%3D08072009%26volume%3D109%26issue%3D7%26spage%3D2929%26epage%3D2950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arindam  Sain</span>, <span class="hlFld-ContribAuthor ">Thirukumaran  Kandasamy</span>, <span class="hlFld-ContribAuthor ">Debdut  Naskar</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              approach to target PI3K/Akt/mTOR axis by selected
              Olea europaea
              phenols in
              PIK3CA
              mutant colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>38 </em>, 1-16. <a href="https://doi.org/10.1080/07391102.2021.1953603" title="DOI URL">https://doi.org/10.1080/07391102.2021.1953603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1953603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1953603%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252Bapproach%252Bto%252Btarget%252BPI3K%25252FAkt%25252FmTOR%252Baxis%252Bby%252Bselected%252BOlea%252Beuropaea%252Bphenols%252Bin%252BPIK3CA%252Bmutant%252Bcolorectal%252Bcancer%26aulast%3DSain%26aufirst%3DArindam%26date%3D2021%26date%3D2021%26volume%3D38%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Cavanah</span>, <span class="hlFld-ContribAuthor ">Junji  Itou</span>, <span class="hlFld-ContribAuthor ">Yudi  Rusman</span>, <span class="hlFld-ContribAuthor ">Naoyuki  Tahara</span>, <span class="hlFld-ContribAuthor ">Jessica M.  Williams</span>, <span class="hlFld-ContribAuthor ">Christine E.  Salomon</span>, <span class="hlFld-ContribAuthor ">Yasuhiko  Kawakami</span>. </span><span class="cited-content_cbyCitation_article-title">A nontoxic fungal natural product modulates fin regeneration in zebrafish larvae upstream of FGF‐WNT developmental signaling. </span><span class="cited-content_cbyCitation_journal-name">Developmental Dynamics</span><span> <strong>2021,</strong> <em>250 </em>
                                    (2)
                                     , 160-174. <a href="https://doi.org/10.1002/dvdy.244" title="DOI URL">https://doi.org/10.1002/dvdy.244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dvdy.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdvdy.244%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopmental%2520Dynamics%26atitle%3DA%252Bnontoxic%252Bfungal%252Bnatural%252Bproduct%252Bmodulates%252Bfin%252Bregeneration%252Bin%252Bzebrafish%252Blarvae%252Bupstream%252Bof%252BFGF%2525E2%252580%252590WNT%252Bdevelopmental%252Bsignaling%26aulast%3DCavanah%26aufirst%3DPaul%26date%3D2021%26date%3D2020%26volume%3D250%26issue%3D2%26spage%3D160%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arokia Vijaya Anand  Mariadoss</span>, <span class="hlFld-ContribAuthor ">SeonJu  Park</span>, <span class="hlFld-ContribAuthor ">Kandasamy  Saravanakumar</span>, <span class="hlFld-ContribAuthor ">Anbazhagan  Sathiyaseelan</span>, <span class="hlFld-ContribAuthor ">Myeong-Hyeon  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Ethyl Acetate Fraction of Helianthus tuberosus L. Induces Anti-Diabetic, and Wound-Healing Activities in Insulin-Resistant Human Liver Cancer and Mouse Fibroblast Cells. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2021,</strong> <em>10 </em>
                                    (1)
                                     , 99. <a href="https://doi.org/10.3390/antiox10010099" title="DOI URL">https://doi.org/10.3390/antiox10010099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox10010099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox10010099%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DEthyl%252BAcetate%252BFraction%252Bof%252BHelianthus%252Btuberosus%252BL.%252BInduces%252BAnti-Diabetic%25252C%252Band%252BWound-Healing%252BActivities%252Bin%252BInsulin-Resistant%252BHuman%252BLiver%252BCancer%252Band%252BMouse%252BFibroblast%252BCells%26aulast%3DMariadoss%26aufirst%3DArokia%2BVijaya%2BAnand%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D1%26spage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">彦凯  王</span>. </span><span class="cited-content_cbyCitation_article-title">Research Progress of Small Molecule Inhibitors of Akt Kinase—Overview of ATP Competitive Inhibitor Research. </span><span class="cited-content_cbyCitation_journal-name">Journal of Organic Chemistry Research</span><span> <strong>2021,</strong> <em>09 </em>
                                    (02)
                                     , 13-21. <a href="https://doi.org/10.12677/JOCR.2021.92003" title="DOI URL">https://doi.org/10.12677/JOCR.2021.92003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/JOCR.2021.92003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FJOCR.2021.92003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Organic%2520Chemistry%2520Research%26atitle%3DResearch%252BProgress%252Bof%252BSmall%252BMolecule%252BInhibitors%252Bof%252BAkt%252BKinase%2525E2%252580%252594Overview%252Bof%252BATP%252BCompetitive%252BInhibitor%252BResearch%26aulast%3D%25E7%258E%258B%26aufirst%3D%25E5%25BD%25A6%25E5%2587%25AF%26date%3D2021%26volume%3D09%26issue%3D02%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samih  Alqawlaq</span>, <span class="hlFld-ContribAuthor ">Izhar  Livne-Bar</span>, <span class="hlFld-ContribAuthor ">Declan  Williams</span>, <span class="hlFld-ContribAuthor ">Joseph  D'Ercole</span>, <span class="hlFld-ContribAuthor ">Sara W.  Leung</span>, <span class="hlFld-ContribAuthor ">Darren  Chan</span>, <span class="hlFld-ContribAuthor ">Alessandra  Tuccitto</span>, <span class="hlFld-ContribAuthor ">Alessandro  Datti</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Wrana</span>, <span class="hlFld-ContribAuthor ">Anita H.  Corbett</span>, <span class="hlFld-ContribAuthor ">Gerold  Schmitt-Ulms</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Sivak</span>. </span><span class="cited-content_cbyCitation_article-title">An endogenous PI3K interactome promoting astrocyte-mediated neuroprotection identifies a novel association with RNA-binding protein ZC3H14. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100118. <a href="https://doi.org/10.1074/jbc.RA120.015389" title="DOI URL">https://doi.org/10.1074/jbc.RA120.015389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA120.015389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA120.015389%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DAn%252Bendogenous%252BPI3K%252Binteractome%252Bpromoting%252Bastrocyte-mediated%252Bneuroprotection%252Bidentifies%252Ba%252Bnovel%252Bassociation%252Bwith%252BRNA-binding%252Bprotein%252BZC3H14%26aulast%3DAlqawlaq%26aufirst%3DSamih%26date%3D2021%26volume%3D296%26spage%3D100118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnold  Markovics</span>, <span class="hlFld-ContribAuthor ">Ágnes  Angyal</span>, <span class="hlFld-ContribAuthor ">Kinga Fanni  Tóth</span>, <span class="hlFld-ContribAuthor ">Dorottya  Ádám</span>, <span class="hlFld-ContribAuthor ">Zsófia  Pénzes</span>, <span class="hlFld-ContribAuthor ">József  Magi</span>, <span class="hlFld-ContribAuthor ">Ágnes  Pór</span>, <span class="hlFld-ContribAuthor ">Ilona  Kovács</span>, <span class="hlFld-ContribAuthor ">Dániel  Törőcsik</span>, <span class="hlFld-ContribAuthor ">Christos C.  Zouboulis</span>, <span class="hlFld-ContribAuthor ">Tamás  Bíró</span>, <span class="hlFld-ContribAuthor ">Attila  Oláh</span>. </span><span class="cited-content_cbyCitation_article-title">GPR119 Is a Potent Regulator of Human Sebocyte Biology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Investigative Dermatology</span><span> <strong>2020,</strong> <em>140 </em>
                                    (10)
                                     , 1909-1918.e8. <a href="https://doi.org/10.1016/j.jid.2020.02.011" title="DOI URL">https://doi.org/10.1016/j.jid.2020.02.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jid.2020.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jid.2020.02.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Investigative%2520Dermatology%26atitle%3DGPR119%252BIs%252Ba%252BPotent%252BRegulator%252Bof%252BHuman%252BSebocyte%252BBiology%26aulast%3DMarkovics%26aufirst%3DArnold%26date%3D2020%26volume%3D140%26issue%3D10%26spage%3D1909%26epage%3D1918.e8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleftherios  Kostaras</span>, <span class="hlFld-ContribAuthor ">Teresa  Kaserer</span>, <span class="hlFld-ContribAuthor ">Glorianne  Lazaro</span>, <span class="hlFld-ContribAuthor ">Sara Farrah  Heuss</span>, <span class="hlFld-ContribAuthor ">Aasia  Hussain</span>, <span class="hlFld-ContribAuthor ">Pedro  Casado</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Cihangir  Yandim</span>, <span class="hlFld-ContribAuthor ">Nicolaos  Palaskas</span>, <span class="hlFld-ContribAuthor ">Yi  Yu</span>, <span class="hlFld-ContribAuthor ">Brian  Schwartz</span>, <span class="hlFld-ContribAuthor ">Florence  Raynaud</span>, <span class="hlFld-ContribAuthor ">Yuen-Li  Chung</span>, <span class="hlFld-ContribAuthor ">Pedro R.  Cutillas</span>, <span class="hlFld-ContribAuthor ">Igor  Vivanco</span>. </span><span class="cited-content_cbyCitation_article-title">A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2020,</strong> <em>123 </em>
                                    (4)
                                     , 542-555. <a href="https://doi.org/10.1038/s41416-020-0889-4" title="DOI URL">https://doi.org/10.1038/s41416-020-0889-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-020-0889-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-020-0889-4%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DA%252Bsystematic%252Bmolecular%252Band%252Bpharmacologic%252Bevaluation%252Bof%252BAKT%252Binhibitors%252Breveals%252Bnew%252Binsight%252Binto%252Btheir%252Bbiological%252Bactivity%26aulast%3DKostaras%26aufirst%3DEleftherios%26date%3D2020%26date%3D2020%26volume%3D123%26issue%3D4%26spage%3D542%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuqian  Deng</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Zhao</span>, <span class="hlFld-ContribAuthor ">Linlin  Qu</span>, <span class="hlFld-ContribAuthor ">Zhiguang  Duan</span>, <span class="hlFld-ContribAuthor ">Rongzhan  Fu</span>, <span class="hlFld-ContribAuthor ">Chenhui  Zhu</span>, <span class="hlFld-ContribAuthor ">Daidi  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>178 </em>, 114038. <a href="https://doi.org/10.1016/j.bcp.2020.114038" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114038%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DGinsenoside%252BRh4%252Bsuppresses%252Baerobic%252Bglycolysis%252Band%252Bthe%252Bexpression%252Bof%252BPD-L1%252Bvia%252Btargeting%252BAKT%252Bin%252Besophageal%252Bcancer%26aulast%3DDeng%26aufirst%3DXuqian%26date%3D2020%26volume%3D178%26spage%3D114038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingchun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanle  Chu</span>, <span class="hlFld-ContribAuthor ">Peizhi  Ma</span>, <span class="hlFld-ContribAuthor ">Shujuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiaoyan  Li</span>, <span class="hlFld-ContribAuthor ">Boya  Chen</span>, <span class="hlFld-ContribAuthor ">Xuejiao  Hong</span>, <span class="hlFld-ContribAuthor ">Jun  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light-mediated photocatalytic cross-coupling of acetenyl ketones with benzyl trifluoroborate. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (6)
                                     , 1073-1077. <a href="https://doi.org/10.1039/C9OB02624J" title="DOI URL">https://doi.org/10.1039/C9OB02624J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02624J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02624J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DVisible-light-mediated%252Bphotocatalytic%252Bcross-coupling%252Bof%252Bacetenyl%252Bketones%252Bwith%252Bbenzyl%252Btrifluoroborate%26aulast%3DZhang%26aufirst%3DLingchun%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D6%26spage%3D1073%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priya  Mahajan</span>, <span class="hlFld-ContribAuthor ">Bhumika  Wadhwa</span>, <span class="hlFld-ContribAuthor ">Manas Ranjan  Barik</span>, <span class="hlFld-ContribAuthor ">Fayaz  Malik</span>, <span class="hlFld-ContribAuthor ">Amit  Nargotra</span>. </span><span class="cited-content_cbyCitation_article-title">Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2020,</strong> <em>24 </em>
                                    (1)
                                     , 45-60. <a href="https://doi.org/10.1007/s11030-019-09924-9" title="DOI URL">https://doi.org/10.1007/s11030-019-09924-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-019-09924-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-019-09924-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DCombining%252Bligand-%252Band%252Bstructure-based%252Bin%252Bsilico%252Bmethods%252Bfor%252Bthe%252Bidentification%252Bof%252Bnatural%252Bproduct-based%252Binhibitors%252Bof%252BAkt1%26aulast%3DMahajan%26aufirst%3DPriya%26date%3D2020%26date%3D2019%26volume%3D24%26issue%3D1%26spage%3D45%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina N.  Makhova</span>, <span class="hlFld-ContribAuthor ">Leonid I.  Belen’kii</span>, <span class="hlFld-ContribAuthor ">Galina A.  Gazieva</span>, <span class="hlFld-ContribAuthor ">Igor L.  Dalinger</span>, <span class="hlFld-ContribAuthor ">Lidia S.  Konstantinova</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">Angelina N.  Kravchenko</span>, <span class="hlFld-ContribAuthor ">Mikhail M.  Krayushkin</span>, <span class="hlFld-ContribAuthor ">Oleg A.  Rakitin</span>, <span class="hlFld-ContribAuthor ">Alexey M.  Starosotnikov</span>, <span class="hlFld-ContribAuthor ">Leonid L.  Fershtat</span>, <span class="hlFld-ContribAuthor ">Svyatoslav A.  Shevelev</span>, <span class="hlFld-ContribAuthor ">Valerik Z.  Shirinian</span>, <span class="hlFld-ContribAuthor ">Vladimir N.  Yarovenko</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the chemistry of nitrogen-, oxygen- and sulfur-containing heterocyclic systems. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2020,</strong> <em>89 </em>
                                    (1)
                                     , 55-124. <a href="https://doi.org/10.1070/RCR4914" title="DOI URL">https://doi.org/10.1070/RCR4914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4914%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DProgress%252Bin%252Bthe%252Bchemistry%252Bof%252Bnitrogen-%25252C%252Boxygen-%252Band%252Bsulfur-containing%252Bheterocyclic%252Bsystems%26aulast%3DMakhova%26aufirst%3DNina%2BN.%26date%3D2020%26date%3D2020%26volume%3D89%26issue%3D1%26spage%3D55%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. Christian  Eberl</span>, <span class="hlFld-ContribAuthor ">Thilo  Werner</span>, <span class="hlFld-ContribAuthor ">Friedrich B.  Reinhard</span>, <span class="hlFld-ContribAuthor ">Stephanie  Lehmann</span>, <span class="hlFld-ContribAuthor ">Douglas  Thomson</span>, <span class="hlFld-ContribAuthor ">Peiling  Chen</span>, <span class="hlFld-ContribAuthor ">Cunyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Christina  Rau</span>, <span class="hlFld-ContribAuthor ">Marcel  Muelbaier</span>, <span class="hlFld-ContribAuthor ">Gerard  Drewes</span>, <span class="hlFld-ContribAuthor ">David  Drewry</span>, <span class="hlFld-ContribAuthor ">Marcus  Bantscheff</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-50335-5" title="DOI URL">https://doi.org/10.1038/s41598-019-50335-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-50335-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-50335-5%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DChemical%252Bproteomics%252Breveals%252Btarget%252Bselectivity%252Bof%252Bclinical%252BJak%252Binhibitors%252Bin%252Bhuman%252Bprimary%252Bcells%26aulast%3DEberl%26aufirst%3DH.%2BChristian%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshihiko  Hirozane</span>, <span class="hlFld-ContribAuthor ">Masashi  Toyofuku</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Yogo</span>, <span class="hlFld-ContribAuthor ">Yukiya  Tanaka</span>, <span class="hlFld-ContribAuthor ">Tomoya  Sameshima</span>, <span class="hlFld-ContribAuthor ">Ikuo  Miyahisa</span>, <span class="hlFld-ContribAuthor ">Masato  Yoshikawa</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based rational design of staurosporine-based fluorescent probe with broad-ranging kinase affinity for kinase panel application. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (21)
                                     , 126641. <a href="https://doi.org/10.1016/j.bmcl.2019.126641" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126641%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Brational%252Bdesign%252Bof%252Bstaurosporine-based%252Bfluorescent%252Bprobe%252Bwith%252Bbroad-ranging%252Bkinase%252Baffinity%252Bfor%252Bkinase%252Bpanel%252Bapplication%26aulast%3DHirozane%26aufirst%3DYoshihiko%26date%3D2019%26volume%3D29%26issue%3D21%26spage%3D126641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Reinecke</span>, <span class="hlFld-ContribAuthor ">Stephanie  Heinzlmeir</span>, <span class="hlFld-ContribAuthor ">Mathias  Wilhelm</span>, <span class="hlFld-ContribAuthor ">Guillaume  Médard</span>, <span class="hlFld-ContribAuthor ">Susan  Klaeger</span>, <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>. </span><span class="cited-content_cbyCitation_article-title">Kinobeads: A Chemical Proteomic Approach for Kinase Inhibitor Selectivity Profiling and Target Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 97-130. <a href="https://doi.org/10.1002/9783527818242.ch4" title="DOI URL">https://doi.org/10.1002/9783527818242.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527818242.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527818242.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DKinobeads%25253A%252BA%252BChemical%252BProteomic%252BApproach%252Bfor%252BKinase%252BInhibitor%252BSelectivity%252BProfiling%252Band%252BTarget%252BDiscovery%26aulast%3DReinecke%26aufirst%3DMaria%26date%3D2019%26date%3D2019%26spage%3D97%26epage%3D130%26pub%3DWiley%26atitle%3DTarget%252BDiscovery%252Band%252BValidation%26aulast%3DPlowright%26aufirst%3DAlleyn%2BT%26date%3D2019%26date%3D2019%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gastón  Amable</span>, <span class="hlFld-ContribAuthor ">Eduardo  Martínez-León</span>, <span class="hlFld-ContribAuthor ">María Elisa  Picco</span>, <span class="hlFld-ContribAuthor ">Nicolas  Di Siervi</span>, <span class="hlFld-ContribAuthor ">Carlos  Davio</span>, <span class="hlFld-ContribAuthor ">Enrique  Rozengurt</span>, <span class="hlFld-ContribAuthor ">Osvaldo  Rey</span>. </span><span class="cited-content_cbyCitation_article-title">Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells. </span><span class="cited-content_cbyCitation_journal-name">The International Journal of Biochemistry & Cell Biology</span><span> <strong>2019,</strong> <em>112 </em>, 88-94. <a href="https://doi.org/10.1016/j.biocel.2019.05.004" title="DOI URL">https://doi.org/10.1016/j.biocel.2019.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biocel.2019.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biocel.2019.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520International%2520Journal%2520of%2520Biochemistry%2520%2526%2520Cell%2520Biology%26atitle%3DMetformin%252Binhibits%252B%2525CE%2525B2-catenin%252Bphosphorylation%252Bon%252BSer-552%252Bthrough%252Ban%252BAMPK%25252FPI3K%25252FAkt%252Bpathway%252Bin%252Bcolorectal%252Bcancer%252Bcells%26aulast%3DAmable%26aufirst%3DGast%25C3%25B3n%26date%3D2019%26volume%3D112%26spage%3D88%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanhao  Lv</span>, <span class="hlFld-ContribAuthor ">Tingting  Du</span>, <span class="hlFld-ContribAuthor ">Ming  Ji</span>, <span class="hlFld-ContribAuthor ">Chunyang  Wang</span>, <span class="hlFld-ContribAuthor ">Songwen  Lin</span>, <span class="hlFld-ContribAuthor ">Nina  Xue</span>, <span class="hlFld-ContribAuthor ">Jing  Jin</span>, <span class="hlFld-ContribAuthor ">Heng  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A novel PI3K/mTOR dual inhibitor XH002 exhibited robust antitumor activity in NSCLC. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2019,</strong> <em>27 </em>
                                    (4)
                                     , 451-459. <a href="https://doi.org/10.1080/1061186X.2018.1542533" title="DOI URL">https://doi.org/10.1080/1061186X.2018.1542533</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1061186X.2018.1542533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1061186X.2018.1542533%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DA%252Bnovel%252BPI3K%25252FmTOR%252Bdual%252Binhibitor%252BXH002%252Bexhibited%252Brobust%252Bantitumor%252Bactivity%252Bin%252BNSCLC%26aulast%3DLv%26aufirst%3DYuanhao%26date%3D2019%26date%3D2018%26volume%3D27%26issue%3D4%26spage%3D451%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengqiu  Song</span>, <span class="hlFld-ContribAuthor ">Ann M.  Bode</span>, <span class="hlFld-ContribAuthor ">Zigang  Dong</span>, <span class="hlFld-ContribAuthor ">Mee-Hyun  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">AKT as a Therapeutic Target for Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2019,</strong> <em>79 </em>
                                    (6)
                                     , 1019-1031. <a href="https://doi.org/10.1158/0008-5472.CAN-18-2738" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-18-2738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-18-2738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-18-2738%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DAKT%252Bas%252Ba%252BTherapeutic%252BTarget%252Bfor%252BCancer%26aulast%3DSong%26aufirst%3DMengqiu%26date%3D2019%26date%3D2019%26volume%3D79%26issue%3D6%26spage%3D1019%26epage%3D1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simin  Zhao</span>, <span class="hlFld-ContribAuthor ">Yanan  Jiang</span>, <span class="hlFld-ContribAuthor ">Jimin  Zhao</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>, <span class="hlFld-ContribAuthor ">Xueshan  Yin</span>, <span class="hlFld-ContribAuthor ">Yanhong  Wang</span>, <span class="hlFld-ContribAuthor ">Yifei  Xie</span>, <span class="hlFld-ContribAuthor ">Xinhuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Lu</span>, <span class="hlFld-ContribAuthor ">Ziming  Dong</span>, <span class="hlFld-ContribAuthor ">Kangdong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Quercetin‐3‐methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways. </span><span class="cited-content_cbyCitation_journal-name">Molecular Carcinogenesis</span><span> <strong>2018,</strong> <em>57 </em>
                                    (11)
                                     , 1540-1552. <a href="https://doi.org/10.1002/mc.22876" title="DOI URL">https://doi.org/10.1002/mc.22876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mc.22876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmc.22876%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Carcinogenesis%26atitle%3DQuercetin%2525E2%252580%2525903%2525E2%252580%252590methyl%252Bether%252Binhibits%252Besophageal%252Bcarcinogenesis%252Bby%252Btargeting%252Bthe%252BAKT%25252FmTOR%25252Fp70S6K%252Band%252BMAPK%252Bpathways%26aulast%3DZhao%26aufirst%3DSimin%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D11%26spage%3D1540%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judit M.  Pérez Ortiz</span>, <span class="hlFld-ContribAuthor ">Nissa  Mollema</span>, <span class="hlFld-ContribAuthor ">Nicholas  Toker</span>, <span class="hlFld-ContribAuthor ">Carolyn J.  Adamski</span>, <span class="hlFld-ContribAuthor ">Brennon  O'Callaghan</span>, <span class="hlFld-ContribAuthor ">Lisa  Duvick</span>, <span class="hlFld-ContribAuthor ">Jillian  Friedrich</span>, <span class="hlFld-ContribAuthor ">Michael A.  Walters</span>, <span class="hlFld-ContribAuthor ">Jessica  Strasser</span>, <span class="hlFld-ContribAuthor ">Jon E.  Hawkinson</span>, <span class="hlFld-ContribAuthor ">Huda Y.  Zoghbi</span>, <span class="hlFld-ContribAuthor ">Christine  Henzler</span>, <span class="hlFld-ContribAuthor ">Harry T.  Orr</span>, <span class="hlFld-ContribAuthor ">Sarita  Lagalwar</span>. </span><span class="cited-content_cbyCitation_article-title">Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2018,</strong> <em>116 </em>, 93-105. <a href="https://doi.org/10.1016/j.nbd.2018.05.002" title="DOI URL">https://doi.org/10.1016/j.nbd.2018.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2018.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2018.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DReduction%252Bof%252Bprotein%252Bkinase%252BA-mediated%252Bphosphorylation%252Bof%252BATXN1-S776%252Bin%252BPurkinje%252Bcells%252Bdelays%252Bonset%252Bof%252BAtaxia%252Bin%252Ba%252BSCA1%252Bmouse%252Bmodel%26aulast%3DP%25C3%25A9rez%2BOrtiz%26aufirst%3DJudit%2BM.%26date%3D2018%26volume%3D116%26spage%3D93%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Onat  Kadioglu</span>, <span class="hlFld-ContribAuthor ">Mohamed  Saeed</span>, <span class="hlFld-ContribAuthor ">Victor  Kuete</span>, <span class="hlFld-ContribAuthor ">Henry J.  Greten</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>. </span><span class="cited-content_cbyCitation_article-title">Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.00355" title="DOI URL">https://doi.org/10.3389/fphar.2018.00355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.00355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.00355%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DOridonin%252BTargets%252BMultiple%252BDrug-Resistant%252BTumor%252BCells%252Bas%252BDetermined%252Bby%252Bin%252BSilico%252Band%252Bin%252BVitro%252BAnalyses%26aulast%3DKadioglu%26aufirst%3DOnat%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyasu  Konno</span>, <span class="hlFld-ContribAuthor ">Ivan K.  Chinn</span>, <span class="hlFld-ContribAuthor ">Diana  Hong</span>, <span class="hlFld-ContribAuthor ">Jordan S.  Orange</span>, <span class="hlFld-ContribAuthor ">James R.  Lupski</span>, <span class="hlFld-ContribAuthor ">Alejandra  Mendoza</span>, <span class="hlFld-ContribAuthor ">Luis A.  Pedroza</span>, <span class="hlFld-ContribAuthor ">Glen N.  Barber</span>. </span><span class="cited-content_cbyCitation_article-title">Pro-inflammation Associated with a Gain-of-Function Mutation (R284S) in the Innate Immune Sensor STING. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2018,</strong> <em>23 </em>
                                    (4)
                                     , 1112-1123. <a href="https://doi.org/10.1016/j.celrep.2018.03.115" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.03.115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.03.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.03.115%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DPro-inflammation%252BAssociated%252Bwith%252Ba%252BGain-of-Function%252BMutation%252B%252528R284S%252529%252Bin%252Bthe%252BInnate%252BImmune%252BSensor%252BSTING%26aulast%3DKonno%26aufirst%3DHiroyasu%26date%3D2018%26volume%3D23%26issue%3D4%26spage%3D1112%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert A.  Copeland</span>, <span class="hlFld-ContribAuthor ">P. Ann  Boriack-Sjodin</span>. </span><span class="cited-content_cbyCitation_article-title">The Elements of Translational Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2018,</strong> <em>25 </em>
                                    (2)
                                     , 128-134. <a href="https://doi.org/10.1016/j.chembiol.2017.11.003" title="DOI URL">https://doi.org/10.1016/j.chembiol.2017.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2017.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2017.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DThe%252BElements%252Bof%252BTranslational%252BChemical%252BBiology%26aulast%3DCopeland%26aufirst%3DRobert%2BA.%26date%3D2018%26volume%3D25%26issue%3D2%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daoguang  Zhang</span>, <span class="hlFld-ContribAuthor ">Dongdong  Tong</span>, <span class="hlFld-ContribAuthor ">Dezhi  Yang</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Fenghe  Zhang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of AKT inhibitors bearing a piperidin-4-yl appendant. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (8)
                                     , 1340-1350. <a href="https://doi.org/10.1039/C8MD00197A" title="DOI URL">https://doi.org/10.1039/C8MD00197A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00197A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00197A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BAKT%252Binhibitors%252Bbearing%252Ba%252Bpiperidin-4-yl%252Bappendant%26aulast%3DZhang%26aufirst%3DDaoguang%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D8%26spage%3D1340%26epage%3D1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dezhi  Yang</span>, <span class="hlFld-ContribAuthor ">Dongdong  Tong</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongtao  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Fenghe  Zhang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of novel Akt1 inhibitors based on an indole scaffold. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (5)
                                     , 791-803. <a href="https://doi.org/10.1111/cbdd.13000" title="DOI URL">https://doi.org/10.1111/cbdd.13000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13000%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bnovel%252BAkt1%252Binhibitors%252Bbased%252Bon%252Ban%252Bindole%252Bscaffold%26aulast%3DYang%26aufirst%3DDezhi%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D5%26spage%3D791%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam J.  Schaenzer</span>, <span class="hlFld-ContribAuthor ">Nathan  Wlodarchak</span>, <span class="hlFld-ContribAuthor ">David H.  Drewry</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>, <span class="hlFld-ContribAuthor ">Warren E.  Rose</span>, <span class="hlFld-ContribAuthor ">Rob  Striker</span>, <span class="hlFld-ContribAuthor ">John-Demian  Sauer</span>. </span><span class="cited-content_cbyCitation_article-title">A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the Listeria monocytogenes PASTA kinase PrkA. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2017,</strong> <em>292 </em>
                                    (41)
                                     , 17037-17045. <a href="https://doi.org/10.1074/jbc.M117.808600" title="DOI URL">https://doi.org/10.1074/jbc.M117.808600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M117.808600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M117.808600%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DA%252Bscreen%252Bfor%252Bkinase%252Binhibitors%252Bidentifies%252Bantimicrobial%252Bimidazopyridine%252Baminofurazans%252Bas%252Bspecific%252Binhibitors%252Bof%252Bthe%252BListeria%252Bmonocytogenes%252BPASTA%252Bkinase%252BPrkA%26aulast%3DSchaenzer%26aufirst%3DAdam%2BJ.%26date%3D2017%26volume%3D292%26issue%3D41%26spage%3D17037%26epage%3D17045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bayard R.  Huck</span>, <span class="hlFld-ContribAuthor ">Igor  Mochalkin</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress towards clinically relevant ATP-competitive Akt inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (13)
                                     , 2838-2848. <a href="https://doi.org/10.1016/j.bmcl.2017.04.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Bprogress%252Btowards%252Bclinically%252Brelevant%252BATP-competitive%252BAkt%252Binhibitors%26aulast%3DHuck%26aufirst%3DBayard%2BR.%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2838%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jillian M.  Silva</span>, <span class="hlFld-ContribAuthor ">Marian M.  Deuker</span>, <span class="hlFld-ContribAuthor ">Bruce C.  Baguley</span>, <span class="hlFld-ContribAuthor ">Martin  McMahon</span>. </span><span class="cited-content_cbyCitation_article-title">PIK3CA
              -mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferation. </span><span class="cited-content_cbyCitation_journal-name">Pigment Cell & Melanoma Research</span><span> <strong>2017,</strong> <em>30 </em>
                                    (3)
                                     , 353-367. <a href="https://doi.org/10.1111/pcmr.12586" title="DOI URL">https://doi.org/10.1111/pcmr.12586</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/pcmr.12586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fpcmr.12586%26sid%3Dliteratum%253Aachs%26jtitle%3DPigment%2520Cell%2520%2526%2520Melanoma%2520Research%26atitle%3DPIK3CA%252B-mutated%252Bmelanoma%252Bcells%252Brely%252Bon%252Bcooperative%252Bsignaling%252Bthrough%252BmTORC1%25252F2%252Bfor%252Bsustained%252Bproliferation%26aulast%3DSilva%26aufirst%3DJillian%2BM.%26date%3D2017%26date%3D2017%26volume%3D30%26issue%3D3%26spage%3D353%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takayuki  Irie</span>, <span class="hlFld-ContribAuthor ">Tokiko  Asami</span>, <span class="hlFld-ContribAuthor ">Ayako  Sawa</span>, <span class="hlFld-ContribAuthor ">Yuko  Uno</span>, <span class="hlFld-ContribAuthor ">Mitsuharu  Hanada</span>, <span class="hlFld-ContribAuthor ">Chika  Taniyama</span>, <span class="hlFld-ContribAuthor ">Yoko  Funakoshi</span>, <span class="hlFld-ContribAuthor ">Hisao  Masai</span>, <span class="hlFld-ContribAuthor ">Masaaki  Sawa</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel furanone derivatives as potent Cdc7 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>130 </em>, 406-418. <a href="https://doi.org/10.1016/j.ejmech.2017.02.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bfuranone%252Bderivatives%252Bas%252Bpotent%252BCdc7%252Bkinase%252Binhibitors%26aulast%3DIrie%26aufirst%3DTakayuki%26date%3D2017%26volume%3D130%26spage%3D406%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivette  Suárez-Arroyo</span>, <span class="hlFld-ContribAuthor ">Yaliz  Loperena-Alvarez</span>, <span class="hlFld-ContribAuthor ">Raysa  Rosario-Acevedo</span>, <span class="hlFld-ContribAuthor ">Michelle  Martínez-Montemayor</span>. </span><span class="cited-content_cbyCitation_article-title">Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Medicines</span><span> <strong>2017,</strong> <em>4 </em>
                                    (1)
                                     , 15. <a href="https://doi.org/10.3390/medicines4010015" title="DOI URL">https://doi.org/10.3390/medicines4010015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/medicines4010015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmedicines4010015%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicines%26atitle%3DGanoderma%252Bspp.%25253A%252BA%252BPromising%252BAdjuvant%252BTreatment%252Bfor%252BBreast%252BCancer%26aulast%3DSu%25C3%25A1rez-Arroyo%26aufirst%3DIvette%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D1%26spage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean Christopher  Chamcheu</span>, <span class="hlFld-ContribAuthor ">Vaqar M.  Adhami</span>, <span class="hlFld-ContribAuthor ">Stephane  Esnault</span>, <span class="hlFld-ContribAuthor ">Mario  Sechi</span>, <span class="hlFld-ContribAuthor ">Imtiaz A.  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Satyshur</span>, <span class="hlFld-ContribAuthor ">Deeba N.  Syed</span>, <span class="hlFld-ContribAuthor ">Shah-Jahan M.  Dodwad</span>, <span class="hlFld-ContribAuthor ">Maria-Ines  Chaves-Rodriquez</span>, <span class="hlFld-ContribAuthor ">B. Jack  Longley</span>, <span class="hlFld-ContribAuthor ">Gary S.  Wood</span>, <span class="hlFld-ContribAuthor ">Hasan  Mukhtar</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features
              In Vitro
              and in an Imiquimod-Induced Psoriasis-Like Disease in Mice. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2017,</strong> <em>26 </em>
                                    (2)
                                     , 49-69. <a href="https://doi.org/10.1089/ars.2016.6769" title="DOI URL">https://doi.org/10.1089/ars.2016.6769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2016.6769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2016.6769%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DDual%252BInhibition%252Bof%252BPI3K%25252FAkt%252Band%252BmTOR%252Bby%252Bthe%252BDietary%252BAntioxidant%25252C%252BDelphinidin%25252C%252BAmeliorates%252BPsoriatic%252BFeatures%252BIn%252BVitro%252Band%252Bin%252Ban%252BImiquimod-Induced%252BPsoriasis-Like%252BDisease%252Bin%252BMice%26aulast%3DChamcheu%26aufirst%3DJean%2BChristopher%26date%3D2017%26volume%3D26%26issue%3D2%26spage%3D49%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Romorini</span>, <span class="hlFld-ContribAuthor ">Ximena  Garate</span>, <span class="hlFld-ContribAuthor ">Gabriel  Neiman</span>, <span class="hlFld-ContribAuthor ">Carlos  Luzzani</span>, <span class="hlFld-ContribAuthor ">Verónica Alejandra  Furmento</span>, <span class="hlFld-ContribAuthor ">Alejandra Sonia  Guberman</span>, <span class="hlFld-ContribAuthor ">Gustavo Emilio  Sevlever</span>, <span class="hlFld-ContribAuthor ">María Elida  Scassa</span>, <span class="hlFld-ContribAuthor ">Santiago Gabriel  Miriuka</span>. </span><span class="cited-content_cbyCitation_article-title">AKT/GSK3β signaling pathway is critically involved in human pluripotent stem cell survival. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep35660" title="DOI URL">https://doi.org/10.1038/srep35660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep35660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep35660%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAKT%25252FGSK3%2525CE%2525B2%252Bsignaling%252Bpathway%252Bis%252Bcritically%252Binvolved%252Bin%252Bhuman%252Bpluripotent%252Bstem%252Bcell%252Bsurvival%26aulast%3DRomorini%26aufirst%3DLeonardo%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brendan C.  Luey</span>, <span class="hlFld-ContribAuthor ">Felicity E. B.  May</span>. </span><span class="cited-content_cbyCitation_article-title">Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer</span><span> <strong>2016,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12943-015-0482-2" title="DOI URL">https://doi.org/10.1186/s12943-015-0482-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12943-015-0482-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12943-015-0482-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%26atitle%3DInsulin-like%252Bgrowth%252Bfactors%252Bare%252Bessential%252Bto%252Bprevent%252Banoikis%252Bin%252Boestrogen-responsive%252Bbreast%252Bcancer%252Bcells%25253A%252Bimportance%252Bof%252Bthe%252Btype%252BI%252BIGF%252Breceptor%252Band%252BPI3-kinase%25252FAkt%252Bpathway%26aulast%3DLuey%26aufirst%3DBrendan%2BC.%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inna  Slynko</span>, <span class="hlFld-ContribAuthor ">Karin  Schmidtkunz</span>, <span class="hlFld-ContribAuthor ">Tobias  Rumpf</span>, <span class="hlFld-ContribAuthor ">Susan  Klaeger</span>, <span class="hlFld-ContribAuthor ">Stephanie  Heinzlmeir</span>, <span class="hlFld-ContribAuthor ">Abdulkarim  Najar</span>, <span class="hlFld-ContribAuthor ">Eric  Metzger</span>, <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>, <span class="hlFld-ContribAuthor ">Roland  Schüle</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Highly Potent Protein Kinase C-Related Kinase 1 Inhibitors by Virtual Screening, Binding Free Energy Rescoring, and in vitro Testing. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (18)
                                     , 2084-2094. <a href="https://doi.org/10.1002/cmdc.201600284" title="DOI URL">https://doi.org/10.1002/cmdc.201600284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600284%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DIdentification%252Bof%252BHighly%252BPotent%252BProtein%252BKinase%2525E2%252580%252585C-Related%252BKinase%2525E2%252580%2525851%252BInhibitors%252Bby%252BVirtual%252BScreening%25252C%252BBinding%252BFree%252BEnergy%252BRescoring%25252C%252Band%252Bin%2525E2%252580%252585vitro%252BTesting%26aulast%3DSlynko%26aufirst%3DInna%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D18%26spage%3D2084%26epage%3D2094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soon Young  Shin</span>, <span class="hlFld-ContribAuthor ">Chang Gun  Kim</span>, <span class="hlFld-ContribAuthor ">You Jung  Jung</span>, <span class="hlFld-ContribAuthor ">Yoongho  Lim</span>, <span class="hlFld-ContribAuthor ">Young Han  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">The UPR inducer DPP23 inhibits the metastatic potential of MDA-MB-231 human breast cancer cells by targeting the Akt–IKK–NF-κB–MMP-9 axis. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep34134" title="DOI URL">https://doi.org/10.1038/srep34134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep34134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep34134%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DThe%252BUPR%252Binducer%252BDPP23%252Binhibits%252Bthe%252Bmetastatic%252Bpotential%252Bof%252BMDA-MB-231%252Bhuman%252Bbreast%252Bcancer%252Bcells%252Bby%252Btargeting%252Bthe%252BAkt%2525E2%252580%252593IKK%2525E2%252580%252593NF-%2525CE%2525BAB%2525E2%252580%252593MMP-9%252Baxis%26aulast%3DShin%26aufirst%3DSoon%2BYoung%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GEORGE MIHAI  NITULESCU</span>, <span class="hlFld-ContribAuthor ">DENISA  MARGINA</span>, <span class="hlFld-ContribAuthor ">PETRAS  JUZENAS</span>, <span class="hlFld-ContribAuthor ">QIAN  PENG</span>, <span class="hlFld-ContribAuthor ">OCTAVIAN TUDOREL  OLARU</span>, <span class="hlFld-ContribAuthor ">EMMANOUIL  SALOUSTROS</span>, <span class="hlFld-ContribAuthor ">CONCETTINA  FENGA</span>, <span class="hlFld-ContribAuthor ">DEMETRIOS A.  SPANDIDOS</span>, <span class="hlFld-ContribAuthor ">MASSIMO  LIBRA</span>, <span class="hlFld-ContribAuthor ">ARISTIDIS M.  TSATSAKIS</span>. </span><span class="cited-content_cbyCitation_article-title">Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review). </span><span class="cited-content_cbyCitation_journal-name">International Journal of Oncology</span><span> <strong>2016,</strong> <em>48 </em>
                                    (3)
                                     , 869-885. <a href="https://doi.org/10.3892/ijo.2015.3306" title="DOI URL">https://doi.org/10.3892/ijo.2015.3306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijo.2015.3306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijo.2015.3306%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Oncology%26atitle%3DAkt%252Binhibitors%252Bin%252Bcancer%252Btreatment%25253A%252BThe%252Blong%252Bjourney%252Bfrom%252Bdrug%252Bdiscovery%252Bto%252Bclinical%252Buse%252B%252528Review%252529%26aulast%3DNITULESCU%26aufirst%3DGEORGE%2BMIHAI%26date%3D2016%26date%3D2015%26volume%3D48%26issue%3D3%26spage%3D869%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott W.  Rogers</span>, <span class="hlFld-ContribAuthor ">Lorise C.  Gahring</span>, . </span><span class="cited-content_cbyCitation_article-title">Upregulation of Nicotinic Acetylcholine Receptor alph4+beta2 through a Ligand-Independent PI3Kbeta Mechanism That Is Enhanced by TNFalpha and the Jak2/p38Mapk Pathways. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , e0143319. <a href="https://doi.org/10.1371/journal.pone.0143319" title="DOI URL">https://doi.org/10.1371/journal.pone.0143319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0143319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0143319%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DUpregulation%252Bof%252BNicotinic%252BAcetylcholine%252BReceptor%252Balph4%25252Bbeta2%252Bthrough%252Ba%252BLigand-Independent%252BPI3Kbeta%252BMechanism%252BThat%252BIs%252BEnhanced%252Bby%252BTNFalpha%252Band%252Bthe%252BJak2%25252Fp38Mapk%252BPathways%26aulast%3DRogers%26aufirst%3DScott%2BW.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3De0143319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasanna  Abeyrathna</span>, <span class="hlFld-ContribAuthor ">Yunchao  Su</span>. </span><span class="cited-content_cbyCitation_article-title">The critical role of Akt in cardiovascular function. </span><span class="cited-content_cbyCitation_journal-name">Vascular Pharmacology</span><span> <strong>2015,</strong> <em>74 </em>, 38-48. <a href="https://doi.org/10.1016/j.vph.2015.05.008" title="DOI URL">https://doi.org/10.1016/j.vph.2015.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.vph.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.vph.2015.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DVascular%2520Pharmacology%26atitle%3DThe%252Bcritical%252Brole%252Bof%252BAkt%252Bin%252Bcardiovascular%252Bfunction%26aulast%3DAbeyrathna%26aufirst%3DPrasanna%26date%3D2015%26volume%3D74%26spage%3D38%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katherine R.  Singleton</span>, <span class="hlFld-ContribAuthor ">Trista K.  Hinz</span>, <span class="hlFld-ContribAuthor ">Emily K.  Kleczko</span>, <span class="hlFld-ContribAuthor ">Lindsay A.  Marek</span>, <span class="hlFld-ContribAuthor ">Jeff  Kwak</span>, <span class="hlFld-ContribAuthor ">Taylor  Harp</span>, <span class="hlFld-ContribAuthor ">Jihye  Kim</span>, <span class="hlFld-ContribAuthor ">Aik Choon  Tan</span>, <span class="hlFld-ContribAuthor ">Lynn E.  Heasley</span>. </span><span class="cited-content_cbyCitation_article-title">Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2015,</strong> <em>75 </em>
                                    (20)
                                     , 4398-4406. <a href="https://doi.org/10.1158/0008-5472.CAN-15-0509" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-15-0509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-15-0509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-15-0509%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DKinome%252BRNAi%252BScreens%252BReveal%252BSynergistic%252BTargeting%252Bof%252BMTOR%252Band%252BFGFR1%252BPathways%252Bfor%252BTreatment%252Bof%252BLung%252BCancer%252Band%252BHNSCC%26aulast%3DSingleton%26aufirst%3DKatherine%2BR.%26date%3D2015%26date%3D2015%26volume%3D75%26issue%3D20%26spage%3D4398%26epage%3D4406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhu  Zhan</span>, <span class="hlFld-ContribAuthor ">Sendong  Lin</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jianbo  Chu</span>, <span class="hlFld-ContribAuthor ">Wenting  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel Benzopyran and Phenylpyrazole Derivatives as Akt Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>85 </em>
                                    (6)
                                     , 770-779. <a href="https://doi.org/10.1111/cbdd.12489" title="DOI URL">https://doi.org/10.1111/cbdd.12489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12489%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BBiological%252BEvaluation%25252C%252Band%252BMolecular%252BDocking%252Bof%252BNovel%252BBenzopyran%252Band%252BPhenylpyrazole%252BDerivatives%252Bas%252BAkt%252BInhibitors%26aulast%3DZhan%26aufirst%3DWenhu%26date%3D2015%26date%3D2014%26volume%3D85%26issue%3D6%26spage%3D770%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Ortolani</span>, <span class="hlFld-ContribAuthor ">Chiara  Ciccarese</span>, <span class="hlFld-ContribAuthor ">Sara  Cingarlini</span>, <span class="hlFld-ContribAuthor ">Giampaolo  Tortora</span>, <span class="hlFld-ContribAuthor ">Francesco  Massari</span>. </span><span class="cited-content_cbyCitation_article-title">Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (12)
                                     , 1809-1828. <a href="https://doi.org/10.2217/fon.15.81" title="DOI URL">https://doi.org/10.2217/fon.15.81</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon.15.81&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon.15.81%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DSuppression%252Bof%252BmTOR%252Bpathway%252Bin%252Bsolid%252Btumors%25253A%252Blessons%252Blearned%252Bfrom%252Bclinical%252Bexperience%252Bin%252Brenal%252Bcell%252Bcarcinoma%252Band%252Bneuroendocrine%252Btumors%252Band%252Bnew%252Bperspectives%26aulast%3DOrtolani%26aufirst%3DSilvia%26date%3D2015%26volume%3D11%26issue%3D12%26spage%3D1809%26epage%3D1828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Igor  Vivanco</span>, <span class="hlFld-ContribAuthor ">Zhi C  Chen</span>, <span class="hlFld-ContribAuthor ">Barbara  Tanos</span>, <span class="hlFld-ContribAuthor ">Barbara  Oldrini</span>, <span class="hlFld-ContribAuthor ">Wan-Ying  Hsieh</span>, <span class="hlFld-ContribAuthor ">Nicolas  Yannuzzi</span>, <span class="hlFld-ContribAuthor ">Carl  Campos</span>, <span class="hlFld-ContribAuthor ">Ingo K  Mellinghoff</span>. </span><span class="cited-content_cbyCitation_article-title">A kinase-independent function of AKT promotes cancer cell survival. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2014,</strong> <em>3 </em><a href="https://doi.org/10.7554/eLife.03751" title="DOI URL">https://doi.org/10.7554/eLife.03751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.03751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.03751%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DA%252Bkinase-independent%252Bfunction%252Bof%252BAKT%252Bpromotes%252Bcancer%252Bcell%252Bsurvival%26aulast%3DVivanco%26aufirst%3DIgor%26date%3D2014%26date%3D2014%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Igor  Vujic</span>, <span class="hlFld-ContribAuthor ">Christian  Posch</span>, <span class="hlFld-ContribAuthor ">Martina  Sanlorenzo</span>, <span class="hlFld-ContribAuthor ">Adam J.  Yen</span>, <span class="hlFld-ContribAuthor ">Aaron  Tsumura</span>, <span class="hlFld-ContribAuthor ">Andrew  Kwong</span>, <span class="hlFld-ContribAuthor ">Valentin  Feichtenschlager</span>, <span class="hlFld-ContribAuthor ">Kevin  Lai</span>, <span class="hlFld-ContribAuthor ">Douglas V.  Arneson</span>, <span class="hlFld-ContribAuthor ">Klemens  Rappersberger</span>, <span class="hlFld-ContribAuthor ">Susana M.  Ortiz-Urda</span>. </span><span class="cited-content_cbyCitation_article-title">Mutant
              NRASQ61
              shares signaling similarities across various cancer types - potential implications for future therapies. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2014,</strong> <em>5 </em>
                                    (17)
                                     , 7936-7944. <a href="https://doi.org/10.18632/oncotarget.2326" title="DOI URL">https://doi.org/10.18632/oncotarget.2326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.2326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.2326%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DMutant%252BNRASQ61%252Bshares%252Bsignaling%252Bsimilarities%252Bacross%252Bvarious%252Bcancer%252Btypes%252B-%252Bpotential%252Bimplications%252Bfor%252Bfuture%252Btherapies%26aulast%3DVujic%26aufirst%3DIgor%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D17%26spage%3D7936%26epage%3D7944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily R.  Derbyshire</span>, <span class="hlFld-ContribAuthor ">Vanessa  Zuzarte-Luís</span>, <span class="hlFld-ContribAuthor ">Andreia D.  Magalhães</span>, <span class="hlFld-ContribAuthor ">Nobutaka  Kato</span>, <span class="hlFld-ContribAuthor ">Paul C.  Sanschagrin</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Wenjun  Zhou</span>, <span class="hlFld-ContribAuthor ">Chandrasekhar V.  Miduturu</span>, <span class="hlFld-ContribAuthor ">Ralph  Mazitschek</span>, <span class="hlFld-ContribAuthor ">Piotr  Sliz</span>, <span class="hlFld-ContribAuthor ">Maria M.  Mota</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Jon  Clardy</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Interrogation of the Malaria Kinome. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2014,</strong> <em>15 </em>
                                    (13)
                                     , 1920-1930. <a href="https://doi.org/10.1002/cbic.201400025" title="DOI URL">https://doi.org/10.1002/cbic.201400025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201400025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201400025%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DChemical%252BInterrogation%252Bof%252Bthe%252BMalaria%252BKinome%26aulast%3DDerbyshire%26aufirst%3DEmily%2BR.%26date%3D2014%26date%3D2014%26volume%3D15%26issue%3D13%26spage%3D1920%26epage%3D1930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samah  Karaki</span>, <span class="hlFld-ContribAuthor ">Carine  Becamel</span>, <span class="hlFld-ContribAuthor ">Samy  Murat</span>, <span class="hlFld-ContribAuthor ">Clotilde  Mannoury la Cour</span>, <span class="hlFld-ContribAuthor ">Mark J.  Millan</span>, <span class="hlFld-ContribAuthor ">Laurent  Prézeau</span>, <span class="hlFld-ContribAuthor ">Joël  Bockaert</span>, <span class="hlFld-ContribAuthor ">Philippe  Marin</span>, <span class="hlFld-ContribAuthor ">Franck  Vandermoere</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser280 by Hallucinogenic versus Nonhallucinogenic Agonists. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Proteomics</span><span> <strong>2014,</strong> <em>13 </em>
                                    (5)
                                     , 1273-1285. <a href="https://doi.org/10.1074/mcp.M113.036558" title="DOI URL">https://doi.org/10.1074/mcp.M113.036558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/mcp.M113.036558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fmcp.M113.036558%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Proteomics%26atitle%3DQuantitative%252BPhosphoproteomics%252BUnravels%252BBiased%252BPhosphorylation%252Bof%252BSerotonin%252B2A%252BReceptor%252Bat%252BSer280%252Bby%252BHallucinogenic%252Bversus%252BNonhallucinogenic%252BAgonists%26aulast%3DKaraki%26aufirst%3DSamah%26date%3D2014%26volume%3D13%26issue%3D5%26spage%3D1273%26epage%3D1285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathieu  Unbekandt</span>, <span class="hlFld-ContribAuthor ">Michael F.  Olson</span>. </span><span class="cited-content_cbyCitation_article-title">The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Medicine</span><span> <strong>2014,</strong> <em>92 </em>
                                    (3)
                                     , 217-225. <a href="https://doi.org/10.1007/s00109-014-1133-6" title="DOI URL">https://doi.org/10.1007/s00109-014-1133-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00109-014-1133-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00109-014-1133-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Medicine%26atitle%3DThe%252Bactin-myosin%252Bregulatory%252BMRCK%252Bkinases%25253A%252Bregulation%25252C%252Bbiological%252Bfunctions%252Band%252Bassociations%252Bwith%252Bhuman%252Bcancer%26aulast%3DUnbekandt%26aufirst%3DMathieu%26date%3D2014%26date%3D2014%26volume%3D92%26issue%3D3%26spage%3D217%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F  Yang</span>, <span class="hlFld-ContribAuthor ">R  Deng</span>, <span class="hlFld-ContribAuthor ">X-J  Qian</span>, <span class="hlFld-ContribAuthor ">S-H  Chang</span>, <span class="hlFld-ContribAuthor ">X-Q  Wu</span>, <span class="hlFld-ContribAuthor ">J  Qin</span>, <span class="hlFld-ContribAuthor ">G-K  Feng</span>, <span class="hlFld-ContribAuthor ">K  Ding</span>, <span class="hlFld-ContribAuthor ">X-F  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Feedback loops blockade potentiates apoptosis induction and antitumor activity of a novel AKT inhibitor DC120 in human liver cancer. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2014,</strong> <em>5 </em>
                                    (3)
                                     , e1114-e1114. <a href="https://doi.org/10.1038/cddis.2014.43" title="DOI URL">https://doi.org/10.1038/cddis.2014.43</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddis.2014.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddis.2014.43%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DFeedback%252Bloops%252Bblockade%252Bpotentiates%252Bapoptosis%252Binduction%252Band%252Bantitumor%252Bactivity%252Bof%252Ba%252Bnovel%252BAKT%252Binhibitor%252BDC120%252Bin%252Bhuman%252Bliver%252Bcancer%26aulast%3DYang%26aufirst%3DF%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D3%26spage%3De1114%26epage%3De1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dezhi  Yang</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Jianzhen  Liu</span>, <span class="hlFld-ContribAuthor ">Hualu  Xing</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Wencheng  Xie</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of novel indole derivatives as AKT inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (1)
                                     , 366-373. <a href="https://doi.org/10.1016/j.bmc.2013.11.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.11.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.11.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252Bindole%252Bderivatives%252Bas%252BAKT%252Binhibitors%26aulast%3DYang%26aufirst%3DDezhi%26date%3D2014%26volume%3D22%26issue%3D1%26spage%3D366%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria  Marsh Durban</span>, <span class="hlFld-ContribAuthor ">Marian M.  Deuker</span>, <span class="hlFld-ContribAuthor ">Marcus W.  Bosenberg</span>, <span class="hlFld-ContribAuthor ">Wayne  Phillips</span>, <span class="hlFld-ContribAuthor ">Martin  McMahon</span>. </span><span class="cited-content_cbyCitation_article-title">Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2013,</strong> <em>123 </em>
                                    (12)
                                     , 5104-5118. <a href="https://doi.org/10.1172/JCI69619" title="DOI URL">https://doi.org/10.1172/JCI69619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI69619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI69619%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DDifferential%252BAKT%252Bdependency%252Bdisplayed%252Bby%252Bmouse%252Bmodels%252Bof%252BBRAFV600E-initiated%252Bmelanoma%26aulast%3DMarsh%2BDurban%26aufirst%3DVictoria%26date%3D2013%26date%3D2013%26volume%3D123%26issue%3D12%26spage%3D5104%26epage%3D5118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen P.H.  Alexander</span>, <span class="hlFld-ContribAuthor ">Helen E.  Benson</span>, <span class="hlFld-ContribAuthor ">Elena  Faccenda</span>, <span class="hlFld-ContribAuthor ">Adam J.  Pawson</span>, <span class="hlFld-ContribAuthor ">Joanna L.  Sharman</span>, <span class="hlFld-ContribAuthor ">Michael  Spedding</span>, <span class="hlFld-ContribAuthor ">John A.  Peters</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Harmar</span>, . </span><span class="cited-content_cbyCitation_article-title">The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2013,</strong> <em>170 </em>
                                    (8)
                                     , 1797-1867. <a href="https://doi.org/10.1111/bph.12451" title="DOI URL">https://doi.org/10.1111/bph.12451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12451%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252BConcise%252BGuide%252Bto%252BPHARMACOLOGY%252B2013%25252F14%25253A%252BEnzymes%26aulast%3DAlexander%26aufirst%3DStephen%2BP.H.%26date%3D2013%26date%3D2013%26volume%3D170%26issue%3D8%26spage%3D1797%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">WEIGUO  CHEN</span>, <span class="hlFld-ContribAuthor ">SIPEI  WU</span>, <span class="hlFld-ContribAuthor ">GONG  ZHANG</span>, <span class="hlFld-ContribAuthor ">WENJUN  WANG</span>, <span class="hlFld-ContribAuthor ">YONGSHENG  SHI</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2013,</strong> <em>6 </em>
                                    (5)
                                     , 1234-1240. <a href="https://doi.org/10.3892/ol.2013.1552" title="DOI URL">https://doi.org/10.3892/ol.2013.1552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2013.1552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2013.1552%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DEffect%252Bof%252BAKT%252Binhibition%252Bon%252Bepithelial-mesenchymal%252Btransition%252Band%252BZEB1-potentiated%252Bradiotherapy%252Bin%252Bnasopharyngeal%252Bcarcinoma%26aulast%3DCHEN%26aufirst%3DWEIGUO%26date%3D2013%26date%3D2013%26volume%3D6%26issue%3D5%26spage%3D1234%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvain  Couty</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Andrew  Kalusa</span>, <span class="hlFld-ContribAuthor ">Celine  Cano</span>, <span class="hlFld-ContribAuthor ">Jon  Travers</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Chiau Ling  Chow</span>, <span class="hlFld-ContribAuthor ">Sam  Burns</span>, <span class="hlFld-ContribAuthor ">Jessica  Schmitt</span>, <span class="hlFld-ContribAuthor ">Lisa  Pickard</span>, <span class="hlFld-ContribAuthor ">Caterina  Barillari</span>, <span class="hlFld-ContribAuthor ">P. Craig  McAndrew</span>, <span class="hlFld-ContribAuthor ">Paul A.  Clarke</span>, <span class="hlFld-ContribAuthor ">Spiros  Linardopoulos</span>, <span class="hlFld-ContribAuthor ">Roger J.  Griffin</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Keith  Jones</span>, <span class="hlFld-ContribAuthor ">Rob L.M.  van Montfort</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2013,</strong> <em>4 </em>
                                    (10)
                                     , 1647-1661. <a href="https://doi.org/10.18632/oncotarget.1255" title="DOI URL">https://doi.org/10.18632/oncotarget.1255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.1255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.1255%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252Bdiscovery%252Bof%252Bpotent%252Bribosomal%252BS6%252Bkinase%252Binhibitors%252Bby%252Bhigh-throughput%252Bscreening%252Band%252Bstructure-guided%252Bdrug%252Bdesign%26aulast%3DCouty%26aufirst%3DSylvain%26date%3D2013%26date%3D2013%26volume%3D4%26issue%3D10%26spage%3D1647%26epage%3D1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James R.  Brown</span>, <span class="hlFld-ContribAuthor ">David  Drewry</span>, <span class="hlFld-ContribAuthor ">Francisco-Javier  Gamo</span>, <span class="hlFld-ContribAuthor ">Jose F.  Garcia-Bustos</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors Among Hits from Malaria Cellular Screens. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 261-291. <a href="https://doi.org/10.1002/9783527675401.ch13" title="DOI URL">https://doi.org/10.1002/9783527675401.ch13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527675401.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527675401.ch13%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252BAmong%252BHits%252Bfrom%252BMalaria%252BCellular%252BScreens%26aulast%3DBrown%26aufirst%3DJames%2BR.%26date%3D2013%26date%3D2013%26spage%3D261%26epage%3D291%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DProtein%252BPhosphorylation%252Bin%252BParasites%26aulast%3DDoerig%26aufirst%3DChristian%26date%3D2013%26volume%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek K.  Vyas</span>, <span class="hlFld-ContribAuthor ">Manjunath  Ghate</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Goel</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2013,</strong> <em>42 </em>, 17-25. <a href="https://doi.org/10.1016/j.jmgm.2013.01.010" title="DOI URL">https://doi.org/10.1016/j.jmgm.2013.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2013.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2013.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%25252C%252Bdocking%252Band%252Bin%252Bsilico%252BADMET%252Banalysis%252Bof%252Bprotein%252Bkinase%252BB%252B%252528PKB%252B%2525CE%2525B2%252529%252Binhibitors%26aulast%3DVyas%26aufirst%3DVivek%2BK.%26date%3D2013%26volume%3D42%26spage%3D17%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.  Posch</span>, <span class="hlFld-ContribAuthor ">H.  Moslehi</span>, <span class="hlFld-ContribAuthor ">L.  Feeney</span>, <span class="hlFld-ContribAuthor ">G. A.  Green</span>, <span class="hlFld-ContribAuthor ">A.  Ebaee</span>, <span class="hlFld-ContribAuthor ">V.  Feichtenschlager</span>, <span class="hlFld-ContribAuthor ">K.  Chong</span>, <span class="hlFld-ContribAuthor ">L.  Peng</span>, <span class="hlFld-ContribAuthor ">M. T.  Dimon</span>, <span class="hlFld-ContribAuthor ">T.  Phillips</span>, <span class="hlFld-ContribAuthor ">A. I.  Daud</span>, <span class="hlFld-ContribAuthor ">T. H.  McCalmont</span>, <span class="hlFld-ContribAuthor ">P. E.  LeBoit</span>, <span class="hlFld-ContribAuthor ">S.  Ortiz-Urda</span>. </span><span class="cited-content_cbyCitation_article-title">Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2013,</strong> <em>110 </em>
                                    (10)
                                     , 4015-4020. <a href="https://doi.org/10.1073/pnas.1216013110" title="DOI URL">https://doi.org/10.1073/pnas.1216013110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1216013110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1216013110%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DCombined%252Btargeting%252Bof%252BMEK%252Band%252BPI3K%25252FmTOR%252Beffector%252Bpathways%252Bis%252Bnecessary%252Bto%252Beffectively%252Binhibit%252BNRAS%252Bmutant%252Bmelanoma%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DPosch%26aufirst%3DC.%26date%3D2013%26date%3D2013%26volume%3D110%26issue%3D10%26spage%3D4015%26epage%3D4020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristen M.  Smith</span>, <span class="hlFld-ContribAuthor ">Catriona H. M.  Jamieson</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutics against Cancer Stem Cells: Targeting the Root of Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,<a href="https://doi.org/10.1002/3527600906.mcb.201200014" title="DOI URL">https://doi.org/10.1002/3527600906.mcb.201200014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/3527600906.mcb.201200014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F3527600906.mcb.201200014%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutics%252Bagainst%252BCancer%252BStem%252BCells%25253A%252BTargeting%252Bthe%252BRoot%252Bof%252BCancer%26aulast%3DSmith%26aufirst%3DKristen%2BM.%26date%3D2013%26date%3D2013%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DEncyclopedia%252Bof%252BMolecular%252BCell%252BBiology%252Band%252BMolecular%252BMedicine%26aulast%3DMeyers%26aufirst%3DRobert%2BA.%26date%3D2006%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dana  Faingold</span>, <span class="hlFld-ContribAuthor ">Dawn  Russell-Hermanns</span>, <span class="hlFld-ContribAuthor ">Silvin  Bakalian</span>. </span><span class="cited-content_cbyCitation_article-title">Prerequisite Genetic Traits for Metastasis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 403-444. <a href="https://doi.org/10.1007/978-1-4614-3685-0_27" title="DOI URL">https://doi.org/10.1007/978-1-4614-3685-0_27</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-3685-0_27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-3685-0_27%26sid%3Dliteratum%253Aachs%26atitle%3DPrerequisite%252BGenetic%252BTraits%252Bfor%252BMetastasis%26aulast%3DFaingold%26aufirst%3DDana%26date%3D2013%26date%3D2013%26spage%3D403%26epage%3D444%26pub%3DSpringer%2520New%2520York%26atitle%3DExperimental%252Band%252BClinical%252BMetastasis%26aulast%3DBurnier%26aufirst%3DJulia%2BV.%26date%3D2013%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>, <span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Klaus P.  Hoeflich</span>, <span class="hlFld-ContribAuthor ">Jonathan  Chernoff</span>. </span><span class="cited-content_cbyCitation_article-title">p21-Activated Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 157-180. <a href="https://doi.org/10.1016/B978-0-12-420146-0.00007-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-420146-0.00007-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-420146-0.00007-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-420146-0.00007-X%26sid%3Dliteratum%253Aachs%26atitle%3Dp21-Activated%252BKinase%252BInhibitors%26aulast%3DRudolph%26aufirst%3DJoachim%26date%3D2013%26spage%3D157%26epage%3D180%26pub%3DElsevier%26atitle%3DInhibitors%252Bof%252Bthe%252BRas%252Bsuperfamily%252BG-proteins%25252C%252BPart%252BB%26date%3D2013%26volume%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyung Hee  Jung</span>, <span class="hlFld-ContribAuthor ">Hong-Mei  Zheng</span>, <span class="hlFld-ContribAuthor ">Yujeong  Jeong</span>, <span class="hlFld-ContribAuthor ">Myung-Joo  Choi</span>, <span class="hlFld-ContribAuthor ">Hyunseung  Lee</span>, <span class="hlFld-ContribAuthor ">Sang-Won  Hong</span>, <span class="hlFld-ContribAuthor ">Hee-Seung  Lee</span>, <span class="hlFld-ContribAuthor ">Mi Kwon  Son</span>, <span class="hlFld-ContribAuthor ">Soyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>, <span class="hlFld-ContribAuthor ">Soon-Sun  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2013,</strong> <em>328 </em>
                                    (1)
                                     , 176-187. <a href="https://doi.org/10.1016/j.canlet.2012.08.005" title="DOI URL">https://doi.org/10.1016/j.canlet.2012.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2012.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2012.08.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DSuppression%252Bof%252Btumor%252Bproliferation%252Band%252Bangiogenesis%252Bof%252Bhepatocellular%252Bcarcinoma%252Bby%252BHS-104%25252C%252Ba%252Bnovel%252Bphosphoinositide%252B3-kinase%252Binhibitor%26aulast%3DJung%26aufirst%3DKyung%2BHee%26date%3D2013%26volume%3D328%26issue%3D1%26spage%3D176%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ipsita  Pal</span>, <span class="hlFld-ContribAuthor ">Mahitosh  Mandal</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2012,</strong> <em>33 </em>
                                    (12)
                                     , 1441-1458. <a href="https://doi.org/10.1038/aps.2012.72" title="DOI URL">https://doi.org/10.1038/aps.2012.72</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2012.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2012.72%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DPI3K%252Band%252BAkt%252Bas%252Bmolecular%252Btargets%252Bfor%252Bcancer%252Btherapy%25253A%252Bcurrent%252Bclinical%252Boutcomes%26aulast%3DPal%26aufirst%3DIpsita%26date%3D2012%26date%3D2012%26volume%3D33%26issue%3D12%26spage%3D1441%26epage%3D1458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran Kumar  Solingapuram Sai</span>, <span class="hlFld-ContribAuthor ">Kun-eek  Kil</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>, <span class="hlFld-ContribAuthor ">Wenhua  Chu</span>, <span class="hlFld-ContribAuthor ">Brian N.  Finck</span>, <span class="hlFld-ContribAuthor ">Justin M.  Rothfuss</span>, <span class="hlFld-ContribAuthor ">Kooresh I.  Shoghi</span>, <span class="hlFld-ContribAuthor ">Michael J.  Welch</span>, <span class="hlFld-ContribAuthor ">Robert J.  Gropler</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, radiolabeling and initial in vivo evaluation of [11C]KSM-01 for imaging PPAR-α receptors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (19)
                                     , 6233-6236. <a href="https://doi.org/10.1016/j.bmcl.2012.08.010" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.08.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.08.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bradiolabeling%252Band%252Binitial%252Bin%252Bvivo%252Bevaluation%252Bof%252B%25255B11C%25255DKSM-01%252Bfor%252Bimaging%252BPPAR-%2525CE%2525B1%252Breceptors%26aulast%3DSolingapuram%2BSai%26aufirst%3DKiran%2BKumar%26date%3D2012%26volume%3D22%26issue%3D19%26spage%3D6233%26epage%3D6236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugen  Lounkine</span>, <span class="hlFld-ContribAuthor ">Peter  Kutchukian</span>, <span class="hlFld-ContribAuthor ">Paula  Petrone</span>, <span class="hlFld-ContribAuthor ">John W.  Davies</span>, <span class="hlFld-ContribAuthor ">Meir  Glick</span>. </span><span class="cited-content_cbyCitation_article-title">Chemotography for multi-target SAR analysis in the context of biological pathways. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (18)
                                     , 5416-5427. <a href="https://doi.org/10.1016/j.bmc.2012.02.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.02.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.02.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DChemotography%252Bfor%252Bmulti-target%252BSAR%252Banalysis%252Bin%252Bthe%252Bcontext%252Bof%252Bbiological%252Bpathways%26aulast%3DLounkine%26aufirst%3DEugen%26date%3D2012%26volume%3D20%26issue%3D18%26spage%3D5416%26epage%3D5427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Wymann</span>. </span><span class="cited-content_cbyCitation_article-title">PI3Ks—Drug Targets in Inflammation and Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 111-181. <a href="https://doi.org/10.1007/978-94-007-3012-0_5" title="DOI URL">https://doi.org/10.1007/978-94-007-3012-0_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-007-3012-0_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-007-3012-0_5%26sid%3Dliteratum%253Aachs%26atitle%3DPI3Ks%2525E2%252580%252594Drug%252BTargets%252Bin%252BInflammation%252Band%252BCancer%26aulast%3DWymann%26aufirst%3DMatthias%26date%3D2012%26date%3D2012%26spage%3D111%26epage%3D181%26pub%3DSpringer%2520Netherlands%26atitle%3DPhosphoinositides%252BI%25253A%252BEnzymes%252Bof%252BSynthesis%252Band%252BDegradation%26aulast%3DBalla%26aufirst%3DTamas%26date%3D2012%26volume%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaohua  Chang</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoxi  Zhuang</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xianwen  Cao</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">New thiazole carboxamides as potent inhibitors of Akt kinases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (2)
                                     , 1208-1212. <a href="https://doi.org/10.1016/j.bmcl.2011.11.080" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.080%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bthiazole%252Bcarboxamides%252Bas%252Bpotent%252Binhibitors%252Bof%252BAkt%252Bkinases%26aulast%3DChang%26aufirst%3DShaohua%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D1208%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Osvaldo  Rey</span>, <span class="hlFld-ContribAuthor ">Wenhan  Chang</span>, <span class="hlFld-ContribAuthor ">Daniel  Bikle</span>, <span class="hlFld-ContribAuthor ">Nora  Rozengurt</span>, <span class="hlFld-ContribAuthor ">Steven H.  Young</span>, <span class="hlFld-ContribAuthor ">Enrique  Rozengurt</span>. </span><span class="cited-content_cbyCitation_article-title">Negative Cross-talk between Calcium-sensing Receptor and β-Catenin Signaling Systems in Colonic Epithelium. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2012,</strong> <em>287 </em>
                                    (2)
                                     , 1158-1167. <a href="https://doi.org/10.1074/jbc.M111.274589" title="DOI URL">https://doi.org/10.1074/jbc.M111.274589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M111.274589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M111.274589%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DNegative%252BCross-talk%252Bbetween%252BCalcium-sensing%252BReceptor%252Band%252B%2525CE%2525B2-Catenin%252BSignaling%252BSystems%252Bin%252BColonic%252BEpithelium%26aulast%3DRey%26aufirst%3DOsvaldo%26date%3D2012%26volume%3D287%26issue%3D2%26spage%3D1158%26epage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margrith E  Mattmann</span>, <span class="hlFld-ContribAuthor ">Sydney L  Stoops</span>, <span class="hlFld-ContribAuthor ">Craig W  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (9)
                                     , 1309-1338. <a href="https://doi.org/10.1517/13543776.2011.587959" title="DOI URL">https://doi.org/10.1517/13543776.2011.587959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.587959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.587959%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibition%252Bof%252BAkt%252Bwith%252Bsmall%252Bmolecules%252Band%252Bbiologics%25253A%252Bhistorical%252Bperspective%252Band%252Bcurrent%252Bstatus%252Bof%252Bthe%252Bpatent%252Blandscape%26aulast%3DMattmann%26aufirst%3DMargrith%2BE%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D9%26spage%3D1309%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mithun  Roy</span>, <span class="hlFld-ContribAuthor ">Balabhadrapatruni V. S. K.  Chakravarthi</span>, <span class="hlFld-ContribAuthor ">Chelliah  Jayabaskaran</span>, <span class="hlFld-ContribAuthor ">Anjali A.  Karande</span>, <span class="hlFld-ContribAuthor ">Akhil R.  Chakravarty</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of metal binding on the antitumor activity and cellular imaging of a metal chelator cationic imidazopyridine derivative. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2011,</strong> <em>40 </em>
                                    (18)
                                     , 4855-4864. <a href="https://doi.org/10.1039/C0DT01717E" title="DOI URL">https://doi.org/10.1039/C0DT01717E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C0DT01717E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC0DT01717E%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DImpact%252Bof%252Bmetal%252Bbinding%252Bon%252Bthe%252Bantitumor%252Bactivity%252Band%252Bcellular%252Bimaging%252Bof%252Ba%252Bmetal%252Bchelator%252Bcationic%252Bimidazopyridine%252Bderivative%26aulast%3DRoy%26aufirst%3DMithun%26date%3D2011%26date%3D2011%26volume%3D40%26issue%3D18%26spage%3D4855%26epage%3D4864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert H.  Bradbury</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors: Approved Drugs and Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 295-344. <a href="https://doi.org/10.1002/0471266949.bmc214" title="DOI URL">https://doi.org/10.1002/0471266949.bmc214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc214%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%25253A%252BApproved%252BDrugs%252Band%252BClinical%252BCandidates%26aulast%3DBradbury%26aufirst%3DRobert%2BH.%26date%3D2010%26date%3D2010%26spage%3D295%26epage%3D344%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Morphy</span>, <span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Approaches for Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 249-274. <a href="https://doi.org/10.1002/0471266949.bmc124" title="DOI URL">https://doi.org/10.1002/0471266949.bmc124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc124%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252BApproaches%252Bfor%252BMultitarget%252BDrugs%26aulast%3DMorphy%26aufirst%3DRichard%26date%3D2010%26date%3D2010%26spage%3D249%26epage%3D274%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Albert</span>, <span class="hlFld-ContribAuthor ">Maria  Serova</span>, <span class="hlFld-ContribAuthor ">Chantal  Dreyer</span>, <span class="hlFld-ContribAuthor ">Marie-Paule  Sablin</span>, <span class="hlFld-ContribAuthor ">Sandrine  Faivre</span>, <span class="hlFld-ContribAuthor ">Eric  Raymond</span>. </span><span class="cited-content_cbyCitation_article-title">New inhibitors of the mammalian target of rapamycin signaling pathway for cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2010,</strong> <em>19 </em>
                                    (8)
                                     , 919-930. <a href="https://doi.org/10.1517/13543784.2010.499121" title="DOI URL">https://doi.org/10.1517/13543784.2010.499121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2010.499121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2010.499121%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DNew%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252Bsignaling%252Bpathway%252Bfor%252Bcancer%26aulast%3DAlbert%26aufirst%3DS%25C3%25A9bastien%26date%3D2010%26date%3D2010%26volume%3D19%26issue%3D8%26spage%3D919%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John J.  Sauk</span>, <span class="hlFld-ContribAuthor ">Nikolaos G.  Nikitakis</span>, <span class="hlFld-ContribAuthor ">Mark A.  Scheper</span>. </span><span class="cited-content_cbyCitation_article-title">Are we on the brink of nonsurgical treatment for ameloblastoma?. </span><span class="cited-content_cbyCitation_journal-name">Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology</span><span> <strong>2010,</strong> <em>110 </em>
                                    (1)
                                     , 68-78. <a href="https://doi.org/10.1016/j.tripleo.2010.01.024" title="DOI URL">https://doi.org/10.1016/j.tripleo.2010.01.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tripleo.2010.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tripleo.2010.01.024%26sid%3Dliteratum%253Aachs%26jtitle%3DOral%2520Surgery%252C%2520Oral%2520Medicine%252C%2520Oral%2520Pathology%252C%2520Oral%2520Radiology%252C%2520and%2520Endodontology%26atitle%3DAre%252Bwe%252Bon%252Bthe%252Bbrink%252Bof%252Bnonsurgical%252Btreatment%252Bfor%252Bameloblastoma%25253F%26aulast%3DSauk%26aufirst%3DJohn%2BJ.%26date%3D2010%26volume%3D110%26issue%3D1%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Morphy</span>, <span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Multitarget Ligands. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 141-164. <a href="https://doi.org/10.1002/9780470584170.ch5" title="DOI URL">https://doi.org/10.1002/9780470584170.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470584170.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470584170.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BMultitarget%252BLigands%26aulast%3DMorphy%26aufirst%3DRichard%26date%3D2010%26date%3D2010%26spage%3D141%26epage%3D164%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DLead%252BGeneration%252BApproaches%252Bin%252BDrug%252BDiscovery%26aulast%3DRankovic%26aufirst%3DZoran%26date%3D2010%26date%3D2010%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia  Hernández-Campos</span>, <span class="hlFld-ContribAuthor ">Israel  Velázquez-Martínez</span>, <span class="hlFld-ContribAuthor ">Rafael  Castillo</span>, <span class="hlFld-ContribAuthor ">Fabian  López-Vallejo</span>, <span class="hlFld-ContribAuthor ">Ping  Jia</span>, <span class="hlFld-ContribAuthor ">Yongping  Yu</span>, <span class="hlFld-ContribAuthor ">Marc A.  Giulianotti</span>, <span class="hlFld-ContribAuthor ">Jose L.  Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Docking of Protein Kinase B Inhibitors: Implications in the Structure-Based Optimization of a Novel Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2010,</strong> <em>4 </em>, no-no. <a href="https://doi.org/10.1111/j.1747-0285.2010.01002.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2010.01002.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2010.01002.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2010.01002.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDocking%252Bof%252BProtein%252BKinase%252BB%252BInhibitors%25253A%252BImplications%252Bin%252Bthe%252BStructure-Based%252BOptimization%252Bof%252Ba%252BNovel%252BScaffold%26aulast%3DHern%25C3%25A1ndez-Campos%26aufirst%3DAlicia%26date%3D2010%26date%3D2010%26volume%3D4%26spage%3Dno%26epage%3Dno" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary K.  Smith</span>, <span class="hlFld-ContribAuthor ">Edgar R.  Wood</span>. </span><span class="cited-content_cbyCitation_article-title">Cell-based assays for kinase drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2010,</strong> <em>7 </em>
                                    (1)
                                     , e13-e19. <a href="https://doi.org/10.1016/j.ddtec.2010.04.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2010.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2010.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2010.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DCell-based%252Bassays%252Bfor%252Bkinase%252Bdrug%252Bdiscovery%26aulast%3DSmith%26aufirst%3DGary%2BK.%26date%3D2010%26volume%3D7%26issue%3D1%26spage%3De13%26epage%3De19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Yeon  Lee</span>, <span class="hlFld-ContribAuthor ">Yong Gyu  Lee</span>, <span class="hlFld-ContribAuthor ">Jaehwi  Lee</span>, <span class="hlFld-ContribAuthor ">Keum-Jin  Yang</span>, <span class="hlFld-ContribAuthor ">Ae Ra  Kim</span>, <span class="hlFld-ContribAuthor ">Joo Young  Kim</span>, <span class="hlFld-ContribAuthor ">Moo-Ho  Won</span>, <span class="hlFld-ContribAuthor ">Jongsun  Park</span>, <span class="hlFld-ContribAuthor ">Byong Chul  Yoo</span>, <span class="hlFld-ContribAuthor ">Sanghee  Kim</span>, <span class="hlFld-ContribAuthor ">Won-Jea  Cho</span>, <span class="hlFld-ContribAuthor ">Jae Youl  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Akt Cys-310-targeted Inhibition by Hydroxylated Benzene Derivatives Is Tightly Linked to Their Immunosuppressive Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2010,</strong> <em>285 </em>
                                    (13)
                                     , 9932-9948. <a href="https://doi.org/10.1074/jbc.M109.074872" title="DOI URL">https://doi.org/10.1074/jbc.M109.074872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M109.074872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M109.074872%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DAkt%252BCys-310-targeted%252BInhibition%252Bby%252BHydroxylated%252BBenzene%252BDerivatives%252BIs%252BTightly%252BLinked%252Bto%252BTheir%252BImmunosuppressive%252BEffects%26aulast%3DLee%26aufirst%3DJi%2BYeon%26date%3D2010%26volume%3D285%26issue%3D13%26spage%3D9932%26epage%3D9948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T. I.  Godovikova</span>, <span class="hlFld-ContribAuthor ">S. K.  Vorontsova</span>, <span class="hlFld-ContribAuthor ">L. D.  Konyushkin</span>, <span class="hlFld-ContribAuthor ">S. I.  Firgang</span>, <span class="hlFld-ContribAuthor ">O. A.  Rakitin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-methyl-4-(5-R-1H-1,2,4-triazol-3-yl)-1,2,5-oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2010,</strong> <em>59 </em>
                                    (2)
                                     , 483-485. <a href="https://doi.org/10.1007/s11172-010-0108-1" title="DOI URL">https://doi.org/10.1007/s11172-010-0108-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-010-0108-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-010-0108-1%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DSynthesis%252Bof%252B3-methyl-4-%2525285-R-1H-1%25252C2%25252C4-triazol-3-yl%252529-1%25252C2%25252C5-oxadiazoles%26aulast%3DGodovikova%26aufirst%3DT.%2BI.%26date%3D2010%26date%3D2010%26volume%3D59%26issue%3D2%26spage%3D483%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah A.  Altomare</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Deng</span>, <span class="hlFld-ContribAuthor ">Antonio  Di Cristofano</span>, <span class="hlFld-ContribAuthor ">Andres J.  Klein-Szanto</span>, <span class="hlFld-ContribAuthor ">Rakesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Joseph R.  Testa</span>. </span><span class="cited-content_cbyCitation_article-title">GSK690693 Delays Tumor Onset and Progression in Genetically Defined Mouse Models Expressing Activated Akt. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2010,</strong> <em>16 </em>
                                    (2)
                                     , 486-496. <a href="https://doi.org/10.1158/1078-0432.CCR-09-1026" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-09-1026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-09-1026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-09-1026%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DGSK690693%252BDelays%252BTumor%252BOnset%252Band%252BProgression%252Bin%252BGenetically%252BDefined%252BMouse%252BModels%252BExpressing%252BActivated%252BAkt%26aulast%3DAltomare%26aufirst%3DDeborah%2BA.%26date%3D2010%26date%3D2010%26volume%3D16%26issue%3D2%26spage%3D486%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jen Jen  Yeh</span>, <span class="hlFld-ContribAuthor ">James P.  Madigan</span>, <span class="hlFld-ContribAuthor ">Paul M.  Campbell</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Roberts</span>, <span class="hlFld-ContribAuthor ">Lanika  DeGraffenreid</span>, <span class="hlFld-ContribAuthor ">Channing J.  Der</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Ras for Anticancer Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 2837-2857. <a href="https://doi.org/10.1016/B978-0-12-374145-5.00329-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-374145-5.00329-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-374145-5.00329-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-374145-5.00329-6%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BRas%252Bfor%252BAnticancer%252BDrug%252BDiscovery%26aulast%3DYeh%26aufirst%3DJen%2BJen%26date%3D2010%26spage%3D2837%26epage%3D2857%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252BCell%252BSignaling%26date%3D2010%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Lin</span>, <span class="hlFld-ContribAuthor ">Dennis S.  Yamashita</span>, <span class="hlFld-ContribAuthor ">Ren  Xie</span>, <span class="hlFld-ContribAuthor ">Jin  Zeng</span>, <span class="hlFld-ContribAuthor ">Wenyong  Wang</span>, <span class="hlFld-ContribAuthor ">Jack  Leber</span>, <span class="hlFld-ContribAuthor ">Igor G.  Safonov</span>, <span class="hlFld-ContribAuthor ">Sharad  Verma</span>, <span class="hlFld-ContribAuthor ">Mei  Li</span>, <span class="hlFld-ContribAuthor ">Louis  LaFrance</span>, <span class="hlFld-ContribAuthor ">Joseph  Venslavsky</span>, <span class="hlFld-ContribAuthor ">Dennis  Takata</span>, <span class="hlFld-ContribAuthor ">Juan I.  Luengo</span>, <span class="hlFld-ContribAuthor ">Jason A.  Kahana</span>, <span class="hlFld-ContribAuthor ">Shuyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Kimberly A.  Robell</span>, <span class="hlFld-ContribAuthor ">Dana  Levy</span>, <span class="hlFld-ContribAuthor ">Rakesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Anthony E.  Choudhry</span>, <span class="hlFld-ContribAuthor ">Michael  Schaber</span>, <span class="hlFld-ContribAuthor ">Zhihong  Lai</span>, <span class="hlFld-ContribAuthor ">Barry S.  Brown</span>, <span class="hlFld-ContribAuthor ">Brian T.  Donovan</span>, <span class="hlFld-ContribAuthor ">Elisabeth A.  Minthorn</span>, <span class="hlFld-ContribAuthor ">Kristin K.  Brown</span>, <span class="hlFld-ContribAuthor ">Dirk A.  Heerding</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (2)
                                     , 684-688. <a href="https://doi.org/10.1016/j.bmcl.2009.11.061" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTetrasubstituted%252Bpyridines%252Bas%252Bpotent%252Band%252Bselective%252BAKT%252Binhibitors%25253A%252BReduced%252BCYP450%252Band%252BhERG%252Binhibition%252Bof%252Baminopyridines%26aulast%3DLin%26aufirst%3DHong%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D684%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Lin</span>, <span class="hlFld-ContribAuthor ">Dennis S.  Yamashita</span>, <span class="hlFld-ContribAuthor ">Jin  Zeng</span>, <span class="hlFld-ContribAuthor ">Ren  Xie</span>, <span class="hlFld-ContribAuthor ">Wenyong  Wang</span>, <span class="hlFld-ContribAuthor ">Sirishkumar  Nidarmarthy</span>, <span class="hlFld-ContribAuthor ">Juan I.  Luengo</span>, <span class="hlFld-ContribAuthor ">Nelson  Rhodes</span>, <span class="hlFld-ContribAuthor ">Victoria B.  Knick</span>, <span class="hlFld-ContribAuthor ">Anthony E.  Choudhry</span>, <span class="hlFld-ContribAuthor ">Zhihong  Lai</span>, <span class="hlFld-ContribAuthor ">Elisabeth A.  Minthorn</span>, <span class="hlFld-ContribAuthor ">Susan L.  Strum</span>, <span class="hlFld-ContribAuthor ">Edgar R.  Wood</span>, <span class="hlFld-ContribAuthor ">Patricia A.  Elkins</span>, <span class="hlFld-ContribAuthor ">Nestor O.  Concha</span>, <span class="hlFld-ContribAuthor ">Dirk A.  Heerding</span>. </span><span class="cited-content_cbyCitation_article-title">2,3,5-Trisubstituted pyridines as selective AKT inhibitors—Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (2)
                                     , 673-678. <a href="https://doi.org/10.1016/j.bmcl.2009.11.064" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.064%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2%25252C3%25252C5-Trisubstituted%252Bpyridines%252Bas%252Bselective%252BAKT%252Binhibitors%2525E2%252580%252594Part%252BI%25253A%252BSubstitution%252Bat%252B2-position%252Bof%252Bthe%252Bcore%252Bpyridine%252Bfor%252BROCK1%252Bselectivity%26aulast%3DLin%26aufirst%3DHong%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D673%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsuya  Okuzumi</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Ducker</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Brian  Aizenstein</span>, <span class="hlFld-ContribAuthor ">Randy  Hoffman</span>, <span class="hlFld-ContribAuthor ">Kevan M.  Shokat</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of indazole based analog sensitive Akt inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2010,</strong> <em>6 </em>
                                    (8)
                                     , 1389. <a href="https://doi.org/10.1039/c003917a" title="DOI URL">https://doi.org/10.1039/c003917a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c003917a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc003917a%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bindazole%252Bbased%252Banalog%252Bsensitive%252BAkt%252Binhibitors%26aulast%3DOkuzumi%26aufirst%3DTatsuya%26date%3D2010%26volume%3D6%26issue%3D8%26spage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose L.  Medina-Franco</span>, <span class="hlFld-ContribAuthor ">Marc A.  Giulianotti</span>, <span class="hlFld-ContribAuthor ">Yongping  Yu</span>, <span class="hlFld-ContribAuthor ">Liangliang  Shen</span>, <span class="hlFld-ContribAuthor ">Libo  Yao</span>, <span class="hlFld-ContribAuthor ">Narender  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel protein kinase B inhibitor by structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (16)
                                     , 4634-4638. <a href="https://doi.org/10.1016/j.bmcl.2009.06.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.06.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.06.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.06.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bprotein%252Bkinase%252BB%252Binhibitor%252Bby%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3DMedina-Franco%26aufirst%3DJose%2BL.%26date%3D2009%26volume%3D19%26issue%3D16%26spage%3D4634%26epage%3D4638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting PI3K signalling in cancer: opportunities, challenges and limitations. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Cancer</span><span> <strong>2009,</strong> <em>9 </em>
                                    (8)
                                     , 550-562. <a href="https://doi.org/10.1038/nrc2664" title="DOI URL">https://doi.org/10.1038/nrc2664</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrc2664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrc2664%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Cancer%26atitle%3DTargeting%252BPI3K%252Bsignalling%252Bin%252Bcancer%25253A%252Bopportunities%25252C%252Bchallenges%252Band%252Blimitations%26aulast%3DEngelman%26aufirst%3DJeffrey%2BA.%26date%3D2009%26volume%3D9%26issue%3D8%26spage%3D550%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsuya  Okuzumi</span>, <span class="hlFld-ContribAuthor ">Dorothea  Fiedler</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Daniel C  Gray</span>, <span class="hlFld-ContribAuthor ">Brian  Aizenstein</span>, <span class="hlFld-ContribAuthor ">Randy  Hoffman</span>, <span class="hlFld-ContribAuthor ">Kevan M  Shokat</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor hijacking of Akt activation. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2009,</strong> <em>5 </em>
                                    (7)
                                     , 484-493. <a href="https://doi.org/10.1038/nchembio.183" title="DOI URL">https://doi.org/10.1038/nchembio.183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.183%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DInhibitor%252Bhijacking%252Bof%252BAkt%252Bactivation%26aulast%3DOkuzumi%26aufirst%3DTatsuya%26date%3D2009%26date%3D2009%26volume%3D5%26issue%3D7%26spage%3D484%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A.  Seefeld</span>, <span class="hlFld-ContribAuthor ">Meagan B.  Rouse</span>, <span class="hlFld-ContribAuthor ">Kenneth C.  McNulty</span>, <span class="hlFld-ContribAuthor ">Lihui  Sun</span>, <span class="hlFld-ContribAuthor ">Jizhou  Wang</span>, <span class="hlFld-ContribAuthor ">Dennis S.  Yamashita</span>, <span class="hlFld-ContribAuthor ">Juan I.  Luengo</span>, <span class="hlFld-ContribAuthor ">ShuYun  Zhang</span>, <span class="hlFld-ContribAuthor ">Elisabeth A.  Minthorn</span>, <span class="hlFld-ContribAuthor ">Nestor O.  Concha</span>, <span class="hlFld-ContribAuthor ">Dirk A.  Heerding</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (8)
                                     , 2244-2248. <a href="https://doi.org/10.1016/j.bmcl.2009.02.094" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.02.094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.02.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.02.094%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B5-pyrrolopyridinyl-2-thiophenecarboxamides%252Bas%252Bpotent%252BAKT%252Bkinase%252Binhibitors%26aulast%3DSeefeld%26aufirst%3DMark%2BA.%26date%3D2009%26volume%3D19%26issue%3D8%26spage%3D2244%26epage%3D2248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meagan B.  Rouse</span>, <span class="hlFld-ContribAuthor ">Mark A.  Seefeld</span>, <span class="hlFld-ContribAuthor ">Jack D.  Leber</span>, <span class="hlFld-ContribAuthor ">Kenneth C.  McNulty</span>, <span class="hlFld-ContribAuthor ">Lihui  Sun</span>, <span class="hlFld-ContribAuthor ">William H.  Miller</span>, <span class="hlFld-ContribAuthor ">ShuYun  Zhang</span>, <span class="hlFld-ContribAuthor ">Elisabeth A.  Minthorn</span>, <span class="hlFld-ContribAuthor ">Nestor O.  Concha</span>, <span class="hlFld-ContribAuthor ">Anthony E.  Choudhry</span>, <span class="hlFld-ContribAuthor ">Michael D.  Schaber</span>, <span class="hlFld-ContribAuthor ">Dirk A.  Heerding</span>. </span><span class="cited-content_cbyCitation_article-title">Aminofurazans as potent inhibitors of AKT kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (5)
                                     , 1508-1511. <a href="https://doi.org/10.1016/j.bmcl.2009.01.002" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAminofurazans%252Bas%252Bpotent%252Binhibitors%252Bof%252BAKT%252Bkinase%26aulast%3DRouse%26aufirst%3DMeagan%2BB.%26date%3D2009%26volume%3D19%26issue%3D5%26spage%3D1508%26epage%3D1511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert G.  Gentles</span>, <span class="hlFld-ContribAuthor ">Shuanghua  Hu</span>, <span class="hlFld-ContribAuthor ">Gene M.  Dubowchik</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 1 Recent Advances in the Discovery of GSK-3 Inhibitors and a Perspective on their Utility for the Treatment of Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2009,</strong>,, 3-26. <a href="https://doi.org/10.1016/S0065-7743(09)04401-7" title="DOI URL">https://doi.org/10.1016/S0065-7743(09)04401-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0065-7743(09)04401-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0065-7743%2809%2904401-7%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B1%252BRecent%252BAdvances%252Bin%252Bthe%252BDiscovery%252Bof%252BGSK-3%252BInhibitors%252Band%252Ba%252BPerspective%252Bon%252Btheir%252BUtility%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%252527s%252BDisease%26aulast%3DGentles%26aufirst%3DRobert%2BG.%26date%3D2009%26spage%3D3%26epage%3D26%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B44%26date%3D2009%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0004.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compound <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Fe powder, AcOH, 75 °C, 1 h (93%); (b) ethyl cyanoacetate, 190 °C, 1 h (59%); (c) (i) NaNO<sub>2</sub>, MeOH; (ii) NH<sub>2</sub>OH/NaOH, 90 °C, 2 h (67%); (d) (Boc)<sub>2</sub>O, DMAP, pyridine, dichloroethane, 90 °C, 18 h (58%); (e) (i) <i>n</i>-BuLi, THF, −78 °C; (ii) B(OMe)<sub>3</sub>, THF, −78 °C to room temp, 1.5 h; (iii) H<sub>2</sub>O<sub>2</sub>/aq NaOH, room temp, 0.5 h (83%); (f) 1,1-dimethylethyl 4-hydroxy-1-piperidinecarboxylate, diethyl azadicarboxylate, polymer bound Ph<sub>3</sub>P, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1.5 h (43%); (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 40 min (97%).</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0005.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compound <b>10</b> and Key Intermediate <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SnCl<sub>2</sub>, HCl, room temp, 1 h (80%); (b) cyanoacetic acid, EDC, NMM, DMF, 0 °C to room temp, 3 h (quant); (c) AcOH, 90 °C, 1 h (88%); (d) NaNO<sub>2</sub>, HCl, room temp, 0.5 h (99%); (e) (i) aq NH<sub>2</sub>OH, Et<sub>3</sub>N, THF, 90 °C, 1.5 h; (ii) Et<sub>3</sub>N, dioxane, 150 °C, 1.5 h (52%); (f) (Boc)<sub>2</sub>O, pyridine, DMAP, dichloroethane, 85 °C, 1 h (78%); (g) (i) <i>n</i>-BuLi, THF, −100 °C; (ii) B(OMe)<sub>3</sub>, THF, −100 °C to room temp, 1.5 h; (iii) H<sub>2</sub>O<sub>2</sub>/NaOH, room temp, 1 h (84%); (h) PhB(OH)<sub>2</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, 18 h (75%); (i) 1,1-dimethylethyl (3-hydroxypropyl)carbamate, polymer-bound Ph<sub>3</sub>P, DEAD, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h; (j) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 2 h (27%, three steps).</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0006.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of compounds <b>12a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <i>n</i>-BuLi, THF, −100 °C; (ii) B(OMe)<sub>3</sub>, THF, −100 °C to room temp, 3 h; (iii) H<sub>2</sub>O<sub>2</sub>/NaOH, room temp, 45 min (59%); (b) 1,1-dimethylethyl (3-bromopropyl)carbamate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 35 °C, 15 h (77%); (c) H−C≡C−R, <i>i</i>-Pr<sub>2</sub>NH, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 110 °C, 2 h; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0007.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compounds <b>3a</b>−<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R-Br or R-Cl, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 35 °C, 15 h; (b) 2-methyl-3-butyn-2-ol, Pd(Ph<sub>3</sub>P)<sub>4</sub>, <i>i</i>-Pr<sub>2</sub>NH, dioxane, 110 °C, 2 h; (c) 2-methyl-3-butyn-2-ol, Pd(Ph<sub>3</sub>P)<sub>4</sub>, Zn dust, NaI, DBU, Et<sub>3</sub>N, DMSO, 80 °C, 3 h; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0008.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Compounds <b>11a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R-B(OH)<sub>2</sub> or R-(tetramethyldioxaborolane), Pd(Ph<sub>3</sub>P)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, 90 °C, 5 h; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (c) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (ii) <i>n</i>-Bu<sub>4</sub>NF, THF.</p></p></figure><figure data-id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0009.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Compounds <b>14a</b> and <b>14b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) 1,3-dibromopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 3.5 h, (67%); (b) R-NH<sub>2</sub>, Et<sub>3</sub>N, DMF, 60 °C, 30 min; (c) 2-methyl-3-butyn-2-ol, Pd(Ph<sub>3</sub>P)<sub>4</sub>, Zn dust, NaI, DBU, Et<sub>3</sub>N, DMSO, 80 °C, 3 h.</p></p></figure><figure data-id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0002.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> modeled into AKT2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0016.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Kinetic characterization of <b>3g</b> against AKT1. (A) IC<sub>50</sub> of compound <b>3g</b> with (filled circles) and without (open circles) a preincubation with AKT1. (B) Recovery of enzymatic activity following rapidly diluting the preformed AKT1−<b>3g</b> complex into substrate mix. Filled circles represent the control reaction in the absence of <b>3g</b>, and open circles represent the dissociation of <b>3g</b> from AKT1. (C) IC<sub>50</sub> values of <b>3g</b> as a function of ATP concentration against AKT1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0017.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cocrystal structure of <b>3g</b> in AKT2(148−481). (A) Compound <b>3g</b> cocrystal structure in AKT2(148−481) with the glycine rich loop omitted for clarity. Hydrogen bonds are indicated as dotted lines. (B) Ribbon diagram representation of AKT2(148−481) cocrystallized with <b>3g</b>. Graphics were prepared using MOE 2006.08, Chemical Computing Group, Inc.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/medium/jm-2008-004527_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0018.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>3g</b> on GSK3β phosphorylation in BT474 xenografts. (A) Dose response effect of <b>3g</b> on GSK3β phosphorylation in BT474 tumors in female SCID mice analyzed 4 h following administration of <b>3g</b>. (B) Time course of inhibition on GSK3β phosphorylation in BT474 tumors in female SCID mice by <b>3g</b> dosed at 20 mg/kg (ip).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8004527/production/images/large/jm-2008-004527_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8004527&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jetzt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span> </span><span class="NLM_article-title">Adenoviral-Mediated Expression of a Kinase-Dead Mutant of Akt Induces Apoptosis Selectively in Tumor Cells and Suppresses Tumor Growth in Mice</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6697</span><span class="NLM_x">–</span> <span class="NLM_lpage">6706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=6697-6706&author=A.+Jetztauthor=J.+A.+Howeauthor=M.+T.+Hornauthor=E.+Maxwellauthor=Z.+Yinauthor=D.+Johnsonauthor=C.+C.+Kumar&title=Adenoviral-Mediated+Expression+of+a+Kinase-Dead+Mutant+of+Akt+Induces+Apoptosis+Selectively+in+Tumor+Cells+and+Suppresses+Tumor+Growth+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJetzt%26aufirst%3DA.%26aulast%3DHowe%26aufirst%3DJ.%2BA.%26aulast%3DHorn%26aufirst%3DM.%2BT.%26aulast%3DMaxwell%26aufirst%3DE.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DC.%2BC.%26atitle%3DAdenoviral-Mediated%2520Expression%2520of%2520a%2520Kinase-Dead%2520Mutant%2520of%2520Akt%2520Induces%2520Apoptosis%2520Selectively%2520in%2520Tumor%2520Cells%2520and%2520Suppresses%2520Tumor%2520Growth%2520in%2520Mice%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D6697%26epage%3D6706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bellacosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1016%2FS0065-230X%2805%2994002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=16095999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=29-86&author=A.+Bellacosaauthor=C.+C.+Kumarauthor=A.+Di+Cristofanoauthor=J.+R.+Testa&title=Activation+of+AKT+Kinases+in+Cancer%3A+Implications+for+Therapeutic+Targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of AKT kinases in cancer: implications for therapeutic targeting</span></div><div class="casAuthors">Bellacosa, Alfonso; Kumar, C. Chandra; Di Cristofano, Antonio; Testa, Joseph Robert</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-86</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The AKT1, AKT2, and AKT3 kinases have emerged as crit. mediators of signal transduction pathways downstream of activated tyrosine kinases and phosphatidylinositol 3-kinase.  An ever-increasing list of AKT substrates has precisely defined the multiple functions of this kinase family in normal physiol. and disease states.  Cellular processes regulated by AKT include cell proliferation and survival, cell size and response to nutrient availability, intermediary metab., angiogenesis, and tissue invasion.  All these processes represent hallmarks of cancer, and a burgeoning literature has defined the importance of AKT alterations in human cancer and exptl. models of tumorigenesis, continuing the legacy represented by the original identification of v-Akt as the transforming oncogene of a murine retrovirus.  Many oncoproteins and tumor suppressors intersect in the AKT pathway, finely regulating cellular functions at the interface of signal transduction and classical metabolic regulation.  This careful balance is altered in human cancer by a variety of activating and inactivating mechanisms that target both AKT and interrelated proteins.  Reprogramming of this altered circuitry by pharmacol. modulation of the AKT pathway represents a powerful strategy for rational cancer therapy.  In this review, we summarize a large body of data, from many types of cancer, indicating that AKT activation is one of the most common mol. alterations in human malignancy.  We also review mechanisms of activation of AKT kinases, examples of therapeutic modulation of the AKT pathway in animal models, and the current status of efforts to target mol. components of the AKT pathway for cancer therapy and, possibly, cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtUdzglK927Vg90H21EOLACvtfcHk0lijE2Ofkc7ssQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D&md5=556e3c5787e0179786db3cb2e2f1dcf6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2805%2994002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252805%252994002-5%26sid%3Dliteratum%253Aachs%26aulast%3DBellacosa%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DC.%2BC.%26aulast%3DDi%2BCristofano%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DActivation%2520of%2520AKT%2520Kinases%2520in%2520Cancer%253A%2520Implications%2520for%2520Therapeutic%2520Targeting%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2005%26volume%3D94%26spage%3D29%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">The Akt/PKB Family of Protein Kinases: A Review of Small Molecule Inhibitors and Progress towards Target Validation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.2174%2F1568026053507714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15853641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=109-125&author=S.+F.+Barnettauthor=M.+T.+Bilodeauauthor=C.+W.+Lindsley&title=The+Akt%2FPKB+Family+of+Protein+Kinases%3A+A+Review+of+Small+Molecule+Inhibitors+and+Progress+towards+Target+Validation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation</span></div><div class="casAuthors">Barnett, Stanley F.; Bilodeau, Mark T.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-125</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent advances in the development and biol. evaluation of small mol. inhibitors for the serine/threonine kinase Akt (PKB).  Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors.  Recent studies indicate that unregulated activation of the PI3K/Akt pathway is a prominent feature of many human cancers and Akt is over-expressed or activated in all major cancers.  Akt is considered an attractive target for chemotherapy and it was postulated that inhibition of Akt alone or in combination with std. cancer chemotherapeutics will reduce the apoptotic threshold and preferentially kill cancer cells.  The development of specific and potent inhibitors will allow this hypothesis to be tested in animals.  The majority of small mol. inhibitors in this nascent field are classic ATP-competitive inhibitors which provide little specificity.  Phosphatidylinositol (PI) analogs were reported to inhibit Akt, but these inhibitors may also have specificity problems with respect to other PH domain contg. proteins and may have poor bioavailability.  None of the inhibitors in these classes were reported to have Akt isoenzyme specificity.  Recently, novel allosteric inhibitors were reported which are pleckstrin homol. domain dependent and exhibit Akt isoenzyme selectivity.  Inhibitors in this class may have sufficient potency and specificity to test for tumor efficacy in animal models and recently reported preliminary expts. are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLzMZqnXaA5bVg90H21EOLACvtfcHk0liC4i6Rgw0VPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLY%253D&md5=44734cf0124197d3c4d5d9be5f7499ca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026053507714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507714%26sid%3Dliteratum%253Aachs%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Akt%252FPKB%2520Family%2520of%2520Protein%2520Kinases%253A%2520A%2520Review%2520of%2520Small%2520Molecule%2520Inhibitors%2520and%2520Progress%2520towards%2520Target%2520Validation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D109%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Altomare, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Perturbations of the AKT Signaling Pathway in Human Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">7455</span><span class="NLM_x">–</span> <span class="NLM_lpage">7464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=7455-7464&author=D.+A.+Altomareauthor=J.+R.+Testa&title=Perturbations+of+the+AKT+Signaling+Pathway+in+Human+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAltomare%26aufirst%3DD.%2BA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DPerturbations%2520of%2520the%2520AKT%2520Signaling%2520Pathway%2520in%2520Human%2520Cancer%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D7455%26epage%3D7464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Dillon, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W. J.</span><span> </span><span class="NLM_article-title">The Phosphatidyl Inositol 3-Kinase Signaling Network: Implications for Human Breast Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1338</span><span class="NLM_x">–</span> <span class="NLM_lpage">1345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1338-1345&author=R.+L.+Dillonauthor=D.+E.+Whiteauthor=W.+J.+Muller&title=The+Phosphatidyl+Inositol+3-Kinase+Signaling+Network%3A+Implications+for+Human+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDillon%26aufirst%3DR.%2BL.%26aulast%3DWhite%26aufirst%3DD.%2BE.%26aulast%3DMuller%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520Phosphatidyl%2520Inositol%25203-Kinase%2520Signaling%2520Network%253A%2520Implications%2520for%2520Human%2520Breast%2520Cancer%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D1338%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chow, L. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span> </span><span class="NLM_article-title">PTEN Function in Normal and Neoplastic Growth</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1016%2Fj.canlet.2005.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=16412571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2msL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2006&pages=184-196&author=L.+M.+L.+Chowauthor=S.+J.+Baker&title=PTEN+Function+in+Normal+and+Neoplastic+Growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN function in normal and neoplastic growth</span></div><div class="casAuthors">Chow, Lionel M. L.; Baker, Suzanne J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-196</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The PTEN tumor suppressor is a central neg. regulator of the PI3K/AKT signaling cascade that influences multiple cellular functions including cell growth, survival, proliferation and migration in a context-dependent manner.  Dysregulation of this signaling pathway contributes to many cancers in man.  PTEN is the most commonly altered component of the PI3K pathway in human malignancies.  Mutations occur in both heritable and sporadic settings, with high frequency in sporadic glioblastoma, prostate and endometrial cancer.  Data from human tumors and animal models support the concept that the effects of PTEN inactivation are tissue-specific.  Elucidation of the mechanisms regulating activation of unique downstream effectors that mediate distinct outcomes of PTEN loss will augment our understanding of tumorigenesis and ultimately lead to novel therapeutic options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB0oHj4Xz-Y7Vg90H21EOLACvtfcHk0liC4i6Rgw0VPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2msL4%253D&md5=5f88f68544cb93f45f0990d9b0abd668</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DL.%2BM.%2BL.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26atitle%3DPTEN%2520Function%2520in%2520Normal%2520and%2520Neoplastic%2520Growth%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D241%26spage%3D184%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaroschak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M. E.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.2174%2F156802607781696864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=17692025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1SmtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1349-1363&author=C.+W.+Lindsleyauthor=S.+F.+Barnettauthor=M.+Yaroschakauthor=M.+T.+Bilodeauauthor=M.+E.+Layton&title=Recent+Progress+in+the+Development+of+ATP-Competitive+and+Allosteric+Akt+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors</span></div><div class="casAuthors">Lindsley, Craig W.; Barnett, Stanley F.; Yaroschak, Melissa; Bilodeau, Mark T.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1349-1363</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent advances in the development and biol. evaluation of small mol. inhibitors for the serine/threonine kinase Akt (PKB).  Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors.  Recent studies indicate that unregulated activation of the PI3K/Akt pathway is a prominent feature of many human cancers and Akt is over-expressed or activated in all major cancers.  Akt is considered an attractive target for cancer therapy and inhibition of Akt alone or in combination with std. cancer chemotherapeutics has been postulated to reduce the apoptotic threshold and preferentially kill cancer cells.  The development of specific and potent inhibitors will allow this hypothesis to be tested in animals.  Recently, several series of small mol., ATP-competitive inhibitors have been reported with a range of Akt potencies and selectivities.  Phosphatidylinositol (PI) analogs have been reported to inhibit Akt, but these inhibitors may also have specificity problems with respect to other pleckstrin homol. (PH) domain contg. proteins and may have poor bioavailability.  In addn., novel allosteric inhibitors have been reported which are PH domain dependent, exhibit selectivity for the individual Akt isoenzymes and inhibit the activity and the activation of Akt.  Compds. within these classes Akt inhibitors have sufficient potency and specificity to test for tumor efficacy in animal models and recently reported preliminary expts. are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnh2ym_1aqP7Vg90H21EOLACvtfcHk0lgY-yJCraaYvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1SmtbrK&md5=e717b21ffac302e074bf80a7897e2591</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F156802607781696864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781696864%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DYaroschak%26aufirst%3DM.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520ATP-Competitive%2520and%2520Allosteric%2520Akt%2520Kinase%2520Inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1349%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Li, Q.</span><span> </span><span class="NLM_article-title">Recent Progress in the Discovery of Akt Inhibitors as Anticancer Agents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">–</span> <span class="NLM_lpage">1130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1517%2F13543776.17.9.1077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1077-1130&author=Q.+Li&title=Recent+Progress+in+the+Discovery+of+Akt+Inhibitors+as+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of Akt inhibitors as anticancer agents</span></div><div class="casAuthors">Li, Qun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1077-1130</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Akt, also referred to as protein kinase B (PKB) or Related to A and C (RAC), is one of the major direct downstream targets of phosphoinositide 3-kinase (PI3K).  As it plays a central role in promoting cancer cell proliferation and survival through a growing list of key substrates, intense efforts are underway to find inhibitors of Akt for the treatment of cancer.  Discovery of potent and novel inhibitors of Akt has been facilitated greatly by the availability of the x-ray structure of the active form of Akt and by its structural similarity with other serine/threonine kinases.  In this review, new Akt inhibitors for the treatment of cancer are comprehensively reviewed, with emphasis on small mol. inhibitors that bind to the ATP-binding site, allosteric sites and the PH domains.  Inhibitors of pseudosubstrates and antisense oligonucleotides, as well as Akt inhibitors with unknown mechanism of actions, are also reviewed.  Results of clin. trials of several Akt drug candidates are briefly discussed.  A brief summary of Akt structure and regulation and the evidences supporting Akt as a cancer target is provided as well.  The patent literature is surveyed through July 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOO0MMNIO1cbVg90H21EOLACvtfcHk0lgY-yJCraaYvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7K&md5=1dab6d144639d87043ce13f16eec6073</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.9.1077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.9.1077%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Discovery%2520of%2520Akt%2520Inhibitors%2520as%2520Anticancer%2520Agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D1077%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safonov, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, S. K.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of AKT/PKB Kinase as a Strategy for Treating Cancer</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=365-376&author=D.+A.+Heerdingauthor=I.+G.+Safonovauthor=S.+K.+Verma&title=Small+Molecule+Inhibitors+of+AKT%2FPKB+Kinase+as+a+Strategy+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DSafonov%26aufirst%3DI.%2BG.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520AKT%252FPKB%2520Kinase%2520as%2520a%2520Strategy%2520for%2520Treating%2520Cancer%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D365%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jefferson, A. B.</span><span> </span><span class="NLM_article-title">Discovery Oof 2-Pyrimidyl-5-Amidothiophenes as Potent Inhibitors for AKT: Synthesis and SAR Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4163</span><span class="NLM_x">–</span> <span class="NLM_lpage">4168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4163-4168&author=X.+Linauthor=J.+M.+Murrayauthor=A.+C.+Ricoauthor=M.+X.+Wangauthor=D.+T.+Chuauthor=Y.+Zhouauthor=M.+Del+Rosarioauthor=S.+Kaufmanauthor=S.+Maauthor=E.+Fangauthor=K.+Crawfordauthor=A.+B.+Jefferson&title=Discovery+Oof+2-Pyrimidyl-5-Amidothiophenes+as+Potent+Inhibitors+for+AKT%3A+Synthesis+and+SAR+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DRico%26aufirst%3DA.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BX.%26aulast%3DChu%26aufirst%3DD.%2BT.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDel%2BRosario%26aufirst%3DM.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DE.%26aulast%3DCrawford%26aufirst%3DK.%26aulast%3DJefferson%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520Oof%25202-Pyrimidyl-5-Amidothiophenes%2520as%2520Potent%2520Inhibitors%2520for%2520AKT%253A%2520Synthesis%2520and%2520SAR%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4163%26epage%3D4168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavetsias, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L.-J.K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Isoquinoline-5-Sulfonamide Inhibitors of Protein Kinase B</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1255-1273&author=I.+Collinsauthor=J.+Caldwellauthor=T.+Fonsecaauthor=A.+Donaldauthor=V.+Bavetsiasauthor=L.-J.K.+Hunterauthor=M.+D.+Garrettauthor=M.+G.+Rowlandsauthor=G.+W.+Aherneauthor=T.+G.+Daviesauthor=V.+Berdiniauthor=S.+J.+Woodheadauthor=D.+Daviesauthor=L.+C.+A.+Seaversauthor=P.+G.+Wyattauthor=P.+Workmanauthor=E.+McDonald&title=Structure-Based+Design+of+Isoquinoline-5-Sulfonamide+Inhibitors+of+Protein+Kinase+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DFonseca%26aufirst%3DT.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DHunter%26aufirst%3DL.-J.K.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DWoodhead%26aufirst%3DS.%2BJ.%26aulast%3DDavies%26aufirst%3DD.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%2BA.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DMcDonald%26aufirst%3DE.%26atitle%3DStructure-Based%2520Design%2520of%2520Isoquinoline-5-Sulfonamide%2520Inhibitors%2520of%2520Protein%2520Kinase%2520B%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1255%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powlas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonigal, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinghofer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramling-Evans, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mika, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span> </span><span class="NLM_article-title">Potent and Selective Inhibitors of Akt Kinases Slow the Progress of Tumors in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1158%2F1535-7163.MCT-05-0005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15956255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFWrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=977-986&author=Y.+Luoauthor=A.+R.+Shoemakerauthor=X.+Liuauthor=K.+W.+Woodsauthor=S.+A.+Thomasauthor=R.+de+Jongauthor=E.+K.+Hanauthor=T.+Liauthor=V.+S.+Stollauthor=J.+A.+Powlasauthor=A.+Oleksijewauthor=M.+J.+Mittenauthor=Y.+Shiauthor=R.+Guanauthor=T.+P.+McGonigalauthor=V.+Klinghoferauthor=E.+F.+Johnsonauthor=J.+D.+Leversonauthor=J.+J.+Bouskaauthor=M.+Mamoauthor=R.+A.+Smithauthor=E.+E.+Gramling-Evansauthor=B.+A.+Zinkerauthor=A.+K.+Mikaauthor=P.+T.+Nguyenauthor=T.+Oltersdorfauthor=S.+H.+Rosenbergauthor=Q.+Liauthor=V.+L.+Giranda&title=Potent+and+Selective+Inhibitors+of+Akt+Kinases+Slow+the+Progress+of+Tumors+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo</span></div><div class="casAuthors">Luo, Yan; Shoemaker, Alexander R.; Liu, Xuesong; Woods, Keith W.; Thomas, Sheela A.; de Jong, Ron; Han, Edward K.; Li, Tongmei; Stoll, Vincent S.; Powlas, Jessica A.; Oleksijew, Anatol; Mitten, Michael J.; Shi, Yan; Guan, Ran; McGonigal, Thomas P.; Klinghofer, Vered; Johnson, Eric F.; Leverson, Joel D.; Bouska, Jennifer J.; Mamo, Mulugeta; Smith, Richard A.; Gramling-Evans, Emily E.; Zinker, Bradley A.; Mika, Amanda K.; Nguyen, Phong T.; Oltersdorf, Tilman; Rosenberg, Saul H.; Li, Qun; Giranda, Vincent L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">977-986</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Akt kinases are central nodes in signal transduction pathways that are important for cellular transformation and tumor progression.  We report the development of a series of potent and selective indazole-pyridine based Akt inhibitors.  These compds., exemplified by A-443654 (Ki = 160 pmol/L vs. Akt1), inhibit Akt-dependent signal transduction in cells and in vivo in a dose-responsive manner.  In vivo, the Akt inhibitors slow the progression of tumors when used as monotherapy or in combination with paclitaxel or rapamycin.  Tumor growth inhibition was obsd. during the dosing interval, and the tumors regrew when compd. administration was ceased.  The therapeutic window for these compds. is narrow.  Efficacy is achieved at doses ∼2-fold lower than the maximally tolerated doses.  Consistent with data from knockout animals, the Akt inhibitors induce an increase in insulin secretion.  They also induce a reactive increase in Akt phosphorylation.  Other toxicities obsd., including malaise and wt. loss, are consistent with abnormalities in glucose metab.  These data show that direct Akt inhibition may be useful in cancer therapy, but significant metabolic toxicities are likely dose limiting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKR0NQe3pou7Vg90H21EOLACvtfcHk0lhjye7s5rehxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFWrtr4%253D&md5=c83ac9ab9b7a880ae34bc8c7792ced31</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0005%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DThomas%26aufirst%3DS.%2BA.%26aulast%3Dde%2BJong%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DPowlas%26aufirst%3DJ.%2BA.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DMcGonigal%26aufirst%3DT.%2BP.%26aulast%3DKlinghofer%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DMamo%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DGramling-Evans%26aufirst%3DE.%2BE.%26aulast%3DZinker%26aufirst%3DB.%2BA.%26aulast%3DMika%26aufirst%3DA.%2BK.%26aulast%3DNguyen%26aufirst%3DP.%2BT.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26atitle%3DPotent%2520and%2520Selective%2520Inhibitors%2520of%2520Akt%2520Kinases%2520Slow%2520the%2520Progress%2520of%2520Tumors%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D977%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of 2,3,5-Trisubstituted Pyridine Derivatives as Potent Akt1 and Akt2 Dual Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1016%2Fj.bmcl.2004.12.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15686884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1elug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=905-909&author=Z.+Zhaoauthor=W.+H.+Leisterauthor=R.+G.+Robinsonauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=H.+E.+Huberauthor=M.+E.+Dugganauthor=C.+W.+Lindsley&title=Discovery+of+2%2C3%2C5-Trisubstituted+Pyridine+Derivatives+as+Potent+Akt1+and+Akt2+Dual+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors</span></div><div class="casAuthors">Zhao, Zhijian; Leister, William H.; Robinson, Ronald G.; Barnett, Stanley F.; Defeo-Jones, Deborah; Jones, Raymond E.; Hartman, George D.; Huff, Joel R.; Huber, Hans E.; Duggan, Mark E.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">905-909</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This letter describes the discovery of a novel series of dual Akt1/Akt2 kinase inhibitors, based on a 2,3,5-trisubstituted pyridine scaffold.  Compds. from this series, which contain a 5-tetrazolyl moiety, exhibit more potent inhibition of Akt2 than Akt1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJOzjnuD-86LVg90H21EOLACvtfcHk0lhh2zkH_1TJCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1elug%253D%253D&md5=a61e2d83a2d7ffdb660255e341deaa9c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.062%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%25202%252C3%252C5-Trisubstituted%2520Pyridine%2520Derivatives%2520as%2520Potent%2520Akt1%2520and%2520Akt2%2520Dual%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D905%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span> </span><span class="NLM_article-title">A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6652</span><span class="NLM_x">–</span> <span class="NLM_lpage">6659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1158%2F0008-5472.CAN-04-1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15374980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6652-6659&author=E.+R.+Woodauthor=A.+T.+Truesdaleauthor=O.+B.+McDonaldauthor=D.+Yuanauthor=A.+Hassellauthor=A.+H.+Dickersonauthor=B.+Ellisauthor=C.+Pennisiauthor=E.+Horneauthor=K.+Lackeyauthor=K.+J.+Alligoodauthor=D.+W.+Rusnakauthor=T.+M.+Gilmerauthor=L.+Shewchuk&title=A+Unique+Structure+for+Epidermal+Growth+Factor+Receptor+Bound+to+GW572016+%28Lapatinib%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells</span></div><div class="casAuthors">Wood, Edgar R.; Truesdale, Anne T.; McDonald, Octerloney B.; Yuan, Derek; Hassell, Anne; Dickerson, Scott H.; Ellis, Byron; Pennisi, Christopher; Horne, Earnest; Lackey, Karen; Alligood, Krystal J.; Rusnak, David W.; Gilmer, Tona M.; Shewchuk, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6652-6659</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GW572016 (Lapatinib) is a tyrosine kinase inhibitor in clin. development for cancer that is a potent dual inhibitor of epidermal growth factor receptor (EGFR, ErbB-1) and ErbB-2.  The authors detd. the crystal structure of EGFR bound to GW572016.  The compd. is bound to an inactive-like conformation of EGFR that is very different from the active-like structure bound by the selective EGFR inhibitor OSI-774 (Tarceva) described previously.  Surprisingly, the authors found that GW572016 has a very slow off-rate from the purified intracellular domains of EGFR and ErbB-2 compared with OSI-774 and another EGFR selective inhibitor, ZD-1839 (Iressa).  Treatment of tumor cells with these inhibitors results in down-regulation of receptor tyrosine phosphorylation.  The authors evaluated the duration of the drug effect after washing away free compd. and found that the rate of recovery of receptor phosphorylation in the tumor cells reflected the inhibitor off-rate from the purified intracellular domain.  The slow off-rate of GW572016 correlates with a prolonged down-regulation of receptor tyrosine phosphorylation in tumor cells.  The differences in the off-rates of these drugs and the ability of GW572016 to inhibit ErbB-2 can be explained by the enzyme-inhibitor structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXjJPy6XYk4rVg90H21EOLACvtfcHk0lhh2zkH_1TJCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D&md5=788d92fc5db9f1ecf9d3fbf3142e5c9f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1168%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DYuan%26aufirst%3DD.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DDickerson%26aufirst%3DA.%2BH.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DPennisi%26aufirst%3DC.%26aulast%3DHorne%26aufirst%3DE.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DA%2520Unique%2520Structure%2520for%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Bound%2520to%2520GW572016%2520%2528Lapatinib%2529%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6652%26epage%3D6659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug−Target Residence Time and Its Implications for Lead Optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug%E2%88%92Target+Residence+Time+and+Its+Implications+for+Lead+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug%25E2%2588%2592Target%2520Residence%2520Time%2520and%2520Its%2520Implications%2520for%2520Lead%2520Optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Rhodes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberwein, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knick, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansing, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geske, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleymenova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhry, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strum, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Characterization of an AKT Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2366</span><span class="NLM_x">–</span> <span class="NLM_lpage">2374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2366-2374&author=N.+Rhodesauthor=D.+A.+Heerdingauthor=D.+R.+Duckettauthor=D.+J.+Eberweinauthor=V.+B.+Knickauthor=T.+J.+Lansingauthor=R.+T.+McConnellauthor=T.+M.+Gilmerauthor=S.+Y.+Zhangauthor=K.+Robellauthor=J.+A.+Kahanaauthor=R.+S.+Geskeauthor=E.+V.+Kleymenovaauthor=A.+E.+Choudhryauthor=Z.+V.+Laiauthor=J.+D.+Leberauthor=E.+A.+Minthornauthor=S.+L.+Strumauthor=E.+R.+Woodauthor=P.+S.+Huangauthor=R.+Kumar&title=Characterization+of+an+AKT+Kinase+Inhibitor+with+Potent+Pharmacodynamic+and+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRhodes%26aufirst%3DN.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DDuckett%26aufirst%3DD.%2BR.%26aulast%3DEberwein%26aufirst%3DD.%2BJ.%26aulast%3DKnick%26aufirst%3DV.%2BB.%26aulast%3DLansing%26aufirst%3DT.%2BJ.%26aulast%3DMcConnell%26aufirst%3DR.%2BT.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DZhang%26aufirst%3DS.%2BY.%26aulast%3DRobell%26aufirst%3DK.%26aulast%3DKahana%26aufirst%3DJ.%2BA.%26aulast%3DGeske%26aufirst%3DR.%2BS.%26aulast%3DKleymenova%26aufirst%3DE.%2BV.%26aulast%3DChoudhry%26aufirst%3DA.%2BE.%26aulast%3DLai%26aufirst%3DZ.%2BV.%26aulast%3DLeber%26aufirst%3DJ.%2BD.%26aulast%3DMinthorn%26aufirst%3DE.%2BA.%26aulast%3DStrum%26aufirst%3DS.%2BL.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520an%2520AKT%2520Kinase%2520Inhibitor%2520with%2520Potent%2520Pharmacodynamic%2520and%2520Antitumor%2520Activity%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2366%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bailey, N.; Bamford, M. J.; Garland, S.; Goodman, K. B.; Cui, H; Hilfiker, M. A.; Lee, D.; Panchal, T. A.; Stavenger, R. A.; Wilson, D. M.; Witherington, J.</span> WO2003080610 A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bailey%2C+N.%3B+Bamford%2C+M.+J.%3B+Garland%2C+S.%3B+Goodman%2C+K.+B.%3B+Cui%2C+H%3B+Hilfiker%2C+M.+A.%3B+Lee%2C+D.%3B+Panchal%2C+T.+A.%3B+Stavenger%2C+R.+A.%3B+Wilson%2C+D.+M.%3B+Witherington%2C+J.+WO2003080610+A1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DN.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bamford, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steadman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span> </span><span class="NLM_article-title">(1<i>H</i>-Imidazo[4,5-<i>C</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine Derivatives: Further Optimisation as Highly Potent and Selective MSK-1-Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3407</span><span class="NLM_x">–</span> <span class="NLM_lpage">3411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3407-3411&author=M.+A.+Bamfordauthor=N.+Baileyauthor=S.+Daviesauthor=D.+K.+Deanauthor=L.+Francisauthor=T.+A.+Panchalauthor=C.+A.+Parrauthor=S.+Sehmiauthor=J.+G.+Steadmanauthor=A.+K.+Takleauthor=J.+T.+Townsendauthor=D.+M.+Wilson&title=%281H-Imidazo%5B4%2C5-C%5Dpyridin-2-yl%29-1%2C2%2C5-oxadiazol-3-ylamine+Derivatives%3A+Further+Optimisation+as+Highly+Potent+and+Selective+MSK-1-Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBamford%26aufirst%3DM.%2BA.%26aulast%3DBailey%26aufirst%3DN.%26aulast%3DDavies%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DFrancis%26aufirst%3DL.%26aulast%3DPanchal%26aufirst%3DT.%2BA.%26aulast%3DParr%26aufirst%3DC.%2BA.%26aulast%3DSehmi%26aufirst%3DS.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DTownsend%26aufirst%3DJ.%2BT.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26atitle%3D%25281H-Imidazo%255B4%252C5-C%255Dpyridin-2-yl%2529-1%252C2%252C5-oxadiazol-3-ylamine%2520Derivatives%253A%2520Further%2520Optimisation%2520as%2520Highly%2520Potent%2520and%2520Selective%2520MSK-1-Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3407%26epage%3D3411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bamford, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberti, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steadman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">(1<i>H</i>-Imidazo[4,5-<i>c</i>]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine Derivatives: A Novel Class of Potent MSK-1-Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3402</span><span class="NLM_x">–</span> <span class="NLM_lpage">3406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3402-3406&author=M.+J.+Bamfordauthor=M.+J.+Albertiauthor=N.+Baileyauthor=S.+Daviesauthor=D.+K.+Deanauthor=A.+Gaibaauthor=S.+Garlandauthor=J.+D.+Harlingauthor=D.+K.+Jungauthor=T.+A.+Panchalauthor=C.+A.+Parrauthor=J.+G.+Steadmanauthor=A.+K.+Takleauthor=T.+Townsendauthor=D.+M.+Wilsonauthor=J.+Witherington&title=%281H-Imidazo%5B4%2C5-c%5Dpyridin-2-yl%29-1%2C2%2C5-oxadiazol-3-ylamine+Derivatives%3A+A+Novel+Class+of+Potent+MSK-1-Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DAlberti%26aufirst%3DM.%2BJ.%26aulast%3DBailey%26aufirst%3DN.%26aulast%3DDavies%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DGarland%26aufirst%3DS.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DPanchal%26aufirst%3DT.%2BA.%26aulast%3DParr%26aufirst%3DC.%2BA.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DTownsend%26aufirst%3DT.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3D%25281H-Imidazo%255B4%252C5-c%255Dpyridin-2-yl%2529-1%252C2%252C5-oxadiazol-3-ylamine%2520Derivatives%253A%2520A%2520Novel%2520Class%2520of%2520Potent%2520MSK-1-Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3402%26epage%3D3406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Stavenger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaitanopoulos, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfiker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viet, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060873p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2-5&author=R.+A.+Stavengerauthor=H.+Cuiauthor=S.+E.+Dowdellauthor=R.+G.+Franzauthor=D.+E.+Gaitanopoulosauthor=K.+B.+Goodmanauthor=M.+A.+Hilfikerauthor=R.+L.+Ivyauthor=J.+D.+Leberauthor=J.+P.+Marinoauthor=H.-J.+Ohauthor=A.+Q.+Vietauthor=W.+Xuauthor=G.+Yeauthor=D.+Zhangauthor=Y.+Zhaoauthor=L.+J.+Jolivetteauthor=M.+S.+Headauthor=S.+F.+Semusauthor=P.+E.+Elkinsauthor=R.+B.+Kirkpatrickauthor=E.+Dulauthor=S.+S.+Khandekarauthor=T.+Yiauthor=D.+K.+Jungauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=D.+J.+Behmauthor=C.+P.+Doeauthor=R.+Bentleyauthor=Z.+X.+Chenauthor=E.+Huauthor=D.+Lee&title=Discovery+of+Aminofurazan-azabenzimidazoles+as+Inhibitors+of+Rho-Kinase+with+High+Kinase+Selectivity+and+Antihypertensive+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm060873p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060873p%26sid%3Dliteratum%253Aachs%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DDowdell%26aufirst%3DS.%2BE.%26aulast%3DFranz%26aufirst%3DR.%2BG.%26aulast%3DGaitanopoulos%26aufirst%3DD.%2BE.%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DHilfiker%26aufirst%3DM.%2BA.%26aulast%3DIvy%26aufirst%3DR.%2BL.%26aulast%3DLeber%26aufirst%3DJ.%2BD.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DViet%26aufirst%3DA.%2BQ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DHead%26aufirst%3DM.%2BS.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DElkins%26aufirst%3DP.%2BE.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DZ.%2BX.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520Aminofurazan-azabenzimidazoles%2520as%2520Inhibitors%2520of%2520Rho-Kinase%2520with%2520High%2520Kinase%2520Selectivity%2520and%2520Antihypertensive%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Irani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SantaLucia, J.,  Jr.</span><span> </span><span class="NLM_article-title">The Synthesis of Anti-Fixed 3-Methyl-3-deaza-2′-deoxyadenosine and Other 3<i>H</i>-Imidazo[4,5-<i>C</i>]pyridine Analogs</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1081%2FNCN-120016477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=12537017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslSq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=737-751&author=R.+J.+Iraniauthor=J.+SantaLucia&title=The+Synthesis+of+Anti-Fixed+3-Methyl-3-deaza-2%E2%80%B2-deoxyadenosine+and+Other+3H-Imidazo%5B4%2C5-C%5Dpyridine+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of anti-fixed 3-methyl-3-deaza-2'-deoxyadenosine and other 3H-imidazo[4,5-c]pyridine analogs</span></div><div class="casAuthors">Irani, Rostem J.; SantaLucia, John, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11 & 12</span>),
    <span class="NLM_cas:pages">737-751</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Rotation of a heterocyclic base around a glycosidic bond allows the formation of syn and anti conformations in nucleosides.  The syn conformation has been obsd. primarily in purine-purine mismatches in DNA duplexes.  Such mismatches give rise to false pos. oligonucleotide hybridization in DNA-based diagnostics.  Here the authors describe the synthesis of an analog of 2'-deoxyadenosine that retains its Watson-Crick functional groups, but cannot form the syn conformation.  In this analog, the N3 atom of 2'-deoxyadenosine is replaced by a C-CH3 group to give 7-methyl-1-β-D-deoxyribofuranosyl-1H-imidazo[4,5-c]pyridin-4-ylamine or 3-methyl-3-deaza-2'-deoxyadenosine (3mddA).  This modification sterically prevents the syn conformation and 3mddA becomes an anti-fixed nucleoside analog of 2'-deoxyadenosine.  The synthesis and conformational anal. of 3mddA and several analogs with an 3H-imidazo[4,5-c]pyridine skeleton are described, as well as their potential applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ0s7FQtdxurVg90H21EOLACvtfcHk0lj2tO24KLAfbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslSq&md5=f42a7a0aa035b6cb82098e710129a7ea</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1081%2FNCN-120016477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-120016477%26sid%3Dliteratum%253Aachs%26aulast%3DIrani%26aufirst%3DR.%2BJ.%26aulast%3DSantaLucia%26aufirst%3DJ.%26atitle%3DThe%2520Synthesis%2520of%2520Anti-Fixed%25203-Methyl-3-deaza-2%25E2%2580%25B2-deoxyadenosine%2520and%2520Other%25203H-Imidazo%255B4%252C5-C%255Dpyridine%2520Analogs%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2002%26volume%3D21%26spage%3D737%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Corbet, J. -P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignani, G.</span><span> </span><span class="NLM_article-title">Selected Patented Cross-Coupling Reaction Technologies</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">2651</span><span class="NLM_x">–</span> <span class="NLM_lpage">2710</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0505268" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVeltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=2651-2710&author=J.+-P.+Corbetauthor=G.+Mignani&title=Selected+Patented+Cross-Coupling+Reaction+Technologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Selected patented cross-coupling reaction technologies</span></div><div class="casAuthors">Corbet, Jean-Pierre; Mignani, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2651-2710</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review dealing with cross-coupling reactions : carbon-carbon coupling reactions (Miyaura-Suzuki reaction, Corriu-Kumada-Tamao reaction, Negishi reaction, etc.) and carbon-nitrogen coupling reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIXYOdKmkYGbVg90H21EOLACvtfcHk0lj2tO24KLAfbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVeltLk%253D&md5=b10d7f1479363f644363f7434e172ee1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr0505268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0505268%26sid%3Dliteratum%253Aachs%26aulast%3DCorbet%26aufirst%3DJ.%2B-P.%26aulast%3DMignani%26aufirst%3DG.%26atitle%3DSelected%2520Patented%2520Cross-Coupling%2520Reaction%2520Technologies%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26spage%3D2651%26epage%3D2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Chinchilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, C.</span><span> </span><span class="NLM_article-title">The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">874</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr050992x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2007&pages=874-922&author=R.+Chinchillaauthor=C.+Najera&title=The+Sonogashira+Reaction%3A+A+Booming+Methodology+in+Synthetic+Organic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Sonogashira reaction: a booming methodology in synthetic organic chemistry</span></div><div class="casAuthors">Chinchilla, Rafael; Najera, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-922</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The palladium-catalyzed sp2-sp coupling reaction between aryl or alkenyl halides or triflates and terminal alkynes, with or without the presence of copper(I) cocatalyst, was reviewed.  The mechanism of Sonogashira reaction was discussed, and the catalysts and reaction conditions were explored as well.  In addn., the application of Sonogashira cross-coupling reaction was also introduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ8ePd8RdbSrVg90H21EOLACvtfcHk0lj2tO24KLAfbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbc%253D&md5=91f627efbf940c60809c2acfe597d3b7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcr050992x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr050992x%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DR.%26aulast%3DNajera%26aufirst%3DC.%26atitle%3DThe%2520Sonogashira%2520Reaction%253A%2520A%2520Booming%2520Methodology%2520in%2520Synthetic%2520Organic%2520Chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2007%26volume%3D107%26spage%3D874%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barford, D.</span><span> </span><span class="NLM_article-title">Crystal Structure of an Activated Akt/Protein Kinase B Ternary Complex with GSK3-Peptide and AMP-PNP</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">940</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=940-944&author=J.+Yangauthor=P.+Cronauthor=V.+M.+Goodauthor=V.+Thompsonauthor=B.+A.+Hemmingsauthor=D.+Barford&title=Crystal+Structure+of+an+Activated+Akt%2FProtein+Kinase+B+Ternary+Complex+with+GSK3-Peptide+and+AMP-PNP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DCron%26aufirst%3DP.%26aulast%3DGood%26aufirst%3DV.%2BM.%26aulast%3DThompson%26aufirst%3DV.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26aulast%3DBarford%26aufirst%3DD.%26atitle%3DCrystal%2520Structure%2520of%2520an%2520Activated%2520Akt%252FProtein%2520Kinase%2520B%2520Ternary%2520Complex%2520with%2520GSK3-Peptide%2520and%2520AMP-PNP%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D940%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><div class="note"><p class="first last">For a excellent description of the various binding pockets available to protein kinase inhibitors, see the following:</p></div><span class="NLM_contrib-group">Liao, J.J.-L.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.J.-L.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lh9l7dR9vm_HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.J.-L.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><div class="note"><p class="first last">BT474 is a breast tumor line chosen because it has activated AKT1 and AKT2 by virtue of ErbB2 overexpression. See the following:</p></div><span class="NLM_contrib-group">Nicholson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streuli, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, N. G.</span><span> </span><span class="NLM_article-title">Autocrine Signalling through Erbb Receptors Promotes Constitutive Activation of Protein Kinase B/Akt in Breast Cancer Cell Lines</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1023%2FA%3A1025765215765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=14572154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlGqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2003&pages=117-128&author=K.+M.+Nicholsonauthor=C.+H.+Streuliauthor=N.+G.+Anderson&title=Autocrine+Signalling+through+Erbb+Receptors+Promotes+Constitutive+Activation+of+Protein+Kinase+B%2FAkt+in+Breast+Cancer+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Autocrine Signalling Through erbB Receptors Promotes Constitutive Activation of Protein Kinase B/Akt in Breast Cancer Cell Lines</span></div><div class="casAuthors">Nicholson, K. M.; Streuli, C. H.; Anderson, N. G.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-128</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">The protein kinase PKB/Akt plays a pivotal role in promoting cell survival and proliferation.  This study investigated the regulation of PKB/Akt activity in breast cancer cells.  In primary invasive breast cancers PKB/Akt exhibited elevated phosphorylation at regulatory site Ser473 in 80% of cases, using immunohistochem.  The degree of phospho-PKB/Akt immunoreactivity was pos. correlated with the extent of its nuclear accumulation.  Moderate/strong staining was seen in 31% of the samples but was absent in tumor-assocd. normal breast epithelia.  To examine the mechanisms of PKB/Akt activation, the authors studied its phosphorylation in a panel of breast cancer cell lines.  PKB/Akt was constitutively phosphorylated on both regulatory sites (Thr308 and Ser473) in the absence of serum growth factors in 7 of 8 lines but not in 2 cell lines derived from normal breast epithelia.  Further anal. revealed that constitutive PKB/Akt phosphorylation was assocd. with loss of PTEN phosphatase expression (CAL51, MDA-MB-468, BT549 cells) and constitutive activation of erbB2 (SKBR3, BT474 cells).  In 2 further breast cancer lines (T47D and HS578T) PKB/Akt phosphorylation was dependent upon autocrine factors acting primary through the epidermal growth factor receptor (EGFR) and erbB2.  Conditioned medium from HS578T cells stimulated EGFR-dependent PKB/Akt phosphorylation in normal breast cells.  These results demonstrate that PKB/Akt is frequently activated in breast cancer through diverse mechanisms, including autocrine signaling via erbB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2xFosv5sCrVg90H21EOLACvtfcHk0lh9l7dR9vm_HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlGqtrk%253D&md5=6efd41e8e1918beb3c7b75ab581a31fe</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1023%2FA%3A1025765215765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1025765215765%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DK.%2BM.%26aulast%3DStreuli%26aufirst%3DC.%2BH.%26aulast%3DAnderson%26aufirst%3DN.%2BG.%26atitle%3DAutocrine%2520Signalling%2520through%2520Erbb%2520Receptors%2520Promotes%2520Constitutive%2520Activation%2520of%2520Protein%2520Kinase%2520B%252FAkt%2520in%2520Breast%2520Cancer%2520Cell%2520Lines%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2003%26volume%3D81%26spage%3D117%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">LNCaP is a prostate line chosen because it has consitutively activated AKT1. See the following:</p></div><span class="NLM_contrib-group">Nakatani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaue, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigel, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, R. A.</span><span> </span><span class="NLM_article-title">Up-Regulation of Akt3 on Estrogen Receptor-Deficient Breast Cancers and Androgen-Independent Prostate Cancer Lines</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">21528</span><span class="NLM_x">–</span> <span class="NLM_lpage">21532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=21528-21532&author=K.+Nakataniauthor=D.+A.+Thompsonauthor=A.+Barthelauthor=H.+Sakaueauthor=W.+Liuauthor=R.+J.+Weigelauthor=R.+A.+Roth&title=Up-Regulation+of+Akt3+on+Estrogen+Receptor-Deficient+Breast+Cancers+and+Androgen-Independent+Prostate+Cancer+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakatani%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DBarthel%26aufirst%3DA.%26aulast%3DSakaue%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWeigel%26aufirst%3DR.%2BJ.%26aulast%3DRoth%26aufirst%3DR.%2BA.%26atitle%3DUp-Regulation%2520of%2520Akt3%2520on%2520Estrogen%2520Receptor-Deficient%2520Breast%2520Cancers%2520and%2520Androgen-Independent%2520Prostate%2520Cancer%2520Lines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D21528%26epage%3D21532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><div class="note"><p class="first last">The inhibition of 89 protein kinases by <b>3g</b> was characterized at GlaxoSmithKline. In addition, <b>3g</b> was also tested in the IC<sub>50</sub> Profiler Express panel (Upstate, Charlottesville, VA) against 209 protein kinases using filter binding activity assays and in the Ambit Biosciences (San Diego, CA) panel against 180 protein kinases measuring binding with phage display technology. As much as possible, the assays were configured so that the IC<sub>50</sub> values approximate the intrinsic binding constant (<i>K</i><sub>i</sub> or <i>K</i><sub>d</sub>) of <b>3g</b> to each enzyme and can therefore be compared for selectivity against these kinases.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+inhibition+of+89+protein+kinases+by+3g+was+characterized+at+GlaxoSmithKline.+In+addition%2C+3g+was+also+tested+in+the+IC50+Profiler+Express+panel+%28Upstate%2C+Charlottesville%2C+VA%29+against+209+protein+kinases+using+filter+binding+activity+assays+and+in+the+Ambit+Biosciences+%28San+Diego%2C+CA%29+panel+against+180+protein+kinases+measuring+binding+with+phage+display+technology.+As+much+as+possible%2C+the+assays+were+configured+so+that+the+IC50+values+approximate+the+intrinsic+binding+constant+%28Ki+or+Kd%29+of+3g+to+each+enzyme+and+can+therefore+be+compared+for+selectivity+against+these+kinases."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Dummler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">Physiological Roles of PKB/Akt Isoforms in Development and Disease</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1042%2FBST0350231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=17371246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1WrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=231-235&author=B.+Dummlerauthor=B.+A.+Hemmings&title=Physiological+Roles+of+PKB%2FAkt+Isoforms+in+Development+and+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological roles of PKB/Akt isoforms in development and disease</span></div><div class="casAuthors">Dummler, B.; Hemmings, B. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-235</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  PKB (protein kinase B, also known as Akt) is a serine/threonine protein kinase that is important in various signaling cascades and acts as a major signal transducer downstream of activated phosphoinositide 3-kinase.  There are three closely related isoforms of PKB in mammalian cells, PKBα (Akt1), PKBβ (Akt2) and PKBγ (Akt3), and this review discusses recent advances in our understanding of the functions of these isoforms in the regulation of adipocyte differentiation, glucose homeostasis and tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo2CyTsdm-MrVg90H21EOLACvtfcHk0lg3SYx28VVBQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1WrsLg%253D&md5=bd50e4a8a2424c2f65f79e4967d9a0d8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1042%2FBST0350231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0350231%26sid%3Dliteratum%253Aachs%26aulast%3DDummler%26aufirst%3DB.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DPhysiological%2520Roles%2520of%2520PKB%252FAkt%2520Isoforms%2520in%2520Development%2520and%2520Disease%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26spage%3D231%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketih, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">The Effects of the Novel, Reversible Epidermal Growth Factor Receptor/Erbb-2 Tyrosine Kinase Inhibitor, GW2016, on the Growth of Human Normal and Tumor-Derived Cell Lines in Vitro and in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=12467226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=85-94&author=D.+W.+Rusnakauthor=K.+Lackeyauthor=K.+Affleckauthor=E.+R.+Woodauthor=K.+J.+Alligoodauthor=N.+Rhodesauthor=B.+R.+Ketihauthor=D.+M.+Murrayauthor=W.+B.+Knightauthor=R.+J.+Mullinauthor=T.+M.+Gilmer&title=The+Effects+of+the+Novel%2C+Reversible+Epidermal+Growth+Factor+Receptor%2FErbb-2+Tyrosine+Kinase+Inhibitor%2C+GW2016%2C+on+the+Growth+of+Human+Normal+and+Tumor-Derived+Cell+Lines+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo</span></div><div class="casAuthors">Rusnak, David W.; Lackey, Karen; Affleck, Karen; Wood, Edgar R.; Alligood, Krystal J.; Rhodes, Nelson; Keith, Barry R.; Murray, Doris M.; Knight, W. Blaine; Mullin, Robert J.; Gilmer, Tona M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-94</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) and ErbB-2 transmembrane tyrosine kinases are currently being targeted by various mechanisms in the treatment of cancer.  GW2016 is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, resp.  This report describes the efficacy in cell growth assays of GW2016 on human tumor cell lines overexpressing either EGFR or ErbB-2: HN5 (head and neck), A-431 (vulva), BT474 (breast), CaLu-3 (lung), and N87 (gastric).  Normal human foreskin fibroblasts, nontumorigenic epithelial cells (HB4a), and nonoverexpressing tumor cells (MCF-7 and T47D) were tested as neg. controls.  After 3 days of compd. exposure, av. IC50 values for growth inhibition in the EGFR- and ErbB-2-overexpressing tumor cell lines were <0.16 μM.  The av. selectivity for the tumor cells vs. the human foreskin fibroblast cell line was 100-fold.  Inhibition of EGFR and ErbB-2 receptor autophosphorylation and phosphorylation of the downstream modulator, AKT, was verified by Western blot anal. in the BT474 and HN5 cell lines.  As a measure of cytotoxicity vs. growth arrest, the HN5 and BT474 cells were assessed in an outgrowth assay after a transient exposure to GW2016.  The cells were treated for 3 days in five concns. of GW2016, and cell growth was monitored for an addnl. 12 days after removal of the compd.  In each of these tumor cell lines, concns. of GW2016 were reached where outgrowth did not occur.  Furthermore, growth arrest and cell death were obsd. in parallel expts., as detd. by bromodeoxyuridine incorporation and propidium iodide staining.  GW2016 treatment inhibited tumor xenograft growth of the HN5 and BT474 cells in a dose-responsive manner at 30 and 100 mg/kg orally, twice daily, with complete inhibition of tumor growth at the higher dose.  Together, these results indicate that GW2016 achieves excellent potency on tumor cells with selectivity for tumor vs. normal cells and suggest that GW2016 has value as a therapy for patients with tumors overexpressing either EGFR or ErbB-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5OJ41zsWu6rVg90H21EOLACvtfcHk0lg3SYx28VVBQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtbs%253D&md5=64fd8cadce83eda3b9b82ab50f1e57b0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRhodes%26aufirst%3DN.%26aulast%3DKetih%26aufirst%3DB.%2BR.%26aulast%3DMurray%26aufirst%3DD.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DThe%2520Effects%2520of%2520the%2520Novel%252C%2520Reversible%2520Epidermal%2520Growth%2520Factor%2520Receptor%252FErbb-2%2520Tyrosine%2520Kinase%2520Inhibitor%252C%2520GW2016%252C%2520on%2520the%2520Growth%2520of%2520Human%2520Normal%2520and%2520Tumor-Derived%2520Cell%2520Lines%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2001%26volume%3D1%26spage%3D85%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Shults, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauffenburger, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imperiali, B.</span><span> </span><span class="NLM_article-title">A Multiplexed Homogeneous Fluorescence-Based Assay for Protein Kinase Activity in Cell Lysates</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8004527&amp;key=10.1038%2Fnmeth747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm8004527&amp;key=15782220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm8004527&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=277-284&author=M.+D.+Shultsauthor=K.+A.+Janesauthor=D.+A.+Lauffenburgerauthor=B.+Imperiali&title=A+Multiplexed+Homogeneous+Fluorescence-Based+Assay+for+Protein+Kinase+Activity+in+Cell+Lysates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates</span></div><div class="casAuthors">Shults, Melissa D.; Janes, Kevin A.; Lauffenburger, Douglas A.; Imperiali, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New methods to quantify protein kinase activities directly from complex cellular mixts. are crit. for understanding biol. regulatory pathways.  Herein, a fluorescence-based chemosensor strategy for the direct measurement of kinase activities in crude mammalian cell lysates is described.  We first designed a new fluorescent peptide reporter substrate for each target kinase.  These kinase chemosensors were readily phosphorylated by recombinant target enzyme and underwent a several-fold fluorescence increase upon phosphorylation.  Then, using unfractionated cell lysates, a homogeneous kinase assay was developed that was reproducible, linear and highly preferential for monitoring changes in cellular activity of the target kinase.  The general protocol was developed for the kinase Akt and then easily extended to measure protein kinase A (PKA) and mitogen-activated protein kinase-assocd. protein kinase 2 (MK2) activities.  This assay platform is immediately useful for studying protein kinase signaling in crude cellular exts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTEkshX0E50LVg90H21EOLACvtfcHk0lg3SYx28VVBQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFejtbs%253D&md5=428545e2f8492bc47ce340cb536a16f4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnmeth747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth747%26sid%3Dliteratum%253Aachs%26aulast%3DShults%26aufirst%3DM.%2BD.%26aulast%3DJanes%26aufirst%3DK.%2BA.%26aulast%3DLauffenburger%26aufirst%3DD.%2BA.%26aulast%3DImperiali%26aufirst%3DB.%26atitle%3DA%2520Multiplexed%2520Homogeneous%2520Fluorescence-Based%2520Assay%2520for%2520Protein%2520Kinase%2520Activity%2520in%2520Cell%2520Lysates%26jtitle%3DNat.%2520Methods%26date%3D2005%26volume%3D2%26spage%3D277%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery. A Guide for Medicinal Chemists and Pharmacologists</span>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery.+A+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery.%2520A%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><div class="note"><p class="first last">See <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><div class="note"><p class="first last">The crystallographic data described have been deposited with the RSCB Protein Data Bank (PDB code for <b>3g</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DOE">3DOE</a>).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+crystallographic+data+described+have+been+deposited+with+the+RSCB+Protein+Data+Bank+%28PDB+code+for+3g%3A+3DOE%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1o6k" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1o6k','PDB','1o6k'); return false;">PDB: 1o6k</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DOE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DOE','PDB','3DOE'); return false;">PDB: 3DOE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i95"><a href="/doi/suppl/10.1021/jm8004527">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_86747"></div></div></div></div></div><hr /></hr><p class="last">Results from the combustion analysis of test compounds and from the kinetic characterization of <b>3g</b> against AKT2 kinase. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8004527/suppl_file/jm8004527_si_001.pdf">jm8004527_si_001.pdf (100.99 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8004527&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-18%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm8004527%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8004527" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                886KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799cd629e2d32b5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
